[{"conversation_id":"554746106765402113","author_id":"116716199","entities":{"mentions":[{"start":0,"end":11,"username":"janvesseur","id":"161378850"},{"start":12,"end":25,"username":"inspire2live","id":"83431239"}],"urls":[{"start":111,"end":133,"url":"http://t.co/vMdNF8A4oN","expanded_url":"http://bit.ly/1DUHFHf","display_url":"bit.ly/1DUHFHf"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"@janvesseur @inspire2live It is not yet authorised, but if applied for it will have an accelerated assessment: http://t.co/vMdNF8A4oN","source":"TweetDeck","id":"555062677631156226","lang":"en","created_at":"2015-01-13T18:03:49.000Z","referenced_tweets":[{"type":"replied_to","id":"554746106765402113"}],"in_reply_to_user_id":"161378850","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554962678251532288","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":112,"end":134,"url":"http://t.co/U4BLpM1icJ","expanded_url":"http://bit.ly/1wanHXb","display_url":"bit.ly/1wanHXb"}],"hashtags":[{"start":24,"end":33,"tag":"guidance"},{"start":89,"end":100,"tag":"veterinary"},{"start":101,"end":110,"tag":"medicine"}],"annotations":{}},"possibly_sensitive":false,"text":"Two weeks to comment on #guidance on persistent, bioaccumulative and toxic substances in #veterinary #medicine: http://t.co/U4BLpM1icJ","source":"Bitly","id":"554962678251532288","lang":"en","created_at":"2015-01-13T11:26:27.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554941999179395072","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/pwSdqq1whQ","expanded_url":"http://bit.ly/1Il9ivQ","display_url":"bit.ly/1Il9ivQ"}],"hashtags":[{"start":18,"end":28,"tag":"guideline"},{"start":32,"end":43,"tag":"biosimilar"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published a #guideline on #biosimilar medicines containing biotechnology-derived proteins as active substance: http://t.co/pwSdqq1whQ","source":"TweetDeck","id":"554941999179395072","lang":"en","created_at":"2015-01-13T10:04:17.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":10,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554941939980967936","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/dS1NTOAWgU","expanded_url":"http://bit.ly/1y4JFMF","display_url":"bit.ly/1y4JFMF"}],"hashtags":[{"start":0,"end":18,"tag":"Pharmacovigilance"},{"start":78,"end":87,"tag":"ambroxol"},{"start":92,"end":103,"tag":"bromhexine"}],"annotations":{}},"possibly_sensitive":false,"text":"#Pharmacovigilance committee considers risk of severe allergic reactions with #ambroxol and #bromhexine to be small: http://t.co/dS1NTOAWgU","source":"TweetDeck","id":"554941939980967936","lang":"en","created_at":"2015-01-13T10:04:03.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":9,"reply_count":1,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554941813816315904","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":86,"end":108,"url":"http://t.co/obxVjLzvWE","expanded_url":"http://bit.ly/17ANNdm","display_url":"bit.ly/17ANNdm"}],"hashtags":[{"start":34,"end":44,"tag":"medicines"},{"start":49,"end":54,"tag":"rare"}],"annotations":{}},"possibly_sensitive":false,"text":"We recommended a record number of #medicines for #rare diseases for approval in 2014: http://t.co/obxVjLzvWE","source":"TweetDeck","id":"554941813816315904","lang":"en","created_at":"2015-01-13T10:03:33.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554941682865930240","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":83,"end":105,"url":"http://t.co/mgVFoMqwmk","expanded_url":"http://bit.ly/1BZluhw","display_url":"bit.ly/1BZluhw"}],"hashtags":[{"start":38,"end":56,"tag":"pharmacovigilance"}],"annotations":{}},"possibly_sensitive":false,"text":"Check the highlights from last week's #pharmacovigilance committee (PRAC) meeting: http://t.co/mgVFoMqwmk","source":"TweetDeck","id":"554941682865930240","lang":"en","created_at":"2015-01-13T10:03:02.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554694637559218176","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":86,"end":108,"url":"http://t.co/obxVjLzvWE","expanded_url":"http://bit.ly/17ANNdm","display_url":"bit.ly/17ANNdm"}],"hashtags":[{"start":34,"end":44,"tag":"medicines"},{"start":49,"end":54,"tag":"rare"}],"annotations":{}},"possibly_sensitive":false,"text":"We recommended a record number of #medicines for #rare diseases for approval in 2014: http://t.co/obxVjLzvWE","source":"Bitly","id":"554694637559218176","lang":"en","created_at":"2015-01-12T17:41:21.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":4,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554693955364085761","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/pwSdqq1whQ","expanded_url":"http://bit.ly/1Il9ivQ","display_url":"bit.ly/1Il9ivQ"}],"hashtags":[{"start":18,"end":28,"tag":"guideline"},{"start":32,"end":43,"tag":"biosimilar"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published a #guideline on #biosimilar medicines containing biotechnology-derived proteins as active substance: http://t.co/pwSdqq1whQ","source":"Bitly","id":"554693955364085761","lang":"en","created_at":"2015-01-12T17:38:39.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":3,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554691061864726528","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/dS1NTOAWgU","expanded_url":"http://bit.ly/1y4JFMF","display_url":"bit.ly/1y4JFMF"}],"hashtags":[{"start":0,"end":18,"tag":"Pharmacovigilance"},{"start":78,"end":87,"tag":"ambroxol"},{"start":92,"end":103,"tag":"bromhexine"}],"annotations":{}},"possibly_sensitive":false,"text":"#Pharmacovigilance committee considers risk of severe allergic reactions with #ambroxol and #bromhexine to be small: http://t.co/dS1NTOAWgU","source":"Bitly","id":"554691061864726528","lang":"en","created_at":"2015-01-12T17:27:09.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554690182390489089","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":93,"end":115,"url":"http://t.co/mgVFoMqwmk","expanded_url":"http://bit.ly/1BZluhw","display_url":"bit.ly/1BZluhw"}],"hashtags":[{"start":48,"end":66,"tag":"pharmacovigilance"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the highlights from last week's #pharmacovigilance committee (PRAC) meeting: http://t.co/mgVFoMqwmk","source":"Bitly","id":"554690182390489089","lang":"en","created_at":"2015-01-12T17:23:39.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554689851883520001","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":95,"end":117,"url":"http://t.co/do9Tk1K7U9","expanded_url":"http://bit.ly/1DFwhz4","display_url":"bit.ly/1DFwhz4"}],"hashtags":[{"start":29,"end":38,"tag":"Lynparza"},{"start":40,"end":49,"tag":"olaparib"},{"start":58,"end":67,"tag":"medicine"},{"start":77,"end":85,"tag":"ovarian"},{"start":86,"end":93,"tag":"cancer"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the EPAR for #Lynparza (#olaparib), a new #medicine to treat #ovarian #cancer: http://t.co/do9Tk1K7U9","source":"Twitter Web Client","id":"554689851883520001","lang":"en","created_at":"2015-01-12T17:22:20.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554689719255465984","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":79,"end":101,"url":"http://t.co/cFDK7GRFAk","expanded_url":"http://bit.ly/18SjN71","display_url":"bit.ly/18SjN71"}],"hashtags":[{"start":62,"end":68,"tag":"audit"},{"start":102,"end":114,"tag":"procurement"}],"annotations":{}},"possibly_sensitive":false,"text":"Two more weeks to answer our tender for provision of internal #audit services: http://t.co/cFDK7GRFAk #procurement","source":"Twitter Web Client","id":"554689719255465984","lang":"en","created_at":"2015-01-12T17:21:49.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554689589106212864","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":91,"end":113,"url":"http://t.co/sN3IxBNsHR","expanded_url":"http://bit.ly/1AAU30G","display_url":"bit.ly/1AAU30G"}],"hashtags":[{"start":4,"end":15,"tag":"veterinary"},{"start":16,"end":25,"tag":"medicine"}],"annotations":{}},"possibly_sensitive":false,"text":"Our #veterinary #medicine committee (CVMP) is meeting this week. Highlights out on Friday: http://t.co/sN3IxBNsHR","source":"Twitter Web Client","id":"554689589106212864","lang":"en","created_at":"2015-01-12T17:21:18.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554686578548019201","author_id":"116716199","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":121,"end":143,"url":"http://t.co/b1xAfJjDbg","expanded_url":"http://goo.gl/uSXsJv","display_url":"goo.gl/uSXsJv"}],"hashtags":[{"start":60,"end":66,"tag":"Ebola"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @WHO: WHO Executive Board will hold a special session on #Ebola on 25 Jan. Documents &amp; information available here http://t.co/b1xAfJjDbg…","source":"TweetDeck","id":"554686578548019201","lang":"en","created_at":"2015-01-12T17:09:20.000Z","referenced_tweets":[{"type":"retweeted","id":"554670791846281218"}],"public_metrics":{"retweet_count":88,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554686530233843712","author_id":"116716199","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":[{"start":62,"end":68,"tag":"EB136"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @WHO: From 26 Jan–3 Feb, WHO Executive Board will hold its #EB136 session. The documents to be discussed, available here http://t.co/Dus…","source":"TweetDeck","id":"554686530233843712","lang":"en","created_at":"2015-01-12T17:09:09.000Z","referenced_tweets":[{"type":"retweeted","id":"554669943120486401"}],"public_metrics":{"retweet_count":36,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554686313723863040","author_id":"116716199","entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"},{"start":122,"end":136,"username":"FierceBiotech","id":"18294197"}],"urls":[{"start":95,"end":117,"url":"http://t.co/v625XHlmRb","expanded_url":"http://ow.ly/HblVp","display_url":"ow.ly/HblVp","status":200,"unwound_url":"https://www.fiercebiotech.com/regulatory/fda-to-publish-guidance-on-social-media-and-clinical-trial-e-consent-2015"}],"hashtags":[{"start":45,"end":57,"tag":"socialmedia"}],"annotations":[{"start":18,"end":20,"probability":0.9184,"type":"Organization","normalized_text":"FDA"}]},"possibly_sensitive":false,"text":"RT @DrugInfoAssn: FDA to publish guidance on #socialmedia and clinical trial e-consent in 2015 http://t.co/v625XHlmRb via @FierceBiotech","source":"TweetDeck","id":"554686313723863040","lang":"en","created_at":"2015-01-12T17:08:17.000Z","referenced_tweets":[{"type":"retweeted","id":"554667483173748737"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554685973507112961","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"urls":{},"hashtags":[{"start":43,"end":53,"tag":"influenza"},{"start":63,"end":75,"tag":"vaccination"},{"start":117,"end":121,"tag":"flu"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @ECDC_Flu: Even with antigenic drift of #influenza viruses, #vaccination still offers the best protection against #flu http://t.co/PBvmH…","source":"TweetDeck","id":"554685973507112961","lang":"en","created_at":"2015-01-12T17:06:56.000Z","referenced_tweets":[{"type":"retweeted","id":"554662904663142402"}],"public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554685856716693504","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"urls":[{"start":108,"end":130,"url":"http://t.co/PBvmHtvtzX","expanded_url":"http://bit.ly/1AQPiAh","display_url":"bit.ly/1AQPiAh"}],"hashtags":[{"start":14,"end":24,"tag":"Influenza"},{"start":47,"end":54,"tag":"Europe"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @ECDC_Flu: #Influenza season has started in #Europe. So far, A(H3N2) is the dominant circulating strain: http://t.co/PBvmHtvtzX http://t…","source":"TweetDeck","id":"554685856716693504","lang":"en","created_at":"2015-01-12T17:06:28.000Z","referenced_tweets":[{"type":"retweeted","id":"554659715381477377"}],"public_metrics":{"retweet_count":47,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554685728983375872","author_id":"116716199","entities":{"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"urls":[{"start":68,"end":90,"url":"http://t.co/ACM800LRYc","expanded_url":"http://bit.ly/1BUmNjV","display_url":"bit.ly/1BUmNjV"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @INFARMED_IP: Ambroxol and bromhexine - completion of the review http://t.co/ACM800LRYc","source":"TweetDeck","id":"554685728983375872","lang":"en","created_at":"2015-01-12T17:05:58.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554685480487628800","author_id":"116716199","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @IMI_JU: Next IMI webinar is on Wed 14 Jan at 14:30 on IMI2 Call 3 'Patient-focused knowledge hub for medicine development' http://t.co/…","source":"TweetDeck","id":"554685480487628800","lang":"en","created_at":"2015-01-12T17:04:58.000Z","referenced_tweets":[{"type":"retweeted","id":"554654934709575682"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554684557849792512","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"EuropaBio","id":"19642657"},{"start":15,"end":24,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":95,"end":108,"tag":"rarediseases"},{"start":109,"end":121,"tag":"orphandrugs"},{"start":122,"end":131,"tag":"biotech4"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EuropaBio: @EMA_News 1 in 2 medicines contains active substance never used in medicines b4 #rarediseases #orphandrugs #biotech4…https:/…","source":"TweetDeck","id":"554684557849792512","lang":"en","created_at":"2015-01-12T17:01:18.000Z","referenced_tweets":[{"type":"retweeted","id":"554637624640413698"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554684544633552896","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"EuropaBio","id":"19642657"},{"start":15,"end":24,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":95,"end":107,"tag":"rardiseases"},{"start":108,"end":120,"tag":"orphandrugs"},{"start":121,"end":131,"tag":"biotech4l"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EuropaBio: @EMA_News 1 in 2 medicines contains active substance never used in medicines b4 #rardiseases #orphandrugs #biotech4l…https:/…","source":"TweetDeck","id":"554684544633552896","lang":"en","created_at":"2015-01-12T17:01:15.000Z","referenced_tweets":[{"type":"retweeted","id":"554637508206526464"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554684402585075712","author_id":"116716199","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":123,"end":132,"username":"euhealth","id":"241171868"}],"urls":[{"start":100,"end":122,"url":"http://t.co/UmDdoqljTb","expanded_url":"http://goo.gl/T3vSVC","display_url":"goo.gl/T3vSVC"}],"hashtags":{},"annotations":[{"start":15,"end":16,"probability":0.6752,"type":"Organization","normalized_text":"EU"}]},"possibly_sensitive":false,"text":"RT @EFPIA: The EU's pharmaceutical committee is establishing an expert group – to be known as STAMP http://t.co/UmDdoqljTb @EUhealth","source":"TweetDeck","id":"554684402585075712","lang":"en","created_at":"2015-01-12T17:00:41.000Z","referenced_tweets":[{"type":"retweeted","id":"554644433090932738"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554684190827249664","author_id":"116716199","entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"urls":[{"start":97,"end":119,"url":"http://t.co/Icpze22k5X","expanded_url":"http://bit.ly/1yM6AcQ","display_url":"bit.ly/1yM6AcQ"}],"hashtags":[{"start":17,"end":26,"tag":"Generics"},{"start":120,"end":132,"tag":"EGAgenerics"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @egagenerics: #Generics can be marketed after the patent for their branded equivalent expires http://t.co/Icpze22k5X #EGAgenerics","source":"TweetDeck","id":"554684190827249664","lang":"en","created_at":"2015-01-12T16:59:51.000Z","referenced_tweets":[{"type":"retweeted","id":"554638942629138433"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554683754095316992","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":116,"end":138,"url":"http://t.co/YDoaLGQMgg","expanded_url":"http://bit.ly/1BUldOY","display_url":"bit.ly/1BUldOY"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @URPLWMiPB: The Polish medicines agency has published a newsletter on medicines for the month of December 2014. \nhttp://t.co/YDoaLGQMgg","source":"TweetDeck","id":"554683754095316992","lang":"en","created_at":"2015-01-12T16:58:07.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554683656451948544","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":113,"end":135,"url":"http://t.co/rEqaw9uSkW","expanded_url":"http://bit.ly/1wPXTN0","display_url":"bit.ly/1wPXTN0"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @GCessak: The Polish medicines agency has published a newsletter on medicines for the month of December 2014. http://t.co/rEqaw9uSkW","source":"TweetDeck","id":"554683656451948544","lang":"en","created_at":"2015-01-12T16:57:43.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554683027046268928","author_id":"116716199","entities":{"mentions":[{"start":3,"end":14,"username":"ZVALatvija","id":"1576993495"}],"urls":[{"start":95,"end":117,"url":"http://t.co/7yrTnQxIUJ","expanded_url":"http://bit.ly/1BUkDkj","display_url":"bit.ly/1BUkDkj"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @ZVALatvija: Last year, the the highest number of orphan medicines was licensed. Read more: http://t.co/7yrTnQxIUJ","source":"TweetDeck","id":"554683027046268928","lang":"en","created_at":"2015-01-12T16:55:13.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554613802462085120","author_id":"116716199","entities":{"mentions":[{"start":3,"end":16,"username":"EuropeanLung","id":"121759520"}],"urls":[{"start":78,"end":100,"url":"http://t.co/AKvocp6NVG","expanded_url":"http://bit.ly/1APOyLJ","display_url":"bit.ly/1APOyLJ"}],"hashtags":[{"start":28,"end":37,"tag":"vaccines"},{"start":63,"end":68,"tag":"lung"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EuropeanLung: Inhalable #vaccines could be used to prevent #lung diseases http://t.co/AKvocp6NVG","source":"TweetDeck","id":"554613802462085120","lang":"en","created_at":"2015-01-12T12:20:09.000Z","referenced_tweets":[{"type":"retweeted","id":"554594136133992448"}],"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554613679636103168","author_id":"116716199","entities":{"mentions":[{"start":20,"end":34,"username":"EU_Commission","id":"157981564"}],"urls":{},"hashtags":[{"start":95,"end":106,"tag":"Biosimilar"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @egabiosimilars: @EU_Commission Consensus Information Document: What you need to know about #Biosimilar Medicinal Products http://t.co/B…","source":"TweetDeck","id":"554613679636103168","lang":"en","created_at":"2015-01-12T12:19:40.000Z","referenced_tweets":[{"type":"retweeted","id":"554593644531838976"}],"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554613506163884032","author_id":"116716199","entities":{"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"urls":[{"start":84,"end":106,"url":"http://t.co/43gToN9uYQ","expanded_url":"http://bit.ly/1wODic2","display_url":"bit.ly/1wODic2"}],"hashtags":[{"start":49,"end":55,"tag":"Ebola"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @WHO_Europe: Full press briefing on status of #Ebola vaccine development so far: http://t.co/43gToN9uYQ","source":"TweetDeck","id":"554613506163884032","lang":"en","created_at":"2015-01-12T12:18:58.000Z","referenced_tweets":[{"type":"retweeted","id":"554589195273265152"}],"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554612858466877441","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":15,"end":19,"tag":"CoE"},{"start":31,"end":41,"tag":"medicrime"}],"annotations":[{"start":116,"end":128,"probability":0.4452,"type":"Organization","normalized_text":"French Senate"}]},"possibly_sensitive":false,"text":"RT @edqm_news: #CoE Convention #medicrime: a draft bill authorizing its ratification was presented last week to the French Senate https://t…","source":"TweetDeck","id":"554612858466877441","lang":"en","created_at":"2015-01-12T12:16:24.000Z","referenced_tweets":[{"type":"retweeted","id":"554567727026020352"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554612778980630528","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":{},"hashtags":[{"start":79,"end":88,"tag":"research"},{"start":101,"end":113,"tag":"RareDisease"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @eurordis: 7th E-Rare Joint Transnational Call for funding for multilateral #research projects on #RareDisease is now open! http://t.co/…","source":"TweetDeck","id":"554612778980630528","lang":"en","created_at":"2015-01-12T12:16:05.000Z","referenced_tweets":[{"type":"retweeted","id":"554567317515169792"}],"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"554612578849423360","author_id":"116716199","entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":110,"end":132,"url":"http://t.co/xrViCHwQDa","expanded_url":"http://bit.ly/1AHI0fB","display_url":"bit.ly/1AHI0fB"}],"hashtags":[{"start":95,"end":109,"tag":"AIFAEditorial"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @Aifa_ufficiale: “Cut-and-paste molecular”: new hope for cures from genetic editing? (part) #AIFAEditorial http://t.co/xrViCHwQDa","source":"TweetDeck","id":"554612578849423360","lang":"en","created_at":"2015-01-12T12:15:17.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"553570870648922112","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":79,"end":101,"url":"http://t.co/cFDK7GRFAk","expanded_url":"http://bit.ly/18SjN71","display_url":"bit.ly/18SjN71"}],"hashtags":[{"start":62,"end":68,"tag":"audit"},{"start":102,"end":114,"tag":"procurement"}],"annotations":{}},"possibly_sensitive":false,"text":"Two weeks left to answer our tender for provision of internal #audit services: http://t.co/cFDK7GRFAk #procurement","source":"Bitly","id":"553570870648922112","lang":"en","created_at":"2015-01-09T15:15:55.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"553570456004231168","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":93,"end":115,"url":"http://t.co/sN3IxBNsHR","expanded_url":"http://bit.ly/1AAU30G","display_url":"bit.ly/1AAU30G"}],"hashtags":[{"start":18,"end":29,"tag":"veterinary"},{"start":30,"end":40,"tag":"medicines"}],"annotations":{}},"possibly_sensitive":false,"text":"Our committee for #veterinary #medicines (CVMP) meets next week. Highlights out next Friday: http://t.co/sN3IxBNsHR","source":"Bitly","id":"553570456004231168","lang":"en","created_at":"2015-01-09T15:14:16.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"553538003432652800","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":79,"end":101,"url":"http://t.co/8IvsBefJ1e","expanded_url":"http://bit.ly/1IydIh4","display_url":"bit.ly/1IydIh4"}],"hashtags":{},"annotations":[{"start":0,"end":10,"probability":0.6415,"type":"Organization","normalized_text":"EU Agencies"}]},"possibly_sensitive":false,"text":"EU Agencies express full solidarity with victims of attack on French magazine: http://t.co/8IvsBefJ1e","source":"Bitly","id":"553538003432652800","lang":"en","created_at":"2015-01-09T13:05:18.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":16,"reply_count":0,"like_count":7,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"553532352656596992","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"}],"urls":[{"start":109,"end":131,"url":"http://t.co/uEeq51agzf","expanded_url":"http://ow.ly/H2Mm2","display_url":"ow.ly/H2Mm2"}],"hashtags":[{"start":71,"end":77,"tag":"H2020"},{"start":78,"end":92,"tag":"SMEinstrument"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EU_H2020: 78 SMEs in 18 countries to receive up to €2.5 million -  #H2020 #SMEinstrument phase 2 cut-off http://t.co/uEeq51agzf http://…","source":"TweetDeck","id":"553532352656596992","lang":"en","created_at":"2015-01-09T12:42:51.000Z","referenced_tweets":[{"type":"retweeted","id":"553512920374841344"}],"public_metrics":{"retweet_count":77,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"553531977048293376","author_id":"116716199","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":[{"start":19,"end":25,"tag":"Ebola"},{"start":91,"end":98,"tag":"Guinea"},{"start":99,"end":107,"tag":"Liberia"},{"start":108,"end":120,"tag":"SierraLeone"}],"annotations":[{"start":9,"end":16,"probability":0.836,"type":"Person","normalized_text":"Dr Kieny"}]},"possibly_sensitive":false,"text":"RT @WHO: Dr Kieny: #Ebola vaccine Phase 3 testing will start end of January or in February #Guinea #Liberia #SierraLeone","source":"TweetDeck","id":"553531977048293376","lang":"en","created_at":"2015-01-09T12:41:22.000Z","referenced_tweets":[{"type":"retweeted","id":"553523014328147972"}],"public_metrics":{"retweet_count":165,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"553519943149682688","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/do9Tk1K7U9","expanded_url":"http://bit.ly/1DFwhz4","display_url":"bit.ly/1DFwhz4"}],"hashtags":[{"start":42,"end":51,"tag":"Lynparza"},{"start":53,"end":62,"tag":"olaparib"},{"start":67,"end":76,"tag":"medicine"},{"start":86,"end":94,"tag":"ovarian"},{"start":95,"end":102,"tag":"cancer"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the assessment report for #Lynparza (#olaparib), a #medicine to treat #ovarian #cancer: http://t.co/do9Tk1K7U9","source":"Bitly","id":"553519943149682688","lang":"en","created_at":"2015-01-09T11:53:33.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"553519565200961536","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/TzxxC2Ba1B","expanded_url":"http://bit.ly/1xUYpzk","display_url":"bit.ly/1xUYpzk"}],"hashtags":[{"start":29,"end":38,"tag":"Vargatef"},{"start":40,"end":51,"tag":"nintedanib"},{"start":56,"end":65,"tag":"medicine"},{"start":95,"end":102,"tag":"cancer"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the EPAR for #Vargatef (#nintedanib), a #medicine to treat non-small cell lung #cancer:\nhttp://t.co/TzxxC2Ba1B","source":"TweetDeck","id":"553519565200961536","lang":"en","created_at":"2015-01-09T11:52:02.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"553160693718188032","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/TzxxC2Ba1B","expanded_url":"http://bit.ly/1xUYpzk","display_url":"bit.ly/1xUYpzk"}],"hashtags":[{"start":42,"end":51,"tag":"Vargatef"},{"start":53,"end":64,"tag":"nintedanib"},{"start":69,"end":78,"tag":"medicine"},{"start":108,"end":115,"tag":"cancer"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the assessment report for #Vargatef (#nintedanib), a #medicine to treat non-small cell lung #cancer:\nhttp://t.co/TzxxC2Ba1B","source":"Bitly","id":"553160693718188032","lang":"en","created_at":"2015-01-08T12:06:01.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"553149511951208448","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"hashtags":{},"annotations":[{"start":61,"end":64,"probability":0.5475,"type":"Organization","normalized_text":"ECDC"}]},"possibly_sensitive":false,"text":"RT @ECDC_EU: New year, new job? Current job opportunities at ECDC include Enterprise Architect, ICT Programme Management Officer  http://t.…","source":"TweetDeck","id":"553149511951208448","lang":"en","created_at":"2015-01-08T11:21:35.000Z","referenced_tweets":[{"type":"retweeted","id":"552864096639795200"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"553149443412078592","author_id":"116716199","entities":{"mentions":[{"start":3,"end":9,"username":"EATGx","id":"273916420"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @EATGx: EATG AVAC meeting on new developments in prevention: EATG in collaboration with AVAC is organizing a multistak... http://t.co/zF…","source":"TweetDeck","id":"553149443412078592","lang":"en","created_at":"2015-01-08T11:21:18.000Z","referenced_tweets":[{"type":"retweeted","id":"552875112144203776"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"553149329079545857","author_id":"116716199","entities":{"mentions":[{"start":3,"end":10,"username":"Uroweb","id":"114455333"}],"urls":[{"start":112,"end":135,"url":"https://t.co/b2ws5vGYFP","expanded_url":"https://www.surveymonkey.com/s/63QCXY3","display_url":"surveymonkey.com/s/63QCXY3"}],"hashtags":[{"start":59,"end":73,"tag":"BladderCancer"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @Uroweb: Please take a moment to complete our survey on #BladderCancer prevention. Your views are important! https://t.co/b2ws5vGYFP","source":"TweetDeck","id":"553149329079545857","lang":"en","created_at":"2015-01-08T11:20:51.000Z","referenced_tweets":[{"type":"retweeted","id":"552919996343791617"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"553149172330029056","author_id":"116716199","entities":{"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"},{"start":20,"end":24,"username":"WHO","id":"14499829"}],"urls":[{"start":107,"end":129,"url":"http://t.co/KdEeoEzyTG","expanded_url":"http://bit.ly/1HP4mPB","display_url":"bit.ly/1HP4mPB"}],"hashtags":[{"start":63,"end":69,"tag":"Ebola"},{"start":70,"end":79,"tag":"vaccines"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @WHO_Europe_VPI: @WHO convenes second high-level meeting on #Ebola #vaccines access and financing today http://t.co/KdEeoEzyTG","source":"TweetDeck","id":"553149172330029056","lang":"en","created_at":"2015-01-08T11:20:14.000Z","referenced_tweets":[{"type":"retweeted","id":"553093558513590272"}],"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"553148896126705664","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"beuctweet","id":"3061421219"},{"start":119,"end":132,"username":"HealthandEnv","id":"89134471"}],"urls":{},"hashtags":[{"start":35,"end":38,"tag":"EP"},{"start":92,"end":102,"tag":"endocrine"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @beuctweet: Important debate in #EP about cancer prevention through better regulation of #endocrine disruptors. via @HealthandEnv http:/…","source":"TweetDeck","id":"553148896126705664","lang":"en","created_at":"2015-01-08T11:19:08.000Z","referenced_tweets":[{"type":"retweeted","id":"553118803882950656"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"553148792388997121","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":65,"end":71,"tag":"Pheur"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @edqm_news: Did you see it? Rapid implementation of corrected #Pheur monograh on Human antithrombin III concentrate (0878) http://t.co/1…","source":"TweetDeck","id":"553148792388997121","lang":"en","created_at":"2015-01-08T11:18:43.000Z","referenced_tweets":[{"type":"retweeted","id":"553126865733693440"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"553148695127289856","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"urls":[{"start":104,"end":126,"url":"http://t.co/kcVe0iFBBP","expanded_url":"http://www.eahp.eu/press-room/new-year-appeal-europe-make-2015-year-action-amr","display_url":"eahp.eu/press-room/new…"}],"hashtags":[{"start":79,"end":103,"tag":"antimicrobialresistance"},{"start":127,"end":131,"tag":"amr"}],"annotations":[{"start":41,"end":46,"probability":0.9856,"type":"Place","normalized_text":"Europe"}]},"possibly_sensitive":false,"text":"RT @EAHPtweet: EAHP's New Year appeal to Europe: Make 2015 a year of action on #antimicrobialresistance http://t.co/kcVe0iFBBP #amr #antibi…","source":"TweetDeck","id":"553148695127289856","lang":"en","created_at":"2015-01-08T11:18:20.000Z","referenced_tweets":[{"type":"retweeted","id":"553131338484576258"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"553148615519371265","author_id":"116716199","entities":{"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"}],"urls":{},"hashtags":{},"annotations":[{"start":39,"end":89,"probability":0.3581,"type":"Other","normalized_text":"ESE ENDO International Endocrine Scholars Programme"}]},"possibly_sensitive":false,"text":"RT @ESEndocrinology: Deadline for 2015 ESE ENDO International Endocrine Scholars Programme (IESP) is fast approaching 15 Jan 2015: http://t…","source":"TweetDeck","id":"553148615519371265","lang":"en","created_at":"2015-01-08T11:18:01.000Z","referenced_tweets":[{"type":"retweeted","id":"553132782118268928"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"553148492558790656","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"urls":[{"start":92,"end":114,"url":"http://t.co/cLSUW5duDg","expanded_url":"http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON498561","display_url":"mhra.gov.uk/NewsCentre/Pre…"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @MHRApress: More than 1,600 websites closed in battle against illegal trade in medicines http://t.co/cLSUW5duDg","source":"TweetDeck","id":"553148492558790656","lang":"en","created_at":"2015-01-08T11:17:32.000Z","referenced_tweets":[{"type":"retweeted","id":"553139404500631552"}],"public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"553148461517135872","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":[{"start":92,"end":114,"url":"http://t.co/2R474jsfvG","expanded_url":"http://bit.ly/1Dp1RUe","display_url":"bit.ly/1Dp1RUe"}],"hashtags":[{"start":52,"end":57,"tag":"EDQM"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @edqm_news: 2014 was an anniversary year for the #EDQM. Read the highlights of the year: http://t.co/2R474jsfvG","source":"TweetDeck","id":"553148461517135872","lang":"en","created_at":"2015-01-08T11:17:24.000Z","referenced_tweets":[{"type":"retweeted","id":"553139486314733568"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552855266107338753","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @edqm_news: New General Chapter on ‘Alternative Methods for Control of Microbiological Quality (5.1.6)’ released for comment http://t.co…","source":"TweetDeck","id":"552855266107338753","lang":"en","created_at":"2015-01-07T15:52:21.000Z","referenced_tweets":[{"type":"retweeted","id":"552817208213397505"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552855099312447488","author_id":"116716199","entities":{"mentions":[{"start":3,"end":18,"username":"PrimaryCare4um","id":"164835748"},{"start":88,"end":98,"username":"HealthFdn","id":"130108575"},{"start":122,"end":130,"username":"YouTube","id":"10228272"}],"urls":[{"start":99,"end":121,"url":"http://t.co/9SVDsob9d1","expanded_url":"http://youtu.be/ZuPuNuxUaHY","display_url":"youtu.be/ZuPuNuxUaHY"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @PrimaryCare4um: Introduction to Quality Improvement Learning Webinars, starting 9/1 @HealthFdn http://t.co/9SVDsob9d1 @YouTube @nsiriwa…","source":"TweetDeck","id":"552855099312447488","lang":"en","created_at":"2015-01-07T15:51:41.000Z","referenced_tweets":[{"type":"retweeted","id":"552826809151025152"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552854991195889666","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"EUTenders","id":"294046348"}],"urls":{},"hashtags":[{"start":67,"end":85,"tag":"PublicProcurement"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EUTenders: Need to refresh rules, thresholds and guidelines on #PublicProcurement in the EU? Check here all you need to know http://t.c…","source":"TweetDeck","id":"552854991195889666","lang":"en","created_at":"2015-01-07T15:51:16.000Z","referenced_tweets":[{"type":"retweeted","id":"552830820676042754"}],"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552852847990407168","author_id":"116716199","entities":{"mentions":[{"start":3,"end":18,"username":"EP_BudgControl","id":"1221108739"},{"start":75,"end":90,"username":"EP_BudgControl","id":"1221108739"}],"urls":{},"hashtags":[{"start":20,"end":30,"tag":"Discharge"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EP_BudgControl: #Discharge: how was EU money spent in R&amp;D in 2013? @EP_BudgControl discussion tmrw from 9am. Full agenda, info here: ht…","source":"TweetDeck","id":"552852847990407168","lang":"en","created_at":"2015-01-07T15:42:45.000Z","referenced_tweets":[{"type":"retweeted","id":"552852157146603520"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552802423161778176","author_id":"116716199","entities":{"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"}],"urls":[{"start":106,"end":128,"url":"http://t.co/ccpOY5DJ3g","expanded_url":"http://bit.ly/1JeVyUx","display_url":"bit.ly/1JeVyUx"}],"hashtags":[{"start":129,"end":140,"tag":"healthcare"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @IAPOtweets: Job alert: we're recruiting a new Operations Director. Deadline is 12 January. More here: http://t.co/ccpOY5DJ3g #healthcare","source":"TweetDeck","id":"552802423161778176","lang":"en","created_at":"2015-01-07T12:22:22.000Z","referenced_tweets":[{"type":"retweeted","id":"552797861776486400"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552802396746039297","author_id":"116716199","entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":76,"end":98,"url":"http://t.co/p11qj6C7ec","expanded_url":"http://1.usa.gov/1xRduBW","display_url":"1.usa.gov/1xRduBW"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @FDAanimalhealth: Animal Drug Approvals January 2015 Update (Green Book) http://t.co/p11qj6C7ec","source":"TweetDeck","id":"552802396746039297","lang":"en","created_at":"2015-01-07T12:22:16.000Z","referenced_tweets":[{"type":"retweeted","id":"552798801925525504"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552802365351665664","author_id":"116716199","entities":{"mentions":[{"start":3,"end":17,"username":"FDADeviceInfo","id":"140427956"}],"urls":[{"start":93,"end":115,"url":"http://t.co/7uF9YbccYK","expanded_url":"http://1.usa.gov/1xRor6n","display_url":"1.usa.gov/1xRor6n"}],"hashtags":[{"start":19,"end":23,"tag":"FDA"},{"start":72,"end":76,"tag":"flu"},{"start":116,"end":130,"tag":"medicaldevice"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @FDADeviceInfo: #FDA grants first CLIA waiver for nucleic acid-based #flu diagnostic test http://t.co/7uF9YbccYK #medicaldevice","source":"TweetDeck","id":"552802365351665664","lang":"en","created_at":"2015-01-07T12:22:09.000Z","referenced_tweets":[{"type":"retweeted","id":"552801615716290560"}],"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552777955022495744","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":103,"end":125,"url":"http://t.co/S5fEGiEsFW","expanded_url":"http://bit.ly/1wWasd8","display_url":"bit.ly/1wWasd8"}],"hashtags":[{"start":13,"end":21,"tag":"Vacancy"},{"start":97,"end":102,"tag":"EFSA"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EFSA_EU: #Vacancy - Call for Head of Risk Assessment and Scientific Assistance Department at #EFSA http://t.co/S5fEGiEsFW","source":"TweetDeck","id":"552777955022495744","lang":"en","created_at":"2015-01-07T10:45:09.000Z","referenced_tweets":[{"type":"retweeted","id":"552765807588311040"}],"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552777884914700289","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":54,"end":63,"username":"eu2015lv","id":"3217949032"}],"urls":[{"start":109,"end":132,"url":"https://t.co/NR8uLcRhdq","expanded_url":"https://eu2015.lv/the-presidency-and-eu/priorities-of-the-latvian-presidency","display_url":"eu2015.lv/the-presidency…"}],"hashtags":[{"start":90,"end":97,"tag":"health"},{"start":99,"end":108,"tag":"eu2015lv"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EU_Health: Priorities &amp; 6 months Programme of @eu2015lv published - what focus in #health? #eu2015lv https://t.co/NR8uLcRhdq http://t.c…","source":"TweetDeck","id":"552777884914700289","lang":"en","created_at":"2015-01-07T10:44:52.000Z","referenced_tweets":[{"type":"retweeted","id":"552766695279165440"}],"public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552777649807171585","author_id":"116716199","entities":{"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"}],"urls":[{"start":103,"end":125,"url":"http://t.co/SMBft5aEE0","expanded_url":"http://www.flunewseurope.org","display_url":"flunewseurope.org"}],"hashtags":[{"start":24,"end":34,"tag":"influenza"},{"start":86,"end":90,"tag":"Flu"}],"annotations":[{"start":45,"end":50,"probability":0.9971,"type":"Place","normalized_text":"Europe"},{"start":96,"end":101,"probability":0.5089,"type":"Place","normalized_text":"Europe"}]},"possibly_sensitive":false,"text":"RT @WHO_Europe_VPI: The #influenza season in Europe is underway. Stay updated through #Flu News Europe\nhttp://t.co/SMBft5aEE0","source":"TweetDeck","id":"552777649807171585","lang":"en","created_at":"2015-01-07T10:43:56.000Z","referenced_tweets":[{"type":"retweeted","id":"551049256241729536"}],"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552757728926777344","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":90,"end":112,"url":"http://t.co/vAfVZBLeMf","expanded_url":"http://bit.ly/14iQTAB","display_url":"bit.ly/14iQTAB"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":35,"end":53,"tag":"pharmacovigilance"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the #agenda of our #pharmacovigilance committee (PRAC) meeting this week: http://t.co/vAfVZBLeMf","source":"TweetDeck","id":"552757728926777344","lang":"en","created_at":"2015-01-07T09:24:46.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552757487947223040","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":95,"end":117,"url":"http://t.co/uL0EpbWT3n","expanded_url":"http://bit.ly/1Amd72q","display_url":"bit.ly/1Amd72q"}],"hashtags":[{"start":19,"end":29,"tag":"guideline"},{"start":59,"end":66,"tag":"plasma"},{"start":118,"end":131,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"Comment on a draft #guideline on clinical investigation of #plasma-derived factor IX products: http://t.co/uL0EpbWT3n #consultation","source":"TweetDeck","id":"552757487947223040","lang":"en","created_at":"2015-01-07T09:23:49.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552542561341300738","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":93,"end":115,"url":"http://t.co/vAfVZBLeMf","expanded_url":"http://bit.ly/14iQTAB","display_url":"bit.ly/14iQTAB"}],"hashtags":[{"start":25,"end":32,"tag":"agenda"},{"start":48,"end":66,"tag":"pharmacovigilance"}],"annotations":{}},"possibly_sensitive":false,"text":"We've just published the #agenda of this week's #pharmacovigilance committee (PRAC) meeting: http://t.co/vAfVZBLeMf","source":"Bitly","id":"552542561341300738","lang":"en","created_at":"2015-01-06T19:09:47.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552517896157794305","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":95,"end":117,"url":"http://t.co/KO1wHCnNDo","expanded_url":"http://bit.ly/1x4NlhU","display_url":"bit.ly/1x4NlhU"},{"start":118,"end":140,"url":"http://t.co/FXzZbMnMPo","expanded_url":"https://twitter.com/EFSA_EU/status/552506940153413633/photo/1","display_url":"pic.twitter.com/FXzZbMnMPo"}],"hashtags":[{"start":30,"end":35,"tag":"cows"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EFSA_EU: Welfare of dairy #cows in small scale farms.Take part in the public consultation! http://t.co/KO1wHCnNDo http://t.co/FXzZbMnMPo","source":"TweetDeck","id":"552517896157794305","lang":"en","created_at":"2015-01-06T17:31:46.000Z","referenced_tweets":[{"type":"retweeted","id":"552506940153413633"}],"public_metrics":{"retweet_count":25,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_552506938685411330"]}},{"conversation_id":"552517583313043456","author_id":"116716199","entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"},{"start":102,"end":117,"username":"BioSpectrumMag","id":"854491902367891456"}],"urls":[{"start":75,"end":97,"url":"http://t.co/x7UHrGAezG","expanded_url":"http://ow.ly/GRZOn","display_url":"ow.ly/GRZOn"}],"hashtags":[{"start":58,"end":65,"tag":"dengue"},{"start":66,"end":74,"tag":"vaccine"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @DrugInfoAssn: Discovery of new antibody could lead to #dengue #vaccine http://t.co/x7UHrGAezG via @BioSpectrumMag","source":"TweetDeck","id":"552517583313043456","lang":"en","created_at":"2015-01-06T17:30:31.000Z","referenced_tweets":[{"type":"retweeted","id":"552498636152897536"}],"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552516471931551744","author_id":"116716199","entities":{"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"},{"start":47,"end":61,"username":"EU_Commission","id":"157981564"},{"start":113,"end":123,"username":"EU_Health","id":"606325697"},{"start":124,"end":132,"username":"Food_EU","id":"2874880006"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @EFA_Patients: New organisational chart of  @EU_Commission Directorate General Health and Food Safety (SANTE) @EU_Health @Food_EU http:/…","source":"TweetDeck","id":"552516471931551744","lang":"en","created_at":"2015-01-06T17:26:06.000Z","referenced_tweets":[{"type":"retweeted","id":"552491841493692416"}],"public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552515662040825857","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":47,"end":59,"tag":"herbaldrugs"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @edqm_news: New General Chapter on HPTLC in #herbaldrugs and herbal drug preparations (2.8.25) released for comment http://t.co/JX3mO7Q2…","source":"TweetDeck","id":"552515662040825857","lang":"en","created_at":"2015-01-06T17:22:53.000Z","referenced_tweets":[{"type":"retweeted","id":"552484227749793794"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552515538749239296","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":[{"start":114,"end":136,"url":"http://t.co/vE8BBhcgEh","expanded_url":"http://europa.eu/!Tt38dR","display_url":"europa.eu/!Tt38dR"}],"hashtags":{},"annotations":[{"start":26,"end":33,"probability":0.3668,"type":"Person","normalized_text":"DG SANTE"}]},"possibly_sensitive":false,"text":"RT @EU_Health: We are now DG SANTE. Here are the email addresses where you can contact our Scientific Committees: http://t.co/vE8BBhcgEh","source":"TweetDeck","id":"552515538749239296","lang":"en","created_at":"2015-01-06T17:22:24.000Z","referenced_tweets":[{"type":"retweeted","id":"552476736508932096"}],"public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552515367802003456","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"urls":[{"start":102,"end":124,"url":"http://t.co/H5XjHDXUkE","expanded_url":"http://ow.ly/GRJn8","display_url":"ow.ly/GRJn8"}],"hashtags":[{"start":125,"end":132,"tag":"GMDP15"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @MHRApress: Latest Orange and Green Guides out now for manufacturers and distributors of medicines http://t.co/H5XjHDXUkE #GMDP15 http:/…","source":"TweetDeck","id":"552515367802003456","lang":"en","created_at":"2015-01-06T17:21:43.000Z","referenced_tweets":[{"type":"retweeted","id":"552474557014376449"}],"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552503904748179456","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/uL0EpbWT3n","expanded_url":"http://bit.ly/1Amd72q","display_url":"bit.ly/1Amd72q"}],"hashtags":[{"start":17,"end":27,"tag":"guideline"},{"start":57,"end":69,"tag":"recombinant"},{"start":80,"end":87,"tag":"plasma"}],"annotations":{}},"possibly_sensitive":false,"text":"Comment on draft #guideline on clinical investigation of #recombinant and human #plasma-derived factor IX products: http://t.co/uL0EpbWT3n","source":"Bitly","id":"552503904748179456","lang":"en","created_at":"2015-01-06T16:36:10.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":1,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552451860846895105","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"nice_intl","id":"794424916133056512"}],"urls":[{"start":68,"end":90,"url":"http://t.co/Aj7Rp6xTL6","expanded_url":"http://www.rand.org/pubs/research_reports/RR899.html","display_url":"rand.org/pubs/research_…"}],"hashtags":{},"annotations":[{"start":91,"end":92,"probability":0.9503,"type":"Place","normalized_text":"UK"}]},"possibly_sensitive":false,"text":"RT @nice_intl: International variation in drug use multi-factorial: http://t.co/Aj7Rp6xTL6 UK within 10% of international average for 8 in …","source":"TweetDeck","id":"552451860846895105","lang":"en","created_at":"2015-01-06T13:09:22.000Z","referenced_tweets":[{"type":"retweeted","id":"552450557177520128"}],"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552439818345779200","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"urls":{},"hashtags":[{"start":83,"end":95,"tag":"biosimilars"}],"annotations":[{"start":113,"end":115,"probability":0.4834,"type":"Organization","normalized_text":"NHS"}]},"possibly_sensitive":false,"text":"RT @NICEcomms: NICE has new updated methods for providing guidance &amp; advice on #biosimilars, as their use on the NHS grows: http://t.co/1MR…","source":"TweetDeck","id":"552439818345779200","lang":"en","created_at":"2015-01-06T12:21:31.000Z","referenced_tweets":[{"type":"retweeted","id":"552439360063541248"}],"public_metrics":{"retweet_count":21,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552431123020931072","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":[{"start":86,"end":108,"url":"http://t.co/JX3mO7Q2oq","expanded_url":"http://bit.ly/1zQp0Zf","display_url":"bit.ly/1zQp0Zf"}],"hashtags":[{"start":109,"end":118,"tag":"european"},{"start":119,"end":133,"tag":"pharmacopoeia"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @edqm_news: Pharmeuropa Issue 27.1  is complete - a great start to the year 2015 ! http://t.co/JX3mO7Q2oq #european #pharmacopoeia","source":"TweetDeck","id":"552431123020931072","lang":"en","created_at":"2015-01-06T11:46:58.000Z","referenced_tweets":[{"type":"retweeted","id":"552406659092742147"}],"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552430527622676480","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @URPLWMiPB: Please be kindly informed that the office is closed today (and will re-open at 08:00 on Tomorow )","source":"TweetDeck","id":"552430527622676480","lang":"en","created_at":"2015-01-06T11:44:36.000Z","referenced_tweets":[{"type":"retweeted","id":"552391523309219840"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552136769349898241","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"urls":{},"hashtags":[{"start":57,"end":70,"tag":"HappyNewYear"},{"start":97,"end":102,"tag":"EJHP"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EAHPtweet: We would like to wish all our followers a #HappyNewYear.The latest edition of the #EJHP is a great start to 2015!\n\nhttp://t.…","source":"TweetDeck","id":"552136769349898241","lang":"en","created_at":"2015-01-05T16:17:18.000Z","referenced_tweets":[{"type":"retweeted","id":"552095993295282176"}],"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552136687145730049","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @FDA_MCMi: Jan. 8-9: Public Workshop - Framework for Regulatory Oversight of Laboratory Developed Tests (LDTs) +webcast http://t.co/0xFM…","source":"TweetDeck","id":"552136687145730049","lang":"en","created_at":"2015-01-05T16:16:59.000Z","referenced_tweets":[{"type":"retweeted","id":"552098943681966081"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552136636642119680","author_id":"116716199","entities":{"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"urls":[{"start":100,"end":122,"url":"http://t.co/km3TmA0NgX","expanded_url":"http://ow.ly/GNUN9","display_url":"ow.ly/GNUN9"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @EU_eHealth: Conference 'Supporting Health by Technology VI' (22 May '15), submissions welcome - http://t.co/km3TmA0NgX @HealthByTech15 …","source":"TweetDeck","id":"552136636642119680","lang":"en","created_at":"2015-01-05T16:16:47.000Z","referenced_tweets":[{"type":"retweeted","id":"552099443546529792"}],"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552136573748518912","author_id":"116716199","entities":{"mentions":[{"start":3,"end":9,"username":"EITeu","id":"330860720"},{"start":32,"end":47,"username":"IntlInnovation","id":"826707924689027072"}],"urls":{},"hashtags":[{"start":110,"end":118,"tag":"EITKICs"}],"annotations":[{"start":62,"end":73,"probability":0.9755,"type":"Person","normalized_text":"Peter Olesen"}]},"possibly_sensitive":false,"text":"RT @EITeu: Check out the newest @IntlInnovation magazine with Peter Olesen elaborating on the achievements of #EITKICs http://t.co/xdnTJOxa…","source":"TweetDeck","id":"552136573748518912","lang":"en","created_at":"2015-01-05T16:16:32.000Z","referenced_tweets":[{"type":"retweeted","id":"552102287783755776"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552136477929652224","author_id":"116716199","entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @Hep_Alliance: 2015 is set to be an exciting year for us -lots of new projects on the way. Sign up to our e-bulletin to hear all 1st htt…","source":"TweetDeck","id":"552136477929652224","lang":"en","created_at":"2015-01-05T16:16:09.000Z","referenced_tweets":[{"type":"retweeted","id":"552106377741860864"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552136297247428608","author_id":"116716199","entities":{"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"}],"urls":[{"start":90,"end":112,"url":"http://t.co/OwCnJ67Gie","expanded_url":"http://bit.ly/IAPOnews","display_url":"bit.ly/IAPOnews"}],"hashtags":[{"start":113,"end":122,"tag":"IAPOnews"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @IAPOtweets: Keep up to date with our work and global patient news each month in 2015! http://t.co/OwCnJ67Gie #IAPOnews http://t.co/EbgX…","source":"TweetDeck","id":"552136297247428608","lang":"en","created_at":"2015-01-05T16:15:26.000Z","referenced_tweets":[{"type":"retweeted","id":"552122971494838272"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552136228087537664","author_id":"116716199","entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"urls":[{"start":115,"end":137,"url":"http://t.co/ly0YfKae7R","expanded_url":"http://ow.ly/GOr1z","display_url":"ow.ly/GOr1z"}],"hashtags":[{"start":37,"end":48,"tag":"LungCancer"},{"start":107,"end":114,"tag":"ELCC15"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @myESMO: Don’t miss out! European #LungCancer Conference abstract submission deadline: 7 Jan, 23:59 CET #ELCC15 http://t.co/ly0YfKae7R","source":"TweetDeck","id":"552136228087537664","lang":"en","created_at":"2015-01-05T16:15:09.000Z","referenced_tweets":[{"type":"retweeted","id":"552124247234326528"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552136207413829632","author_id":"116716199","entities":{"mentions":[{"start":3,"end":10,"username":"Uroweb","id":"114455333"}],"urls":[{"start":112,"end":135,"url":"https://t.co/b2ws5vGYFP","expanded_url":"https://www.surveymonkey.com/s/63QCXY3","display_url":"surveymonkey.com/s/63QCXY3"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @Uroweb: Please take a moment to complete our survey on bladder cancer prevention. Your views are important! https://t.co/b2ws5vGYFP","source":"TweetDeck","id":"552136207413829632","lang":"en","created_at":"2015-01-05T16:15:04.000Z","referenced_tweets":[{"type":"retweeted","id":"552124905144471553"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552083394893713408","author_id":"116716199","entities":{"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":85,"end":101,"username":"HealthcareITNew","id":"575203311"}],"urls":[{"start":58,"end":80,"url":"http://t.co/xuTlJ1sni8","expanded_url":"http://ow.ly/GN2ng","display_url":"ow.ly/GN2ng"}],"hashtags":[{"start":24,"end":33,"tag":"healthIT"},{"start":102,"end":110,"tag":"ehealth"},{"start":111,"end":119,"tag":"mhealth"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EU_eHealth: 'Top 10 #healthIT predictions for 2015' - http://t.co/xuTlJ1sni8 via @healthcareITnew #ehealth #mhealth","source":"TweetDeck","id":"552083394893713408","lang":"en","created_at":"2015-01-05T12:45:13.000Z","referenced_tweets":[{"type":"retweeted","id":"552029293560463361"}],"public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552083289612513282","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"urls":{},"hashtags":[{"start":115,"end":127,"tag":"ECPCAGM2015"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @cancereu: Did you register for 2015 ECPC Annual General Meeting?Be part of EU's biggest cancer patients event! #ECPCAGM2015 http://t.co…","source":"TweetDeck","id":"552083289612513282","lang":"en","created_at":"2015-01-05T12:44:48.000Z","referenced_tweets":[{"type":"retweeted","id":"552036969606561792"}],"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552083265524228096","author_id":"116716199","entities":{"mentions":[{"start":3,"end":16,"username":"eumsplatform","id":"600110872"},{"start":75,"end":91,"username":"PanEuroNetworks","id":"367637736"}],"urls":[{"start":93,"end":115,"url":"http://t.co/YYylou4XeY","expanded_url":"http://bit.ly/1g3AhR6","display_url":"bit.ly/1g3AhR6"}],"hashtags":[{"start":117,"end":135,"tag":"MultipleSclerosis"}],"annotations":[{"start":51,"end":66,"probability":0.9843,"type":"Person","normalized_text":"Maggie Alexander"}]},"possibly_sensitive":false,"text":"RT @eumsplatform: Extensive interview with our CEO Maggie Alexander in the @PanEuroNetworks: http://t.co/YYylou4XeY! #MultipleSclerosis  #H…","source":"TweetDeck","id":"552083265524228096","lang":"en","created_at":"2015-01-05T12:44:42.000Z","referenced_tweets":[{"type":"retweeted","id":"552039429607817216"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552083197723688960","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"H2020SME","id":"874591855626858496"}],"urls":{},"hashtags":[{"start":14,"end":20,"tag":"H2020"},{"start":21,"end":35,"tag":"SMEinstrument"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @H2020SME: #H2020 #SMEinstrument project: BMEVLP - Biomarkers for clinical assessment of lungs intended for transplant by http://t.co/q5…","source":"TweetDeck","id":"552083197723688960","lang":"en","created_at":"2015-01-05T12:44:26.000Z","referenced_tweets":[{"type":"retweeted","id":"552042159491547136"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552082940130504704","author_id":"116716199","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @IMI_JU: Happy new year from IMI! Ready to start 2015 with tips on IMI's rules and procedures? Sign up for our webinar on 9 /1 http://t.…","source":"TweetDeck","id":"552082940130504704","lang":"en","created_at":"2015-01-05T12:43:24.000Z","referenced_tweets":[{"type":"retweeted","id":"552050711316668416"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552082916038422528","author_id":"116716199","entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":122,"end":144,"url":"http://t.co/uMmvSZKhlL","expanded_url":"http://www.epda.eu.com/en/research-papers/2015/brain/01-02-brain/","display_url":"epda.eu.com/en/research-pa…"}],"hashtags":[{"start":18,"end":30,"tag":"Subthalamic"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @euparkinsons: #Subthalamic stimulation modulates cortical motor network activity &amp; synchronization in Parkinson’s http://t.co/uMmvSZKhlL","source":"TweetDeck","id":"552082916038422528","lang":"en","created_at":"2015-01-05T12:43:19.000Z","referenced_tweets":[{"type":"retweeted","id":"552050940665012224"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552082857490153472","author_id":"116716199","entities":{"mentions":[{"start":3,"end":18,"username":"PrimaryCare4um","id":"164835748"},{"start":88,"end":93,"username":"NEJM","id":"25950355"}],"urls":{},"hashtags":[{"start":110,"end":122,"tag":"PrimaryCare"}],"annotations":[{"start":79,"end":84,"probability":0.9879,"type":"Place","normalized_text":"Sweden"}]},"possibly_sensitive":false,"text":"RT @PrimaryCare4um: The Public–Private Pendulum — Patient Choice and Equity in Sweden — @NEJM incl a focus on #PrimaryCare developments htt…","source":"TweetDeck","id":"552082857490153472","lang":"en","created_at":"2015-01-05T12:43:05.000Z","referenced_tweets":[{"type":"retweeted","id":"552056500470812672"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"546967602455904256","author_id":"116716199","entities":{"mentions":[{"start":0,"end":15,"username":"PaulineCastres","id":"2828136269"},{"start":16,"end":24,"username":"Food_EU","id":"2874880006"}],"urls":[{"start":118,"end":140,"url":"http://t.co/5PAOeHMHlU","expanded_url":"http://bit.ly/1zcJ8cR","display_url":"bit.ly/1zcJ8cR"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"@PaulineCastres @Food_EU Public health risk is from antimicrobial resistance. Legislatve options are being discussed: http://t.co/5PAOeHMHlU","source":"TweetDeck","id":"552047491919929344","lang":"en","created_at":"2015-01-05T10:22:33.000Z","referenced_tweets":[{"type":"replied_to","id":"548854163623645184"}],"in_reply_to_user_id":"2828136269","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"551891985859379201","author_id":"116716199","entities":{"mentions":[{"start":0,"end":12,"username":"BettinaRyll","id":"810969654"}],"urls":[{"start":115,"end":137,"url":"http://t.co/XOVRm9qNV0","expanded_url":"http://bit.ly/1pGKjsR","display_url":"bit.ly/1pGKjsR"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"@BettinaRyll Please see the published report and contact the email address provided if you'd like further details: http://t.co/XOVRm9qNV0","source":"TweetDeck","id":"552044999588986881","lang":"en","created_at":"2015-01-05T10:12:39.000Z","referenced_tweets":[{"type":"replied_to","id":"551891985859379201"}],"in_reply_to_user_id":"810969654","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"552035008899477504","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/L25tIbNunG","expanded_url":"http://bit.ly/1GTxBjM","display_url":"bit.ly/1GTxBjM"}],"hashtags":[{"start":35,"end":42,"tag":"orphan"},{"start":43,"end":53,"tag":"medicines"}],"annotations":{}},"possibly_sensitive":false,"text":"The minutes are available from our #orphan #medicines committee (COMP) meeting in November: http://t.co/L25tIbNunG","source":"TweetDeck","id":"552035008899477504","lang":"en","created_at":"2015-01-05T09:32:57.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547442288335785984","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"urls":[{"start":95,"end":118,"url":"https://t.co/Htl0Nn2yT0","expanded_url":"https://www.nice.org.uk/news/blog/nice-year-in-review-guidance-year-in-review-part-1","display_url":"nice.org.uk/news/blog/nice…"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @NICEcomms: Take a peek at the most popular guidance and advice for the first half of 2014: https://t.co/Htl0Nn2yT0","source":"TweetDeck","id":"547442288335785984","lang":"en","created_at":"2014-12-23T17:23:07.000Z","referenced_tweets":[{"type":"retweeted","id":"547441727687368705"}],"public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547438545603133442","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":96,"end":118,"url":"http://t.co/ehUl3OwZiS","expanded_url":"http://bit.ly/1sUpif3","display_url":"bit.ly/1sUpif3"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @AEMPSGOB: Electronic submission of periodic safety update reports for veterinary medicines: http://t.co/ehUl3OwZiS","source":"TweetDeck","id":"547438545603133442","lang":"en","created_at":"2014-12-23T17:08:14.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547413357964582912","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":[{"start":115,"end":137,"url":"http://t.co/sCvYSOgqfR","expanded_url":"http://bit.ly/mini-sentinel","display_url":"bit.ly/mini-sentinel"}],"hashtags":{},"annotations":[{"start":30,"end":32,"probability":0.6133,"type":"Organization","normalized_text":"FDA"},{"start":61,"end":76,"probability":0.6232,"type":"Organization","normalized_text":"Sentinel Program"}]},"possibly_sensitive":false,"text":"RT @FDACBER: Did you miss the FDA Basics webinar on the Mini-Sentinel Program? You can watch the presentation now. http://t.co/sCvYSOgqfR","source":"TweetDeck","id":"547413357964582912","lang":"en","created_at":"2014-12-23T15:28:09.000Z","referenced_tweets":[{"type":"retweeted","id":"547412354133004290"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547413233590894592","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"FDAWomen","id":"65416742"}],"urls":[{"start":55,"end":77,"url":"http://t.co/77Qrbv0m5m","expanded_url":"http://ow.ly/GltFd","display_url":"ow.ly/GltFd"}],"hashtags":[{"start":49,"end":53,"tag":"flu"}],"annotations":[{"start":14,"end":16,"probability":0.9691,"type":"Organization","normalized_text":"FDA"}]},"possibly_sensitive":false,"text":"RT @FDAWomen: FDA approves new drug to treat the #flu: http://t.co/77Qrbv0m5m","source":"TweetDeck","id":"547413233590894592","lang":"en","created_at":"2014-12-23T15:27:39.000Z","referenced_tweets":[{"type":"retweeted","id":"547407631103827968"}],"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547398463731023872","author_id":"116716199","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":[{"start":67,"end":89,"url":"http://t.co/EQm0Msa0J7","expanded_url":"http://bit.ly/IMInews","display_url":"bit.ly/IMInews"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @IMI_JU: Missed our last newsletter of 2014? Catch up online at http://t.co/EQm0Msa0J7","source":"TweetDeck","id":"547398463731023872","lang":"en","created_at":"2014-12-23T14:28:58.000Z","referenced_tweets":[{"type":"retweeted","id":"547398416654159873"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547397130424680449","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":98,"end":120,"url":"http://t.co/L25tIbNunG","expanded_url":"http://bit.ly/1GTxBjM","display_url":"bit.ly/1GTxBjM"}],"hashtags":[{"start":61,"end":68,"tag":"orphan"},{"start":69,"end":79,"tag":"medicines"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the minutes from the November meeting of our #orphan #medicines committee (COMP): http://t.co/L25tIbNunG","source":"Bitly","id":"547397130424680449","lang":"en","created_at":"2014-12-23T14:23:40.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547396634611818496","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":105,"end":127,"url":"http://t.co/1R5Iifh4hw","expanded_url":"http://bit.ly/1GSKNVT","display_url":"bit.ly/1GSKNVT"}],"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"}],"annotations":{}},"possibly_sensitive":false,"text":"Our #pharmacovigilance committee (PRAC) meets again in early January 2015. Highlights out on Friday 9th: http://t.co/1R5Iifh4hw","source":"Twitter Web Client","id":"547396634611818496","lang":"en","created_at":"2014-12-23T14:21:42.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547396228963897345","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":90,"end":112,"url":"http://t.co/LkqQ5UYnjL","expanded_url":"http://bit.ly/1wgPmBo","display_url":"bit.ly/1wgPmBo"}],"hashtags":[{"start":10,"end":17,"tag":"herbal"},{"start":31,"end":39,"tag":"Serenoa"},{"start":113,"end":126,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"Our draft #herbal monograph on #Serenoa repens (saw palmetto fruit) is open for comments: http://t.co/LkqQ5UYnjL #consultation","source":"Twitter Web Client","id":"547396228963897345","lang":"en","created_at":"2014-12-23T14:20:05.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547396040765095936","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":102,"end":124,"url":"http://t.co/XxrgmY7oK8","expanded_url":"http://bit.ly/1vA4Yll","display_url":"bit.ly/1vA4Yll"}],"hashtags":[{"start":126,"end":139,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"One more week to comment on regulatory acceptance of 3R (replacement, reduction, refinement) testing: http://t.co/XxrgmY7oK8  #consultation","source":"Twitter Web Client","id":"547396040765095936","lang":"en","created_at":"2014-12-23T14:19:20.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547395700800376832","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":83,"end":105,"url":"http://t.co/HsqgSldRHW","expanded_url":"http://bit.ly/1zeto42","display_url":"bit.ly/1zeto42"}],"hashtags":[{"start":10,"end":17,"tag":"herbal"},{"start":31,"end":37,"tag":"Carum"},{"start":45,"end":53,"tag":"caraway"},{"start":106,"end":119,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"Our draft #herbal monograph on #Carum carvi (#caraway fruit) is open for comments: http://t.co/HsqgSldRHW #consultation","source":"Twitter Web Client","id":"547395700800376832","lang":"en","created_at":"2014-12-23T14:17:59.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547395318829293568","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":81,"end":103,"url":"http://t.co/KafAw4OXp0","expanded_url":"http://bit.ly/1CAjNbo","display_url":"bit.ly/1CAjNbo"}],"hashtags":[{"start":10,"end":17,"tag":"herbal"},{"start":31,"end":37,"tag":"Carum"},{"start":45,"end":53,"tag":"caraway"},{"start":104,"end":117,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"Our draft #herbal monograph on #Carum carvi (#caraway oil) is open for comments: http://t.co/KafAw4OXp0 #consultation","source":"Twitter Web Client","id":"547395318829293568","lang":"en","created_at":"2014-12-23T14:16:28.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547394763172089856","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/P7ei4XVAjs","expanded_url":"http://bit.ly/1thRMPp","display_url":"bit.ly/1thRMPp"}],"hashtags":[{"start":37,"end":47,"tag":"guideline"},{"start":70,"end":80,"tag":"medicines"},{"start":85,"end":91,"tag":"Crohn"},{"start":127,"end":140,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"One more week to comment on revising #guideline on development of new #medicines for #Crohn’s disease: http://t.co/P7ei4XVAjs  #consultation","source":"Twitter Web Client","id":"547394763172089856","lang":"en","created_at":"2014-12-23T14:14:16.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547394606212853760","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":65,"end":87,"url":"http://t.co/BMMCSkIF6K","expanded_url":"http://bit.ly/1zySaxG","display_url":"bit.ly/1zySaxG"}],"hashtags":[{"start":32,"end":40,"tag":"vacancy"},{"start":89,"end":101,"tag":"recruitment"}],"annotations":{}},"possibly_sensitive":false,"text":"Two more weeks to apply for our #vacancy for a Business Analyst: http://t.co/BMMCSkIF6K  #recruitment","source":"Twitter Web Client","id":"547394606212853760","lang":"en","created_at":"2014-12-23T14:13:38.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547394438419738624","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @FDACBER: Open for comment: Draft guidance on Minimal Manipulation of Human Cells, Tissues, &amp; Cellular &amp; Tissue-Based Products. http://t…","source":"TweetDeck","id":"547394438419738624","lang":"en","created_at":"2014-12-23T14:12:58.000Z","referenced_tweets":[{"type":"retweeted","id":"547394246479581184"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547394296870363136","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":64,"end":86,"url":"http://t.co/EpOSh7xPot","expanded_url":"http://bit.ly/11xUdHf","display_url":"bit.ly/11xUdHf"}],"hashtags":[{"start":32,"end":40,"tag":"vacancy"},{"start":88,"end":100,"tag":"recruitment"}],"annotations":{}},"possibly_sensitive":false,"text":"Two more weeks to apply for our #vacancy for a Project Manager: http://t.co/EpOSh7xPot  #recruitment","source":"Twitter Web Client","id":"547394296870363136","lang":"en","created_at":"2014-12-23T14:12:25.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547394120621518849","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":63,"end":85,"url":"http://t.co/APg1U6OztY","expanded_url":"http://bit.ly/1zTdBJX","display_url":"bit.ly/1zTdBJX"}],"hashtags":[{"start":32,"end":40,"tag":"vacancy"},{"start":47,"end":53,"tag":"Legal"},{"start":87,"end":99,"tag":"recruitment"}],"annotations":{}},"possibly_sensitive":false,"text":"Two more weeks to apply for our #vacancy for a #Legal Officer: http://t.co/APg1U6OztY  #recruitment","source":"Twitter Web Client","id":"547394120621518849","lang":"en","created_at":"2014-12-23T14:11:43.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547393970905825280","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":98,"end":120,"url":"http://t.co/PT6NS5Pw5f","expanded_url":"http://bit.ly/1qxgyLb","display_url":"bit.ly/1qxgyLb"}],"hashtags":[{"start":122,"end":135,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"One week left to comment on revising guideline on epidemiology of blood-transmissible infections: http://t.co/PT6NS5Pw5f  #consultation","source":"Twitter Web Client","id":"547393970905825280","lang":"en","created_at":"2014-12-23T14:11:07.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547393775740649472","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/2zKAvs1lPV","expanded_url":"http://bit.ly/11glWeN","display_url":"bit.ly/11glWeN"}],"hashtags":[{"start":16,"end":29,"tag":"consultation"},{"start":100,"end":113,"tag":"tuberculosis"}],"annotations":{}},"possibly_sensitive":false,"text":"Two weeks left: #consultation on our qualification opinion on in vitro hollow-fibre-system model of #tuberculosis: http://t.co/2zKAvs1lPV","source":"Twitter Web Client","id":"547393775740649472","lang":"en","created_at":"2014-12-23T14:10:20.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547393457728520192","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":99,"end":121,"url":"http://t.co/0IIdOW1v8S","expanded_url":"http://bit.ly/1w2jYqb","display_url":"bit.ly/1w2jYqb"}],"hashtags":[{"start":34,"end":44,"tag":"guideline"},{"start":48,"end":58,"tag":"medicines"},{"start":122,"end":135,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"One more week to comment on draft #guideline on #medicines to prevent chronic renal insufficiency: http://t.co/0IIdOW1v8S #consultation","source":"Twitter Web Client","id":"547393457728520192","lang":"en","created_at":"2014-12-23T14:09:05.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547393109739728896","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":80,"end":102,"url":"http://t.co/SSaYHJJrTL","expanded_url":"http://bit.ly/1sfC1ys","display_url":"bit.ly/1sfC1ys"}],"hashtags":[{"start":32,"end":40,"tag":"vacancy"},{"start":104,"end":116,"tag":"recruitment"}],"annotations":{}},"possibly_sensitive":false,"text":"Two more weeks to apply for our #vacancy for a Quality of Medicines Specialist: http://t.co/SSaYHJJrTL  #recruitment","source":"Twitter Web Client","id":"547393109739728896","lang":"en","created_at":"2014-12-23T14:07:42.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547392867048906752","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/npqMwRFGhF","expanded_url":"http://bit.ly/1oAAOtS","display_url":"bit.ly/1oAAOtS"}],"hashtags":[{"start":37,"end":47,"tag":"guideline"},{"start":66,"end":76,"tag":"medicines"},{"start":81,"end":92,"tag":"ulcerative"},{"start":93,"end":101,"tag":"colitis"},{"start":127,"end":140,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"One week left to comment on revising #guideline on development of #medicines for #ulcerative #colitis: http://t.co/npqMwRFGhF  #consultation","source":"Twitter Web Client","id":"547392867048906752","lang":"en","created_at":"2014-12-23T14:06:44.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547392673343369216","author_id":"116716199","entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"urls":[{"start":55,"end":77,"url":"http://t.co/Icpze22k5X","expanded_url":"http://bit.ly/1yM6AcQ","display_url":"bit.ly/1yM6AcQ"}],"hashtags":[{"start":78,"end":90,"tag":"EGAgenerics"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @egagenerics: How long does patent protection last? http://t.co/Icpze22k5X #EGAgenerics","source":"TweetDeck","id":"547392673343369216","lang":"en","created_at":"2014-12-23T14:05:58.000Z","referenced_tweets":[{"type":"retweeted","id":"547391189821833217"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547392525401870336","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"urls":{},"hashtags":{},"annotations":[{"start":23,"end":55,"probability":0.461,"type":"Organization","normalized_text":"FDA Oncologic Drugs Advisory Comm"}]},"possibly_sensitive":false,"text":"RT @FDA_MCMi: 1/7/15 - FDA Oncologic Drugs Advisory Comm to discuss BLA for  proposed biosimilar to NEUPOGEN (filgrastim) http://t.co/JZ1hG…","source":"TweetDeck","id":"547392525401870336","lang":"en","created_at":"2014-12-23T14:05:22.000Z","referenced_tweets":[{"type":"retweeted","id":"547384954766639104"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547351367124537345","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":117,"end":139,"url":"http://t.co/VmZDKMfyRk","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/12/news_detail_002243.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":{},"annotations":[{"start":76,"end":80,"probability":0.3349,"type":"Place","normalized_text":"PSURs"}]},"possibly_sensitive":false,"text":"RT @GCessak: Simplification of submission of product information updates in PSURs for nationally authorised products http://t.co/VmZDKMfyRk","source":"TweetDeck","id":"547351367124537345","lang":"en","created_at":"2014-12-23T11:21:49.000Z","referenced_tweets":[{"type":"retweeted","id":"547345966488363008"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547351354138968064","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":106,"end":128,"url":"http://t.co/HvPJeWy8L1","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/12/news_detail_002244.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":{},"annotations":[{"start":13,"end":15,"probability":0.3955,"type":"Organization","normalized_text":"EMA"}]},"possibly_sensitive":false,"text":"RT @GCessak: EMA published a report giving an update on the status of the adaptive pathways pilot project http://t.co/HvPJeWy8L1","source":"TweetDeck","id":"547351354138968064","lang":"en","created_at":"2014-12-23T11:21:46.000Z","referenced_tweets":[{"type":"retweeted","id":"547345592889143296"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547351308060327936","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"WEBRADR","id":"2797520425"}],"urls":[{"start":121,"end":143,"url":"http://t.co/g3Us4sSFp6","expanded_url":"http://web-radr.eu/goals/","display_url":"web-radr.eu/goals/"}],"hashtags":[{"start":35,"end":46,"tag":"datamining"},{"start":62,"end":70,"tag":"BigData"},{"start":83,"end":93,"tag":"healthapp"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @WEBRADR: WEB-RADR will develop #datamining techniques for #BigData &amp; an EU #healthapp for ADR reporting. Read at http://t.co/g3Us4sSFp6…","source":"TweetDeck","id":"547351308060327936","lang":"en","created_at":"2014-12-23T11:21:35.000Z","referenced_tweets":[{"type":"retweeted","id":"544822929662697472"}],"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547336112507981824","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/1R5Iifh4hw","expanded_url":"http://bit.ly/1GSKNVT","display_url":"bit.ly/1GSKNVT"}],"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"}],"annotations":{}},"possibly_sensitive":false,"text":"Our #pharmacovigilance committee (PRAC) is meeting in the first week of January. Highlights out on Friday 9th: http://t.co/1R5Iifh4hw","source":"Bitly","id":"547336112507981824","lang":"en","created_at":"2014-12-23T10:21:12.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547335544095911936","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":102,"end":124,"url":"http://t.co/fFHetDCM0W","expanded_url":"http://bit.ly/1vA4Yll","display_url":"bit.ly/1vA4Yll"}],"hashtags":[{"start":125,"end":138,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"One week left to comment on regulatory acceptance of 3R (replacement, reduction, refinement) testing: http://t.co/fFHetDCM0W #consultation","source":"Bitly","id":"547335544095911936","lang":"en","created_at":"2014-12-23T10:18:57.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547334682552303616","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":91,"end":113,"url":"http://t.co/LkqQ5UYnjL","expanded_url":"http://bit.ly/1wgPmBo","display_url":"bit.ly/1wgPmBo"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":32,"end":39,"tag":"herbal"},{"start":53,"end":61,"tag":"Serenoa"}],"annotations":{}},"possibly_sensitive":false,"text":"#Consultation open on our draft #herbal monograph on #Serenoa repens (saw palmetto fruit): http://t.co/LkqQ5UYnjL","source":"Bitly","id":"547334682552303616","lang":"en","created_at":"2014-12-23T10:15:31.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547333977900871680","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":87,"end":109,"url":"http://t.co/HsqgSldRHW","expanded_url":"http://bit.ly/1zeto42","display_url":"bit.ly/1zeto42"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":35,"end":42,"tag":"herbal"},{"start":56,"end":62,"tag":"Carum"},{"start":70,"end":78,"tag":"caraway"}],"annotations":{}},"possibly_sensitive":false,"text":"#Consultation is open on our draft #herbal monograph on #Carum carvi (#caraway fruit): http://t.co/HsqgSldRHW","source":"Bitly","id":"547333977900871680","lang":"en","created_at":"2014-12-23T10:12:43.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547333173848576000","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":85,"end":107,"url":"http://t.co/KafAw4OXp0","expanded_url":"http://bit.ly/1CAjNbo","display_url":"bit.ly/1CAjNbo"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":35,"end":42,"tag":"herbal"},{"start":56,"end":62,"tag":"Carum"},{"start":70,"end":78,"tag":"caraway"}],"annotations":{}},"possibly_sensitive":false,"text":"#Consultation is open on our draft #herbal monograph on #Carum carvi (#caraway oil): http://t.co/KafAw4OXp0","source":"Bitly","id":"547333173848576000","lang":"en","created_at":"2014-12-23T10:09:32.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547332603481968640","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":95,"end":117,"url":"http://t.co/acevxxnOwB","expanded_url":"http://bit.ly/1zbHRh9","display_url":"bit.ly/1zbHRh9"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":42,"end":52,"tag":"medicines"}],"annotations":{}},"possibly_sensitive":false,"text":"The #minutes from our committee for human #medicines (CHMP) meeting in November are available: http://t.co/acevxxnOwB","source":"Twitter Web Client","id":"547332603481968640","lang":"en","created_at":"2014-12-23T10:07:16.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547332312544079872","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/RFVvJSoRnl","expanded_url":"http://bit.ly/1xEh9lL","display_url":"bit.ly/1xEh9lL"}],"hashtags":[{"start":20,"end":29,"tag":"guidance"},{"start":45,"end":56,"tag":"veterinary"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published new #guidance on classifying #veterinary medicines for minor use minor species (MUMS)/limited market: http://t.co/RFVvJSoRnl","source":"Twitter Web Client","id":"547332312544079872","lang":"en","created_at":"2014-12-23T10:06:06.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547332010210263041","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":98,"end":120,"url":"http://t.co/paDak7LfGz","expanded_url":"http://bit.ly/1CpfzWR","display_url":"bit.ly/1CpfzWR"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"We've simplified product-information updates following PSURs for nationally authorised medicines: http://t.co/paDak7LfGz","source":"Twitter Web Client","id":"547332010210263041","lang":"en","created_at":"2014-12-23T10:04:54.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547331074238742528","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/AQojUvnBQS","expanded_url":"http://bit.ly/1JJq5u4","display_url":"bit.ly/1JJq5u4"}],"hashtags":[{"start":32,"end":49,"tag":"adaptivepathways"},{"start":61,"end":71,"tag":"medicines"}],"annotations":{}},"possibly_sensitive":false,"text":"We've provided an update on our #adaptivepathways pilot: six #medicines so far selected to go forward: http://t.co/AQojUvnBQS","source":"Twitter Web Client","id":"547331074238742528","lang":"en","created_at":"2014-12-23T10:01:11.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547329025417703424","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/P7ei4XVAjs","expanded_url":"http://bit.ly/1thRMPp","display_url":"bit.ly/1thRMPp"}],"hashtags":[{"start":37,"end":47,"tag":"guideline"},{"start":70,"end":80,"tag":"medicines"},{"start":85,"end":91,"tag":"Crohn"},{"start":126,"end":139,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"One week left to comment on revising #guideline on development of new #medicines for #Crohn’s disease: http://t.co/P7ei4XVAjs #consultation","source":"Twitter Web Client","id":"547329025417703424","lang":"en","created_at":"2014-12-23T09:53:03.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547328772790554625","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":65,"end":87,"url":"http://t.co/BMMCSkIF6K","expanded_url":"http://bit.ly/1zySaxG","display_url":"bit.ly/1zySaxG"}],"hashtags":[{"start":32,"end":40,"tag":"vacancy"},{"start":88,"end":100,"tag":"recruitment"}],"annotations":{}},"possibly_sensitive":false,"text":"Two weeks left to apply for our #vacancy for a Business Analyst: http://t.co/BMMCSkIF6K #recruitment","source":"Bitly","id":"547328772790554625","lang":"en","created_at":"2014-12-23T09:52:02.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547328349887283200","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":64,"end":86,"url":"http://t.co/EpOSh7xPot","expanded_url":"http://bit.ly/11xUdHf","display_url":"bit.ly/11xUdHf"}],"hashtags":[{"start":32,"end":40,"tag":"vacancy"},{"start":87,"end":99,"tag":"recruitment"}],"annotations":{}},"possibly_sensitive":false,"text":"Two weeks left to apply for our #vacancy for a Project Manager: http://t.co/EpOSh7xPot #recruitment","source":"Bitly","id":"547328349887283200","lang":"en","created_at":"2014-12-23T09:50:22.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547327918087888896","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":63,"end":85,"url":"http://t.co/APg1U6OztY","expanded_url":"http://bit.ly/1zTdBJX","display_url":"bit.ly/1zTdBJX"}],"hashtags":[{"start":32,"end":40,"tag":"vacancy"},{"start":47,"end":53,"tag":"Legal"},{"start":86,"end":98,"tag":"recruitment"}],"annotations":{}},"possibly_sensitive":false,"text":"Two weeks left to apply for our #vacancy for a #Legal Officer: http://t.co/APg1U6OztY #recruitment","source":"Bitly","id":"547327918087888896","lang":"en","created_at":"2014-12-23T09:48:39.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547327382139711488","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":98,"end":120,"url":"http://t.co/PT6NS5Pw5f","expanded_url":"http://bit.ly/1qxgyLb","display_url":"bit.ly/1qxgyLb"}],"hashtags":[{"start":121,"end":134,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"One more week to comment on revising guideline on epidemiology of blood-transmissible infections: http://t.co/PT6NS5Pw5f #consultation","source":"Bitly","id":"547327382139711488","lang":"en","created_at":"2014-12-23T09:46:31.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547326843918229504","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":102,"end":124,"url":"http://t.co/2zKAvs1lPV","expanded_url":"http://bit.ly/11glWeN","display_url":"bit.ly/11glWeN"}],"hashtags":[{"start":87,"end":100,"tag":"tuberculosis"},{"start":125,"end":138,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"Two weeks to comment on qualification opinion on in vitro hollow-fibre-system model of #tuberculosis: http://t.co/2zKAvs1lPV #consultation","source":"Twitter Web Client","id":"547326843918229504","lang":"en","created_at":"2014-12-23T09:44:23.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547326061051408384","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":99,"end":121,"url":"http://t.co/0IIdOW1v8S","expanded_url":"http://bit.ly/1w2jYqb","display_url":"bit.ly/1w2jYqb"}],"hashtags":[{"start":34,"end":44,"tag":"guideline"},{"start":48,"end":58,"tag":"medicines"},{"start":123,"end":136,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"One week left to comment on draft #guideline on #medicines to prevent chronic renal insufficiency: http://t.co/0IIdOW1v8S  #consultation","source":"Twitter Web Client","id":"547326061051408384","lang":"en","created_at":"2014-12-23T09:41:16.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547325514554568705","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":80,"end":102,"url":"http://t.co/SSaYHJJrTL","expanded_url":"http://bit.ly/1sfC1ys","display_url":"bit.ly/1sfC1ys"}],"hashtags":[{"start":32,"end":40,"tag":"vacancy"},{"start":103,"end":115,"tag":"recruitment"}],"annotations":{}},"possibly_sensitive":false,"text":"Two weeks left to apply for our #vacancy for a Quality of Medicines Specialist: http://t.co/SSaYHJJrTL #recruitment","source":"Bitly","id":"547325514554568705","lang":"en","created_at":"2014-12-23T09:39:06.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547324965360775168","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/npqMwRFGhF","expanded_url":"http://bit.ly/1oAAOtS","display_url":"bit.ly/1oAAOtS"}],"hashtags":[{"start":37,"end":47,"tag":"guideline"},{"start":66,"end":76,"tag":"medicines"},{"start":81,"end":92,"tag":"ulcerative"},{"start":93,"end":101,"tag":"colitis"},{"start":126,"end":139,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"One more week to comment on revising #guideline on development of #medicines for #ulcerative #colitis: http://t.co/npqMwRFGhF #consultation","source":"Twitter Web Client","id":"547324965360775168","lang":"en","created_at":"2014-12-23T09:36:55.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547323644599607296","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":{},"hashtags":[{"start":13,"end":26,"tag":"EFSAExpo2015"},{"start":94,"end":109,"tag":"RiskAssessment"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EFSA_EU: #EFSAExpo2015 conference “will bring together the brightest brains in regulatory #RiskAssessment” says EFSA’s ED Url http://t.…","source":"TweetDeck","id":"547323644599607296","lang":"en","created_at":"2014-12-23T09:31:40.000Z","referenced_tweets":[{"type":"retweeted","id":"547315687556153344"}],"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547086107868135424","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":80,"end":102,"url":"http://t.co/HYKAEf0w58","expanded_url":"http://bit.ly/1JHE83g","display_url":"bit.ly/1JHE83g"}],"hashtags":[{"start":38,"end":45,"tag":"herbal"},{"start":46,"end":56,"tag":"medicines"},{"start":68,"end":78,"tag":"estragole"},{"start":103,"end":116,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"Comment on public statement on use of #herbal #medicines containing #estragole: http://t.co/HYKAEf0w58 #consultation","source":"TweetDeck","id":"547086107868135424","lang":"en","created_at":"2014-12-22T17:47:47.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547086066206146560","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":96,"end":118,"url":"http://t.co/eYVkVYas6E","expanded_url":"http://bit.ly/1xaJh0f","display_url":"bit.ly/1xaJh0f"}],"hashtags":[{"start":38,"end":45,"tag":"herbal"},{"start":46,"end":56,"tag":"medicines"},{"start":68,"end":77,"tag":"pulegone"},{"start":82,"end":94,"tag":"menthofuran"},{"start":119,"end":132,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"Comment on public statement on use of #herbal #medicines containing #pulegone and #menthofuran: http://t.co/eYVkVYas6E #consultation","source":"TweetDeck","id":"547086066206146560","lang":"en","created_at":"2014-12-22T17:47:37.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547085876128653312","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":71,"end":93,"url":"http://t.co/QlHXmsw9BR","expanded_url":"http://bit.ly/1zbhVlJ","display_url":"bit.ly/1zbhVlJ"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"We are closed from this Wednesday 24 Dec 2014 until Monday 5 Jan 2015: http://t.co/QlHXmsw9BR","source":"TweetDeck","id":"547085876128653312","lang":"en","created_at":"2014-12-22T17:46:51.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547083760312008704","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":85,"end":107,"url":"http://t.co/AQojUvnBQS","expanded_url":"http://bit.ly/1JJq5u4","display_url":"bit.ly/1JJq5u4"}],"hashtags":[{"start":4,"end":14,"tag":"medicines"}],"annotations":{}},"possibly_sensitive":false,"text":"Six #medicines so far selected to go forward in our adaptive pathways pilot project: http://t.co/AQojUvnBQS","source":"Bitly","id":"547083760312008704","lang":"en","created_at":"2014-12-22T17:38:27.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547052379313811456","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"urls":{},"hashtags":[{"start":35,"end":45,"tag":"influenza"},{"start":113,"end":118,"tag":"H3N2"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @ECDC_Flu: More cases of severe #influenza may be expected this season, see ECDC risk assessment on drifted A(#H3N2) viruses: http://t.c…","source":"TweetDeck","id":"547052379313811456","lang":"en","created_at":"2014-12-22T15:33:45.000Z","referenced_tweets":[{"type":"retweeted","id":"547048674766098432"}],"public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547049914086481921","author_id":"116716199","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":[{"start":112,"end":134,"url":"http://t.co/jL2eT1boa5","expanded_url":"http://bit.ly/1GOxhTk","display_url":"bit.ly/1GOxhTk"}],"hashtags":{},"annotations":[{"start":53,"end":57,"probability":0.9992,"type":"Place","normalized_text":"Spain"},{"start":70,"end":75,"probability":0.9742,"type":"Place","normalized_text":"France"}]},"possibly_sensitive":false,"text":"RT @IMI_JU: Coming up in January: IMI 2 info days in Spain (13/1) and France (16/1) Info &amp; registration via http://t.co/jL2eT1boa5","source":"TweetDeck","id":"547049914086481921","lang":"en","created_at":"2014-12-22T15:23:57.000Z","referenced_tweets":[{"type":"retweeted","id":"547037512825589760"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547049724902404096","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":98,"end":120,"url":"http://t.co/paDak7LfGz","expanded_url":"http://bit.ly/1CpfzWR","display_url":"bit.ly/1CpfzWR"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"We've simplified the submission of product information updates in periodic safety update reports: http://t.co/paDak7LfGz","source":"Bitly","id":"547049724902404096","lang":"en","created_at":"2014-12-22T15:23:12.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547044410127818752","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/RFVvJSoRnl","expanded_url":"http://bit.ly/1xEh9lL","display_url":"bit.ly/1xEh9lL"}],"hashtags":[{"start":8,"end":17,"tag":"guidance"},{"start":39,"end":50,"tag":"veterinary"},{"start":51,"end":61,"tag":"medicines"}],"annotations":{}},"possibly_sensitive":false,"text":"Adopted #guidance on classification of #veterinary #medicines for minor use minor species (MUMS) / limited market: http://t.co/RFVvJSoRnl","source":"Bitly","id":"547044410127818752","lang":"en","created_at":"2014-12-22T15:02:05.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547034602859425792","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":108,"end":130,"url":"http://t.co/EbIjABT2bj","expanded_url":"http://bit.ly/1zbHcfH","display_url":"bit.ly/1zbHcfH"}],"hashtags":[{"start":13,"end":16,"tag":"EU"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EFSA_EU: #EU Menu: data collection contracts awarded, guidance updated. Project now covers 14 countries http://t.co/EbIjABT2bj http://t…","source":"TweetDeck","id":"547034602859425792","lang":"en","created_at":"2014-12-22T14:23:07.000Z","referenced_tweets":[{"type":"retweeted","id":"547034448420556800"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547029840898306048","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":87,"end":109,"url":"http://t.co/acevxxnOwB","expanded_url":"http://bit.ly/1zbHRh9","display_url":"bit.ly/1zbHRh9"}],"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":56,"end":66,"tag":"medicines"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the #minutes of our committee for human #medicines (CHMP) in November: http://t.co/acevxxnOwB","source":"Bitly","id":"547029840898306048","lang":"en","created_at":"2014-12-22T14:04:12.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547027432646410241","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"Food_EU","id":"2874880006"}],"urls":[{"start":116,"end":138,"url":"http://t.co/mptbi539rl","expanded_url":"http://bit.ly/1zcJ8cR","display_url":"bit.ly/1zcJ8cR"}],"hashtags":[{"start":13,"end":16,"tag":"EU"},{"start":79,"end":91,"tag":"antibiotics"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @Food_EU: #EU experts propose measures 2 minimise antimicrobial resistance: #antibiotics in veterinary medicines http://t.co/mptbi539rl …","source":"TweetDeck","id":"547027432646410241","lang":"en","created_at":"2014-12-22T13:54:37.000Z","referenced_tweets":[{"type":"retweeted","id":"546967602455904256"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547027394771845120","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":15,"end":27,"username":"CentroCREER","id":"154210893"}],"urls":{},"hashtags":[{"start":41,"end":53,"tag":"RareDisease"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @eurordis: .@CentroCREER: the Spanish #RareDisease resource centre providing services to patients, families and professionals http://t.c…","source":"TweetDeck","id":"547027394771845120","lang":"en","created_at":"2014-12-22T13:54:28.000Z","referenced_tweets":[{"type":"retweeted","id":"546968662637543424"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547027358252007424","author_id":"116716199","entities":{"mentions":[{"start":3,"end":18,"username":"PrimaryCare4um","id":"164835748"},{"start":66,"end":80,"username":"NuffieldTrust","id":"110975254"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @PrimaryCare4um: Now more than ever: why pharmacy needs to act @NuffieldTrust pharmacists role in new models of health &amp; social care htt…","source":"TweetDeck","id":"547027358252007424","lang":"en","created_at":"2014-12-22T13:54:20.000Z","referenced_tweets":[{"type":"retweeted","id":"546971627880075264"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547027133567336449","author_id":"116716199","entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"urls":[{"start":103,"end":125,"url":"http://t.co/yepx9MULXL","expanded_url":"http://bit.ly/1DM66uc","display_url":"bit.ly/1DM66uc"}],"hashtags":[{"start":95,"end":102,"tag":"health"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @egagenerics: Over 75% of Europeans think the Internet is a good way to find out more about #health http://t.co/yepx9MULXL","source":"TweetDeck","id":"547027133567336449","lang":"en","created_at":"2014-12-22T13:53:26.000Z","referenced_tweets":[{"type":"retweeted","id":"546983504441901056"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547027089426509824","author_id":"116716199","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":116,"end":138,"url":"http://t.co/Yh6eFO2y8I","expanded_url":"http://goo.gl/MQA1hO","display_url":"goo.gl/MQA1hO"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @WHO: Introduction of inactivated polio vaccine in 2015 to be one of most ambitious vaccine roll-outs in history http://t.co/Yh6eFO2y8I …","source":"TweetDeck","id":"547027089426509824","lang":"en","created_at":"2014-12-22T13:53:16.000Z","referenced_tweets":[{"type":"retweeted","id":"546984524836372480"}],"public_metrics":{"retweet_count":147,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547027066080985088","author_id":"116716199","entities":{"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"}],"urls":[{"start":116,"end":138,"url":"http://t.co/OwCnJ67Gie","expanded_url":"http://bit.ly/IAPOnews","display_url":"bit.ly/IAPOnews"}],"hashtags":[{"start":76,"end":84,"tag":"patient"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @IAPOtweets: Want to keep up with our work in 2015? Or hear about global #patient news each month? Sign up here: http://t.co/OwCnJ67Gie","source":"TweetDeck","id":"547027066080985088","lang":"en","created_at":"2014-12-22T13:53:10.000Z","referenced_tweets":[{"type":"retweeted","id":"546984791728734208"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547026986351484928","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":106,"end":128,"url":"http://t.co/DQFCMwhtzS","expanded_url":"http://bit.ly/1qAa8jx","display_url":"bit.ly/1qAa8jx"}],"hashtags":[{"start":35,"end":53,"tag":"PesticideResidues"},{"start":86,"end":98,"tag":"Interactive"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EFSA_EU: Explore the levels of #PesticideResidues for the food products analysed. #Interactive report http://t.co/DQFCMwhtzS http://t.c…","source":"TweetDeck","id":"547026986351484928","lang":"en","created_at":"2014-12-22T13:52:51.000Z","referenced_tweets":[{"type":"retweeted","id":"546988399698395136"}],"public_metrics":{"retweet_count":21,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547026782088859648","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"H2020SME","id":"874591855626858496"}],"urls":[{"start":92,"end":114,"url":"http://t.co/QN9Uy9lIHL","expanded_url":"http://ow.ly/FTpwD","display_url":"ow.ly/FTpwD"}],"hashtags":[{"start":34,"end":40,"tag":"H2020"},{"start":41,"end":55,"tag":"SMEinstrument"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @H2020SME: Coming January 2015 #H2020 #SMEinstrument quarterly newsletter. Subscribe now http://t.co/QN9Uy9lIHL","source":"TweetDeck","id":"547026782088859648","lang":"en","created_at":"2014-12-22T13:52:02.000Z","referenced_tweets":[{"type":"retweeted","id":"547013992250875906"}],"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547026759297019904","author_id":"116716199","entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":88,"end":110,"url":"http://t.co/H2mfjTRCze","expanded_url":"http://bit.ly/10z9dnb","display_url":"bit.ly/10z9dnb"}],"hashtags":[{"start":60,"end":65,"tag":"EPDA"},{"start":67,"end":79,"tag":"MyPDJourney"}],"annotations":[{"start":18,"end":57,"probability":0.3467,"type":"Other","normalized_text":"European Parkinson's Disease Association"}]},"possibly_sensitive":false,"text":"RT @euparkinsons: European Parkinson's Disease Association (#EPDA) #MyPDJourney Survey: http://t.co/H2mfjTRCze Please RT &amp; share on #Facebo…","source":"TweetDeck","id":"547026759297019904","lang":"en","created_at":"2014-12-22T13:51:57.000Z","referenced_tweets":[{"type":"retweeted","id":"547016217651712001"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547026723427328000","author_id":"116716199","entities":{"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"}],"urls":[{"start":66,"end":88,"url":"http://t.co/hW5wMhIi2J","expanded_url":"http://www.ese-hormones.org","display_url":"ese-hormones.org"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @ESEndocrinology: ESE | ESE Meeting Grants - worth €400 each! \nhttp://t.co/hW5wMhIi2J","source":"TweetDeck","id":"547026723427328000","lang":"en","created_at":"2014-12-22T13:51:48.000Z","referenced_tweets":[{"type":"retweeted","id":"547018266141405184"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"547026697250680833","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"EU_OSHA","id":"23600999"}],"urls":[{"start":97,"end":119,"url":"http://t.co/4b88YrkVsS","expanded_url":"http://bit.ly/1v2iDjr","display_url":"bit.ly/1v2iDjr"}],"hashtags":[{"start":23,"end":30,"tag":"stress"},{"start":31,"end":42,"tag":"prevention"},{"start":120,"end":135,"tag":"EUmanagestress"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EU_OSHA: Workplace #stress #prevention keeps workers healthy and productive in the long term http://t.co/4b88YrkVsS #EUmanagestress","source":"TweetDeck","id":"547026697250680833","lang":"en","created_at":"2014-12-22T13:51:42.000Z","referenced_tweets":[{"type":"retweeted","id":"547020030769381376"}],"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"546982027736932352","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":82,"end":104,"url":"http://t.co/HYKAEf0w58","expanded_url":"http://bit.ly/1JHE83g","display_url":"bit.ly/1JHE83g"}],"hashtags":[{"start":40,"end":47,"tag":"herbal"},{"start":48,"end":58,"tag":"medicines"},{"start":70,"end":80,"tag":"estragole"},{"start":105,"end":118,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"Comment on a public statement on use of #herbal #medicines containing #estragole: http://t.co/HYKAEf0w58 #consultation","source":"Bitly","id":"546982027736932352","lang":"en","created_at":"2014-12-22T10:54:12.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"546981750342422529","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":98,"end":120,"url":"http://t.co/eYVkVYas6E","expanded_url":"http://bit.ly/1xaJh0f","display_url":"bit.ly/1xaJh0f"}],"hashtags":[{"start":40,"end":47,"tag":"herbal"},{"start":48,"end":58,"tag":"medicines"},{"start":70,"end":79,"tag":"pulegone"},{"start":84,"end":96,"tag":"menthofuran"},{"start":121,"end":134,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"Comment on a public statement on use of #herbal #medicines containing #pulegone and #menthofuran: http://t.co/eYVkVYas6E #consultation","source":"Bitly","id":"546981750342422529","lang":"en","created_at":"2014-12-22T10:53:06.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"546981319381897216","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":68,"end":90,"url":"http://t.co/QlHXmsw9BR","expanded_url":"http://bit.ly/1zbhVlJ","display_url":"bit.ly/1zbhVlJ"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"We are closed from this Wednesday, re-opening on Monday 5 Jan 2015: http://t.co/QlHXmsw9BR","source":"Bitly","id":"546981319381897216","lang":"en","created_at":"2014-12-22T10:51:23.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"546967762728669184","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/bVy2pp9sz8","expanded_url":"http://bit.ly/1Am8WCn","display_url":"bit.ly/1Am8WCn"}],"hashtags":[{"start":29,"end":39,"tag":"Trulicity"},{"start":41,"end":53,"tag":"dulaglutide"},{"start":62,"end":71,"tag":"medicine"},{"start":83,"end":92,"tag":"diabetes"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the EPAR for #Trulicity (#dulaglutide), a new #medicine for type-2 #diabetes: http://t.co/bVy2pp9sz8","source":"TweetDeck","id":"546967762728669184","lang":"en","created_at":"2014-12-22T09:57:31.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"546967649046253568","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":89,"end":111,"url":"http://t.co/uNBqmojFVR","expanded_url":"http://bit.ly/1C91Gf4","display_url":"bit.ly/1C91Gf4"}],"hashtags":[{"start":81,"end":87,"tag":"RD114"},{"start":112,"end":125,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"Comment on our draft reflection paper on heat treatment to inactivate retrovirus #RD114: http://t.co/uNBqmojFVR #consultation","source":"TweetDeck","id":"546967649046253568","lang":"en","created_at":"2014-12-22T09:57:04.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"546967507119390720","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":101,"end":123,"url":"http://t.co/aO26q5r2I5","expanded_url":"http://bit.ly/1H2bBkU","display_url":"bit.ly/1H2bBkU"}],"hashtags":[{"start":29,"end":35,"tag":"Nuwiq"},{"start":37,"end":48,"tag":"simoctocog"},{"start":71,"end":80,"tag":"medicine"},{"start":85,"end":97,"tag":"haemophilia"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the EPAR for #Nuwiq (#simoctocog alfa (rFVIII)), a new #medicine for #haemophilia A: http://t.co/aO26q5r2I5","source":"TweetDeck","id":"546967507119390720","lang":"en","created_at":"2014-12-22T09:56:30.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"546966979656298497","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":79,"end":101,"url":"http://t.co/ZO2oRL6Z7p","expanded_url":"http://bit.ly/1v7sg0L","display_url":"bit.ly/1v7sg0L"}],"hashtags":[{"start":25,"end":34,"tag":"stemcell"}],"annotations":{}},"possibly_sensitive":false,"text":"We recommended the first #stemcell therapy for approval in the European Union: http://t.co/ZO2oRL6Z7p","source":"TweetDeck","id":"546966979656298497","lang":"en","created_at":"2014-12-22T09:54:24.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"546966554974638080","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":97,"end":119,"url":"http://t.co/lClyLnunA9","expanded_url":"http://bit.ly/1sGAOL0","display_url":"bit.ly/1sGAOL0"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"Our Management Board adopted the 2015-2016 work programme for the Agency at last week's meeting: http://t.co/lClyLnunA9","source":"TweetDeck","id":"546966554974638080","lang":"en","created_at":"2014-12-22T09:52:43.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"546966307443593217","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":86,"end":108,"url":"http://t.co/5PAOeHMHlU","expanded_url":"http://bit.ly/1zcJ8cR","display_url":"bit.ly/1zcJ8cR"}],"hashtags":[{"start":61,"end":73,"tag":"antibiotics"}],"annotations":{}},"possibly_sensitive":false,"text":"We've issued recommendations to mitigate risks due to use of #antibiotics in animals: http://t.co/5PAOeHMHlU","source":"TweetDeck","id":"546966307443593217","lang":"en","created_at":"2014-12-22T09:51:44.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":3,"reply_count":2,"like_count":3,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"546965951271665664","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":91,"end":113,"url":"http://t.co/V98KH4unSQ","expanded_url":"http://bit.ly/1x58tVO","display_url":"bit.ly/1x58tVO"}],"hashtags":[{"start":67,"end":78,"tag":"veterinary"},{"start":79,"end":89,"tag":"medicines"},{"start":114,"end":127,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"Comment on our paper on replacement of cell lines in immunological #veterinary #medicines: http://t.co/V98KH4unSQ #consultation","source":"TweetDeck","id":"546965951271665664","lang":"en","created_at":"2014-12-22T09:50:19.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"546965614305501184","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":99,"end":121,"url":"http://t.co/TF9CftqAZm","expanded_url":"http://bit.ly/1JeV8Od","display_url":"bit.ly/1JeV8Od"}],"hashtags":[{"start":30,"end":38,"tag":"Mysimba"},{"start":40,"end":51,"tag":"naltrexone"},{"start":54,"end":64,"tag":"bupropion"}],"annotations":{}},"possibly_sensitive":false,"text":"We've recommended approval of #Mysimba (#naltrexone / #bupropion) for weight management in adults: http://t.co/TF9CftqAZm","source":"TweetDeck","id":"546965614305501184","lang":"en","created_at":"2014-12-22T09:48:59.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":3,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"546965237338238976","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":101,"end":123,"url":"http://t.co/OZg7WGueaP","expanded_url":"http://bit.ly/1wL7Oac","display_url":"bit.ly/1wL7Oac"}],"hashtags":[{"start":29,"end":39,"tag":"Tadalafil"},{"start":57,"end":66,"tag":"medicine"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the EPAR for #Tadalafil Mylan, a generic #medicine for erectile dysfunction and BPH: http://t.co/OZg7WGueaP","source":"TweetDeck","id":"546965237338238976","lang":"en","created_at":"2014-12-22T09:47:29.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"546961276740849666","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":105,"end":127,"url":"http://t.co/wzzgD3FX0G","expanded_url":"http://bit.ly/1wSR27S","display_url":"bit.ly/1wSR27S"}],"hashtags":[{"start":10,"end":20,"tag":"medicines"}],"annotations":{}},"possibly_sensitive":false,"text":"Our human #medicines committee (CHMP) recommended 7 new medicines for approval last week (82 this year): http://t.co/wzzgD3FX0G","source":"TweetDeck","id":"546961276740849666","lang":"en","created_at":"2014-12-22T09:31:45.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"546012362764197888","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":107,"end":129,"url":"http://t.co/bVy2pp9sz8","expanded_url":"http://bit.ly/1Am8WCn","display_url":"bit.ly/1Am8WCn"}],"hashtags":[{"start":42,"end":52,"tag":"Trulicity"},{"start":54,"end":66,"tag":"dulaglutide"},{"start":75,"end":84,"tag":"medicine"},{"start":96,"end":105,"tag":"diabetes"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the assessment report for #Trulicity (#dulaglutide), a new #medicine for type-2 #diabetes: http://t.co/bVy2pp9sz8","source":"Bitly","id":"546012362764197888","lang":"en","created_at":"2014-12-19T18:41:06.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"546011722700832768","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/OZg7WGueaP","expanded_url":"http://bit.ly/1wL7Oac","display_url":"bit.ly/1wL7Oac"}],"hashtags":[{"start":42,"end":52,"tag":"Tadalafil"},{"start":70,"end":79,"tag":"medicine"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the assessment report for #Tadalafil Mylan, a generic #medicine for erectile dysfunction and BPH: http://t.co/OZg7WGueaP","source":"Bitly","id":"546011722700832768","lang":"en","created_at":"2014-12-19T18:38:33.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545994028031160320","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"FDAWomen","id":"65416742"}],"urls":[{"start":69,"end":91,"url":"http://t.co/6fX8FEyMWZ","expanded_url":"http://ow.ly/Gbnku","display_url":"ow.ly/Gbnku"}],"hashtags":{},"annotations":[{"start":14,"end":16,"probability":0.8689,"type":"Organization","normalized_text":"FDA"}]},"possibly_sensitive":false,"text":"RT @FDAWomen: FDA approves new drug to treat advanced ovarian cancer http://t.co/6fX8FEyMWZ","source":"TweetDeck","id":"545994028031160320","lang":"en","created_at":"2014-12-19T17:28:15.000Z","referenced_tweets":[{"type":"retweeted","id":"545993151811686400"}],"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545993995118460928","author_id":"116716199","entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":[{"start":75,"end":97,"url":"http://t.co/ARkQGl0nys","expanded_url":"http://go.usa.gov/MNgJ","display_url":"go.usa.gov/MNgJ"}],"hashtags":{},"annotations":[{"start":19,"end":21,"probability":0.8395,"type":"Organization","normalized_text":"FDA"}]},"possibly_sensitive":false,"text":"RT @FDA_Drug_Info: FDA approves new drug to treat advanced ovarian cancer: http://t.co/ARkQGl0nys.","source":"TweetDeck","id":"545993995118460928","lang":"en","created_at":"2014-12-19T17:28:07.000Z","referenced_tweets":[{"type":"retweeted","id":"545992207078293504"}],"public_metrics":{"retweet_count":28,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545993695779377153","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":101,"end":123,"url":"http://t.co/lClyLnunA9","expanded_url":"http://bit.ly/1sGAOL0","display_url":"bit.ly/1sGAOL0"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"Our Management Board adopted the 2015-2016 work programme for the Agency during this week's meeting: http://t.co/lClyLnunA9","source":"Bitly","id":"545993695779377153","lang":"en","created_at":"2014-12-19T17:26:55.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545988207427723265","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"FDAMedia","id":"2528303509"}],"urls":[{"start":96,"end":118,"url":"http://t.co/OxmZwMRBdi","expanded_url":"http://go.usa.gov/M5rd","display_url":"go.usa.gov/M5rd"}],"hashtags":{},"annotations":[{"start":14,"end":16,"probability":0.7301,"type":"Organization","normalized_text":"FDA"}]},"possibly_sensitive":false,"text":"RT @FDAMedia: FDA approves drug + companion diagnostic for BRCA-related advanced ovarian cancer http://t.co/OxmZwMRBdi","source":"TweetDeck","id":"545988207427723265","lang":"en","created_at":"2014-12-19T17:05:07.000Z","referenced_tweets":[{"type":"retweeted","id":"545982895849238528"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545979708727644161","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/aO26q5r2I5","expanded_url":"http://bit.ly/1H2bBkU","display_url":"bit.ly/1H2bBkU"}],"hashtags":[{"start":42,"end":48,"tag":"Nuwiq"},{"start":50,"end":61,"tag":"simoctocog"},{"start":84,"end":93,"tag":"medicine"},{"start":98,"end":110,"tag":"haemophilia"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the assessment report for #Nuwiq (#simoctocog alfa (rFVIII)), a new #medicine for #haemophilia A: http://t.co/aO26q5r2I5","source":"Bitly","id":"545979708727644161","lang":"en","created_at":"2014-12-19T16:31:21.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545978987026337792","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/5PAOeHMHlU","expanded_url":"http://bit.ly/1zcJ8cR","display_url":"bit.ly/1zcJ8cR"}],"hashtags":[{"start":69,"end":81,"tag":"antibiotics"}],"annotations":{}},"possibly_sensitive":false,"text":"We've issued recommendations to mitigate the risks due to the use of #antibiotics in animals: http://t.co/5PAOeHMHlU","source":"Bitly","id":"545978987026337792","lang":"en","created_at":"2014-12-19T16:28:28.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545978535442411520","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":102,"end":124,"url":"http://t.co/uNBqmojFVR","expanded_url":"http://bit.ly/1C91Gf4","display_url":"bit.ly/1C91Gf4"}],"hashtags":[{"start":125,"end":138,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"Send us your comments on our draft reflection paper on heat treatment to inactivate retrovirus RD114: http://t.co/uNBqmojFVR #consultation","source":"Bitly","id":"545978535442411520","lang":"en","created_at":"2014-12-19T16:26:41.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545978045245710336","author_id":"116716199","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @IMI_JU: The last IMI newsletter of 2014 is out! Call launches, new directors, updates from the projects and more at http://t.co/EQm0Msa…","source":"TweetDeck","id":"545978045245710336","lang":"en","created_at":"2014-12-19T16:24:44.000Z","referenced_tweets":[{"type":"retweeted","id":"545977475269132288"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545977875254755328","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/V98KH4unSQ","expanded_url":"http://bit.ly/1x58tVO","display_url":"bit.ly/1x58tVO"}],"hashtags":[{"start":126,"end":139,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"Send us your comments on our paper on replacement of cell lines in immunological veterinary medicines: http://t.co/V98KH4unSQ #consultation","source":"Bitly","id":"545977875254755328","lang":"en","created_at":"2014-12-19T16:24:03.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545977141788430336","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":19,"end":24,"tag":"EDQM"}],"annotations":[{"start":80,"end":88,"probability":0.9684,"type":"Other","normalized_text":"Christmas"}]},"possibly_sensitive":false,"text":"RT @edqm_news: The #EDQM reminds you that the offices will be closed during the Christmas period and will reopen on 5 January 2015. Merry C…","source":"TweetDeck","id":"545977141788430336","lang":"en","created_at":"2014-12-19T16:21:09.000Z","referenced_tweets":[{"type":"retweeted","id":"545974481689509888"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545977120032559104","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":85,"end":96,"tag":"Veterinary"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @edqm_news: The VBPR Contact List for the competent authorities for Immunological #Veterinary Medicinal Products was updated: http://t.c…","source":"TweetDeck","id":"545977120032559104","lang":"en","created_at":"2014-12-19T16:21:03.000Z","referenced_tweets":[{"type":"retweeted","id":"545973893115437056"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545977091788132352","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":[{"start":114,"end":136,"url":"http://t.co/MJT70hMgFo","expanded_url":"http://bit.ly/1xzaFEy","display_url":"bit.ly/1xzaFEy"}],"hashtags":[{"start":48,"end":63,"tag":"overthecounter"}],"annotations":[{"start":86,"end":91,"probability":0.9541,"type":"Place","normalized_text":"Zagreb"}]},"possibly_sensitive":false,"text":"RT @edqm_news: Just published: proceedings from #overthecounter medicines workshop in Zagreb, 20-21 November 2014 http://t.co/MJT70hMgFo","source":"TweetDeck","id":"545977091788132352","lang":"en","created_at":"2014-12-19T16:20:57.000Z","referenced_tweets":[{"type":"retweeted","id":"545971912628006912"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545918763347214337","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":16,"end":25,"username":"EMA_News","id":"116716199"}],"urls":[{"start":101,"end":123,"url":"http://t.co/AkHHWMxj1y","expanded_url":"http://bit.ly/1v7sg0L","display_url":"bit.ly/1v7sg0L"}],"hashtags":[{"start":48,"end":57,"tag":"stemcell"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EU_Health: .@EMA_News recommended the first #stemcell therapy for approval in the European Union http://t.co/AkHHWMxj1y http://t.co/fyz…","source":"TweetDeck","id":"545918763347214337","lang":"en","created_at":"2014-12-19T12:29:10.000Z","referenced_tweets":[{"type":"retweeted","id":"545918463567728640"}],"public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545916366830989313","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":99,"end":121,"url":"http://t.co/TF9CftqAZm","expanded_url":"http://bit.ly/1JeV8Od","display_url":"bit.ly/1JeV8Od"}],"hashtags":[{"start":18,"end":26,"tag":"Mysimba"},{"start":28,"end":39,"tag":"naltrexone"},{"start":42,"end":52,"tag":"bupropion"}],"annotations":{}},"possibly_sensitive":false,"text":"We've recommended #Mysimba (#naltrexone / #bupropion) for approval in weight management in adults: http://t.co/TF9CftqAZm","source":"Bitly","id":"545916366830989313","lang":"en","created_at":"2014-12-19T12:19:39.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":3,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545915967176712192","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":82,"end":104,"url":"http://t.co/ZO2oRL6Z7p","expanded_url":"http://bit.ly/1v7sg0L","display_url":"bit.ly/1v7sg0L"}],"hashtags":[{"start":28,"end":37,"tag":"stemcell"}],"annotations":{}},"possibly_sensitive":false,"text":"We've recommended the first #stemcell therapy for approval in the European Union: http://t.co/ZO2oRL6Z7p","source":"Bitly","id":"545915967176712192","lang":"en","created_at":"2014-12-19T12:18:03.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":16,"reply_count":1,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545915495548203008","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":106,"end":128,"url":"http://t.co/wzzgD3FX0G","expanded_url":"http://bit.ly/1wSR27S","display_url":"bit.ly/1wSR27S"}],"hashtags":[{"start":10,"end":19,"tag":"medicine"}],"annotations":{}},"possibly_sensitive":false,"text":"Our human #medicine committee (CHMP) has recommended 7 new medicines for approval (82 overall this year): http://t.co/wzzgD3FX0G","source":"Bitly","id":"545915495548203008","lang":"en","created_at":"2014-12-19T12:16:11.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":17,"reply_count":0,"like_count":3,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545884609628864512","author_id":"116716199","entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"},{"start":20,"end":27,"username":"US_FDA","id":"208120290"}],"urls":[{"start":96,"end":118,"url":"http://t.co/Ahc1y3FMfS","expanded_url":"http://bit.ly/1DRdKn1","display_url":"bit.ly/1DRdKn1"}],"hashtags":[{"start":61,"end":68,"tag":"trials"},{"start":72,"end":82,"tag":"medicines"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @Aifa_ufficiale: @US_FDA updates its guidance on clinical #trials on #medicines for children http://t.co/Ahc1y3FMfS","source":"TweetDeck","id":"545884609628864512","lang":"en","created_at":"2014-12-19T10:13:27.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545880300157669376","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":54,"end":66,"tag":"Antibiotics"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @edqm_news: Just out: New report classification of #Antibiotics and Chemotherapeutics for Dermatological Use, and Racecadotril http://t.…","source":"TweetDeck","id":"545880300157669376","lang":"en","created_at":"2014-12-19T09:56:20.000Z","referenced_tweets":[{"type":"retweeted","id":"545873504173064192"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545877483644796928","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":{},"hashtags":{},"annotations":[{"start":13,"end":33,"probability":0.5472,"type":"Organization","normalized_text":"EFSA Management Board"}]},"possibly_sensitive":false,"text":"RT @EFSA_EU: EFSA Management Board adopts Multi-annual Programme: learn more about EFSA’s projects for the next three years http://t.co/3Ec…","source":"TweetDeck","id":"545877483644796928","lang":"en","created_at":"2014-12-19T09:45:08.000Z","referenced_tweets":[{"type":"retweeted","id":"545861375982317568"}],"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545870616436703232","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/W6ybPETMRE","expanded_url":"http://bit.ly/1C1YdPp","display_url":"bit.ly/1C1YdPp"}],"hashtags":[{"start":29,"end":38,"tag":"Moventig"},{"start":40,"end":50,"tag":"naloxegol"},{"start":55,"end":64,"tag":"medicine"},{"start":69,"end":82,"tag":"constipation"},{"start":93,"end":101,"tag":"opioids"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the EPAR for #Moventig (#naloxegol), a #medicine for #constipation caused by #opioids: http://t.co/W6ybPETMRE","source":"TweetDeck","id":"545870616436703232","lang":"en","created_at":"2014-12-19T09:17:51.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545635860742692864","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":[{"start":104,"end":126,"url":"http://t.co/RNn1QeX1xE","expanded_url":"http://europa.eu/!NB94rB","display_url":"europa.eu/!NB94rB"}],"hashtags":[{"start":61,"end":72,"tag":"Innovation"},{"start":96,"end":103,"tag":"Ageing"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EU_Health: Save the date: 9-10/03/15: European Summit on #Innovation for Active and Healthy #Ageing http://t.co/RNn1QeX1xE  #AgeingSumm…","source":"TweetDeck","id":"545635860742692864","lang":"en","created_at":"2014-12-18T17:45:01.000Z","referenced_tweets":[{"type":"retweeted","id":"545576096096600066"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545635728269774848","author_id":"116716199","entities":{"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"}],"urls":[{"start":109,"end":131,"url":"http://t.co/hOaEf8LIVR","expanded_url":"http://goo.gl/0D4OKh","display_url":"goo.gl/0D4OKh"}],"hashtags":[{"start":45,"end":56,"tag":"continence"},{"start":57,"end":62,"tag":"care"},{"start":79,"end":88,"tag":"dementia"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @AlzheimerEurope: Our report on improving #continence #care for people with #dementia is free to download http://t.co/hOaEf8LIVR http://…","source":"TweetDeck","id":"545635728269774848","lang":"en","created_at":"2014-12-18T17:44:29.000Z","referenced_tweets":[{"type":"retweeted","id":"545593181203881984"}],"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545635010934747136","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":{},"hashtags":[{"start":70,"end":73,"tag":"EU"},{"start":74,"end":81,"tag":"Health"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EU_Health: 'Health, like happiness, can be difficult to measure.' #EU #Health newsletter on Health @ Glance report http://t.co/0SCnZjLC…","source":"TweetDeck","id":"545635010934747136","lang":"en","created_at":"2014-12-18T17:41:38.000Z","referenced_tweets":[{"type":"retweeted","id":"545607012340744193"}],"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545634842592169986","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":[{"start":107,"end":129,"url":"http://t.co/Yk2uyMrS5Z","expanded_url":"http://bit.ly/1Gvpw4B","display_url":"bit.ly/1Gvpw4B"}],"hashtags":{},"annotations":[{"start":40,"end":71,"probability":0.3731,"type":"Other","normalized_text":"Blood Proficiency Testing Scheme"}]},"possibly_sensitive":false,"text":"RT @edqm_news: Just published: view the Blood Proficiency Testing Scheme (B- PTS) studies planned for 2015 http://t.co/Yk2uyMrS5Z #bloodtra…","source":"TweetDeck","id":"545634842592169986","lang":"en","created_at":"2014-12-18T17:40:58.000Z","referenced_tweets":[{"type":"retweeted","id":"545619490596487169"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545634753446412288","author_id":"116716199","entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":102,"end":124,"url":"http://t.co/qyyuZNsSIG","expanded_url":"http://bit.ly/13gn6b7","display_url":"bit.ly/13gn6b7"}],"hashtags":[{"start":10,"end":15,"tag":"ANSM"},{"start":48,"end":61,"tag":"epidemiology"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @ansm: #ANSM is supporting two platforms for #epidemiology studies in the area of health products: http://t.co/qyyuZNsSIG","source":"TweetDeck","id":"545634753446412288","lang":"en","created_at":"2014-12-18T17:40:37.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545605409806233600","author_id":"116716199","entities":{"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"}],"urls":[{"start":100,"end":122,"url":"http://t.co/jAe76QTcKi","expanded_url":"http://bit.ly/16vP5G0","display_url":"bit.ly/16vP5G0"}],"hashtags":[{"start":37,"end":50,"tag":"patientvoice"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @IAPOtweets: We'll be sharing the #patientvoice on a global scale at WHO EB meeting in Jan 2015: http://t.co/jAe76QTcKi http://t.co/6lJ5…","source":"TweetDeck","id":"545605409806233600","lang":"en","created_at":"2014-12-18T15:44:01.000Z","referenced_tweets":[{"type":"retweeted","id":"545605001075494912"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545582622941147136","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":95,"end":117,"url":"http://t.co/0IIdOW1v8S","expanded_url":"http://bit.ly/1w2jYqb","display_url":"bit.ly/1w2jYqb"}],"hashtags":[{"start":30,"end":40,"tag":"guideline"},{"start":44,"end":54,"tag":"medicines"},{"start":118,"end":131,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"Two weeks to comment on draft #guideline on #medicines to prevent chronic renal insufficiency: http://t.co/0IIdOW1v8S #consultation","source":"Bitly","id":"545582622941147136","lang":"en","created_at":"2014-12-18T14:13:28.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545546866507927552","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/LBNLpi3Gym","expanded_url":"http://bit.ly/1J3rL1h","display_url":"bit.ly/1J3rL1h"}],"hashtags":[{"start":46,"end":62,"tag":"epidemiological"},{"start":91,"end":102,"tag":"infections"},{"start":127,"end":140,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"Two weeks to comment on revising guideline on #epidemiological data on blood-transmissible #infections: http://t.co/LBNLpi3Gym #consultation","source":"TweetDeck","id":"545546866507927552","lang":"en","created_at":"2014-12-18T11:51:23.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545546818768363520","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":99,"end":121,"url":"http://t.co/P7ei4XVAjs","expanded_url":"http://bit.ly/1thRMPp","display_url":"bit.ly/1thRMPp"}],"hashtags":[{"start":33,"end":43,"tag":"guideline"},{"start":66,"end":76,"tag":"medicines"},{"start":81,"end":87,"tag":"Crohn"},{"start":122,"end":135,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"Two weeks to comment on revising #guideline on development of new #medicines for #Crohn’s disease: http://t.co/P7ei4XVAjs #consultation","source":"TweetDeck","id":"545546818768363520","lang":"en","created_at":"2014-12-18T11:51:12.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545546786006638592","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/npqMwRFGhF","expanded_url":"http://bit.ly/1oAAOtS","display_url":"bit.ly/1oAAOtS"}],"hashtags":[{"start":33,"end":43,"tag":"guideline"},{"start":66,"end":76,"tag":"medicines"},{"start":81,"end":92,"tag":"ulcerative"},{"start":93,"end":101,"tag":"colitis"},{"start":126,"end":139,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"Two weeks to comment on revising #guideline on development of new #medicines for #ulcerative #colitis: http://t.co/npqMwRFGhF #consultation","source":"TweetDeck","id":"545546786006638592","lang":"en","created_at":"2014-12-18T11:51:04.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545520051290636288","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/W6ybPETMRE","expanded_url":"http://bit.ly/1C1YdPp","display_url":"bit.ly/1C1YdPp"}],"hashtags":[{"start":42,"end":51,"tag":"Moventig"},{"start":53,"end":63,"tag":"naloxegol"},{"start":68,"end":77,"tag":"medicine"},{"start":82,"end":95,"tag":"constipation"},{"start":106,"end":114,"tag":"opioids"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the assessment report for #Moventig (#naloxegol), a #medicine for #constipation caused by #opioids: http://t.co/W6ybPETMRE","source":"Bitly","id":"545520051290636288","lang":"en","created_at":"2014-12-18T10:04:50.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545284365010632704","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"hashtags":[{"start":39,"end":57,"tag":"infectiousdisease"},{"start":64,"end":77,"tag":"epidemiology"},{"start":95,"end":108,"tag":"microbiology"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @ECDC_EU: Interested in training in #infectiousdisease field #epidemiology or public health #microbiology? Apply by 2 Feb 2015: http://t…","source":"TweetDeck","id":"545284365010632704","lang":"en","created_at":"2014-12-17T18:28:18.000Z","referenced_tweets":[{"type":"retweeted","id":"545241335981424641"}],"public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545283380045426688","author_id":"116716199","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":108,"end":124,"username":"gatesfoundation","id":"17899109"}],"urls":{},"hashtags":[{"start":12,"end":17,"tag":"IMI2"},{"start":45,"end":55,"tag":"pertussis"},{"start":58,"end":72,"tag":"WhoopingCough"},{"start":73,"end":82,"tag":"vaccines"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @IMI_JU: #IMI2 Call 3 includes a topic on #pertussis / #WhoopingCough #vaccines where IMI will work with @gatesfoundation http://t.co/wm…","source":"TweetDeck","id":"545283380045426688","lang":"en","created_at":"2014-12-17T18:24:23.000Z","referenced_tweets":[{"type":"retweeted","id":"545259825060642816"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545283351511592960","author_id":"116716199","entities":{"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"}],"urls":[{"start":69,"end":91,"url":"http://t.co/73Ew9B41iC","expanded_url":"http://bit.ly/1FKVmtH","display_url":"bit.ly/1FKVmtH"},{"start":108,"end":130,"url":"http://t.co/9hJSc9ywdg","expanded_url":"https://twitter.com/IAPOtweets/status/545260846172340224/photo/1","display_url":"pic.twitter.com/9hJSc9ywdg"}],"hashtags":[{"start":92,"end":97,"tag":"news"},{"start":98,"end":107,"tag":"patients"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @IAPOtweets: Did you miss our December newsletter? Catch up here: http://t.co/73Ew9B41iC #news #patients http://t.co/9hJSc9ywdg","source":"TweetDeck","id":"545283351511592960","lang":"en","created_at":"2014-12-17T18:24:16.000Z","referenced_tweets":[{"type":"retweeted","id":"545260846172340224"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_545260845404815362"]}},{"conversation_id":"545283305646878722","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":{},"hashtags":[{"start":22,"end":25,"tag":"EU"},{"start":47,"end":58,"tag":"healthcare"},{"start":72,"end":86,"tag":"patientsafety"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EU_Health: Future #EU agenda on quality of #healthcare: emphasis on #patientsafety - final opinion &amp; contributions available http://t.c…","source":"TweetDeck","id":"545283305646878722","lang":"en","created_at":"2014-12-17T18:24:05.000Z","referenced_tweets":[{"type":"retweeted","id":"545265094092144641"}],"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545283273933725696","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"urls":[{"start":68,"end":90,"url":"http://t.co/Z8p7VKMiPo","expanded_url":"http://ht.ly/G2K5M","display_url":"ht.ly/G2K5M"}],"hashtags":{},"annotations":[{"start":14,"end":16,"probability":0.72,"type":"Organization","normalized_text":"FDA"},{"start":63,"end":66,"probability":0.91,"type":"Place","normalized_text":"U.S."}]},"possibly_sensitive":false,"text":"RT @FDA_MCMi: FDA fact sheet: Biosafety and Biosecurity in the U.S. http://t.co/Z8p7VKMiPo","source":"TweetDeck","id":"545283273933725696","lang":"en","created_at":"2014-12-17T18:23:58.000Z","referenced_tweets":[{"type":"retweeted","id":"545269718488449024"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545283176894320641","author_id":"116716199","entities":{"mentions":[{"start":3,"end":18,"username":"rarediseaseday","id":"19982434"}],"urls":[{"start":96,"end":118,"url":"http://t.co/Nr0r6VSMC2","expanded_url":"http://ow.ly/FUUD4","display_url":"ow.ly/FUUD4"}],"hashtags":[{"start":33,"end":45,"tag":"RareDisease"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @rarediseaseday: Download the #RareDisease Day information pack and communication materials! http://t.co/Nr0r6VSMC2","source":"TweetDeck","id":"545283176894320641","lang":"en","created_at":"2014-12-17T18:23:34.000Z","referenced_tweets":[{"type":"retweeted","id":"545277604937617408"}],"public_metrics":{"retweet_count":23,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545280473296285696","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/npqMwRFGhF","expanded_url":"http://bit.ly/1oAAOtS","display_url":"bit.ly/1oAAOtS"}],"hashtags":[{"start":33,"end":43,"tag":"guideline"},{"start":66,"end":76,"tag":"medicines"},{"start":81,"end":92,"tag":"ulcerative"},{"start":93,"end":101,"tag":"colitis"},{"start":126,"end":139,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"Two weeks to comment on revising #guideline on development of new #medicines for #ulcerative #colitis: http://t.co/npqMwRFGhF #consultation","source":"Bitly","id":"545280473296285696","lang":"en","created_at":"2014-12-17T18:12:50.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545280143259090944","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":99,"end":121,"url":"http://t.co/P7ei4XVAjs","expanded_url":"http://bit.ly/1thRMPp","display_url":"bit.ly/1thRMPp"}],"hashtags":[{"start":33,"end":43,"tag":"guideline"},{"start":66,"end":76,"tag":"medicines"},{"start":81,"end":87,"tag":"Crohn"},{"start":122,"end":135,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"Two weeks to comment on revising #guideline on development of new #medicines for #Crohn’s disease: http://t.co/P7ei4XVAjs #consultation","source":"Bitly","id":"545280143259090944","lang":"en","created_at":"2014-12-17T18:11:31.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545277215970455552","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/LBNLpi3Gym","expanded_url":"http://bit.ly/1J3rL1h","display_url":"bit.ly/1J3rL1h"}],"hashtags":[{"start":46,"end":62,"tag":"epidemiological"},{"start":91,"end":102,"tag":"infections"},{"start":127,"end":140,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"Two weeks to comment on revising guideline on #epidemiological data on blood-transmissible #infections: http://t.co/LBNLpi3Gym #consultation","source":"Bitly","id":"545277215970455552","lang":"en","created_at":"2014-12-17T17:59:53.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545276359430635520","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":82,"end":104,"url":"http://t.co/5Yw5m1OEtt","expanded_url":"http://bit.ly/1IXaHtu","display_url":"bit.ly/1IXaHtu"}],"hashtags":[{"start":63,"end":69,"tag":"Ebola"}],"annotations":{}},"possibly_sensitive":false,"text":"More information on safety and efficacy needed on experimental #Ebola treatments: http://t.co/5Yw5m1OEtt","source":"TweetDeck","id":"545276359430635520","lang":"en","created_at":"2014-12-17T17:56:29.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545275951752691712","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":86,"end":108,"url":"http://t.co/TOpUqdjcjM","expanded_url":"http://bit.ly/1yYgEDo","display_url":"bit.ly/1yYgEDo"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"Our Management Board is meeting tomorrow. We'll publish highlights after the meeting: http://t.co/TOpUqdjcjM","source":"TweetDeck","id":"545275951752691712","lang":"en","created_at":"2014-12-17T17:54:52.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545275766188294145","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":67,"end":89,"url":"http://t.co/dm5KD7k8Va","expanded_url":"http://bit.ly/1AChFOB","display_url":"bit.ly/1AChFOB"}],"hashtags":[{"start":38,"end":49,"tag":"veterinary"}],"annotations":{}},"possibly_sensitive":false,"text":"We have a new expert group to support #veterinary novel therapies: http://t.co/dm5KD7k8Va","source":"TweetDeck","id":"545275766188294145","lang":"en","created_at":"2014-12-17T17:54:08.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545275505780748288","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":66,"end":88,"url":"http://t.co/Pehg2dXo6Q","expanded_url":"http://bit.ly/16pN5Pl","display_url":"bit.ly/16pN5Pl"}],"hashtags":[{"start":20,"end":30,"tag":"guideline"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published our #guideline on quality of transdermal patches: http://t.co/Pehg2dXo6Q","source":"TweetDeck","id":"545275505780748288","lang":"en","created_at":"2014-12-17T17:53:05.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545275342915919872","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":70,"end":92,"url":"http://t.co/Y41VXz75ja","expanded_url":"http://bit.ly/1wCQFzj","display_url":"bit.ly/1wCQFzj"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the #agenda of our Management Board meeting tomorrow: http://t.co/Y41VXz75ja","source":"TweetDeck","id":"545275342915919872","lang":"en","created_at":"2014-12-17T17:52:27.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"545275057082482688","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":73,"end":95,"url":"http://t.co/XE1SpRyLfy","expanded_url":"http://bit.ly/13uy25Y","display_url":"bit.ly/13uy25Y"}],"hashtags":[{"start":20,"end":28,"tag":"minutes"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the #minutes of our Management Board meeting in October: http://t.co/XE1SpRyLfy","source":"TweetDeck","id":"545275057082482688","lang":"en","created_at":"2014-12-17T17:51:18.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544915874860523520","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":80,"end":102,"url":"http://t.co/XE1SpRyLfy","expanded_url":"http://bit.ly/13uy25Y","display_url":"bit.ly/13uy25Y"}],"hashtags":[{"start":25,"end":33,"tag":"minutes"}],"annotations":{}},"possibly_sensitive":false,"text":"We've just published the #minutes from our Management Board meeting in October: http://t.co/XE1SpRyLfy","source":"Bitly","id":"544915874860523520","lang":"en","created_at":"2014-12-16T18:04:03.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544915195932712961","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":74,"end":96,"url":"http://t.co/Y41VXz75ja","expanded_url":"http://bit.ly/1wCQFzj","display_url":"bit.ly/1wCQFzj"}],"hashtags":[{"start":25,"end":32,"tag":"agenda"}],"annotations":{}},"possibly_sensitive":false,"text":"We've just published the #agenda of this week's Management Board meeting: http://t.co/Y41VXz75ja","source":"Bitly","id":"544915195932712961","lang":"en","created_at":"2014-12-16T18:01:21.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544914658839523328","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":71,"end":93,"url":"http://t.co/Pehg2dXo6Q","expanded_url":"http://bit.ly/16pN5Pl","display_url":"bit.ly/16pN5Pl"}],"hashtags":[{"start":25,"end":35,"tag":"guideline"}],"annotations":{}},"possibly_sensitive":false,"text":"We've just published our #guideline on quality of transdermal patches: http://t.co/Pehg2dXo6Q","source":"Bitly","id":"544914658839523328","lang":"en","created_at":"2014-12-16T17:59:13.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544914011029270528","author_id":"116716199","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":71,"end":75,"username":"EMA","id":"2183581"}],"urls":[{"start":76,"end":98,"url":"http://t.co/4ErdNBm2zn","expanded_url":"http://goo.gl/8s7dHV","display_url":"goo.gl/8s7dHV"}],"hashtags":[{"start":43,"end":54,"tag":"veterinary"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EFPIA: New EMA expert group to support #veterinary novel therapies @EMA http://t.co/4ErdNBm2zn","source":"TweetDeck","id":"544914011029270528","lang":"en","created_at":"2014-12-16T17:56:38.000Z","referenced_tweets":[{"type":"retweeted","id":"544909910736384000"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544908488393375744","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":[{"start":95,"end":117,"url":"http://t.co/zBTbuicWUL","expanded_url":"http://go.usa.gov/FtSR","display_url":"go.usa.gov/FtSR"}],"hashtags":[{"start":27,"end":31,"tag":"flu"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @FDACBER: Learn how the #flu vaccine is made and approved each year. It’s a year-round job! http://t.co/zBTbuicWUL","source":"TweetDeck","id":"544908488393375744","lang":"en","created_at":"2014-12-16T17:34:42.000Z","referenced_tweets":[{"type":"retweeted","id":"544908124092514306"}],"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544908263947763713","author_id":"116716199","entities":{"mentions":{},"urls":{},"hashtags":[{"start":20,"end":31,"tag":"DidYouKnow"}],"annotations":[{"start":112,"end":113,"probability":0.7183,"type":"Organization","normalized_text":"EU"}]},"possibly_sensitive":false,"text":"RT @egabiosimilars: #DidYouKnow We have more than 400 million treatment days worldwide clinical experience with EU approved #biosimilarmedi…","source":"TweetDeck","id":"544908263947763713","lang":"en","created_at":"2014-12-16T17:33:48.000Z","referenced_tweets":[{"type":"retweeted","id":"544899280679759872"}],"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544907979364265986","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":[{"start":109,"end":131,"url":"http://t.co/ceSI0HPUjK","expanded_url":"http://bit.ly/1EtO2jF","display_url":"bit.ly/1EtO2jF"}],"hashtags":[{"start":19,"end":33,"tag":"certification"},{"start":132,"end":136,"tag":"CEP"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @edqm_news: New #certification monthly report shows 23 CEPs granted this month out of 24 new applications http://t.co/ceSI0HPUjK #CEP","source":"TweetDeck","id":"544907979364265986","lang":"en","created_at":"2014-12-16T17:32:40.000Z","referenced_tweets":[{"type":"retweeted","id":"544893584739405824"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544907866046750720","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"FDAMedia","id":"2528303509"}],"urls":{},"hashtags":{},"annotations":[{"start":14,"end":16,"probability":0.9179,"type":"Organization","normalized_text":"FDA"}]},"possibly_sensitive":false,"text":"RT @FDAMedia: FDA proposes electronic distribution of Rx medication information to ensure best info gets to prescribers http://t.co/kY6cr6m…","source":"TweetDeck","id":"544907866046750720","lang":"en","created_at":"2014-12-16T17:32:13.000Z","referenced_tweets":[{"type":"retweeted","id":"544891713794621440"}],"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544888740901302272","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":78,"end":100,"url":"http://t.co/dm5KD7k8Va","expanded_url":"http://bit.ly/1AChFOB","display_url":"bit.ly/1AChFOB"}],"hashtags":[{"start":101,"end":112,"tag":"veterinary"}],"annotations":{}},"possibly_sensitive":false,"text":"We've set up a new expert group to focus on innovative medicines for animals: http://t.co/dm5KD7k8Va #veterinary","source":"Bitly","id":"544888740901302272","lang":"en","created_at":"2014-12-16T16:16:14.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544884596522094592","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":39,"end":44,"tag":"EDQM"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @edqm_news: Did you see it? The new #EDQM Physico-chemical and Biological Proficiency testing scheme for 2015 is now online http://t.co/…","source":"TweetDeck","id":"544884596522094592","lang":"en","created_at":"2014-12-16T15:59:45.000Z","referenced_tweets":[{"type":"retweeted","id":"544883709393268736"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544878863143034880","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":{},"hashtags":[{"start":79,"end":92,"tag":"EURegulation"}],"annotations":[{"start":96,"end":120,"probability":0.2937,"type":"Organization","normalized_text":"Orphan Medicinal Products"}]},"possibly_sensitive":false,"text":"RT @eurordis: 16 December marks the 15 year anniversary of the adoption of the #EURegulation on Orphan Medicinal Products http://t.co/uwuhl…","source":"TweetDeck","id":"544878863143034880","lang":"en","created_at":"2014-12-16T15:36:58.000Z","referenced_tweets":[{"type":"retweeted","id":"544877406079967232"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544874096044302336","author_id":"116716199","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":[{"start":110,"end":132,"url":"http://t.co/M8fNP9XkXd","expanded_url":"http://bit.ly/webinarsCall3-4","display_url":"bit.ly/webinarsCall3-4"}],"hashtags":{},"annotations":[{"start":20,"end":24,"probability":0.3435,"type":"Person","normalized_text":"MAPPs"}]},"possibly_sensitive":false,"text":"RT @IMI_JU: What is MAPPs? Find out and learn how you can be part of a MAPP IMI project at tomorrow's webinar http://t.co/M8fNP9XkXd","source":"TweetDeck","id":"544874096044302336","lang":"en","created_at":"2014-12-16T15:18:02.000Z","referenced_tweets":[{"type":"retweeted","id":"544857020730732544"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544840092955996160","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/TOpUqdjcjM","expanded_url":"http://bit.ly/1yYgEDo","display_url":"bit.ly/1yYgEDo"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"Our Management Board is meeting this week. We'll publish highlights once the meeting is over: http://t.co/TOpUqdjcjM","source":"Bitly","id":"544840092955996160","lang":"en","created_at":"2014-12-16T13:02:55.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544839418713210880","author_id":"116716199","entities":{"mentions":[{"start":3,"end":14,"username":"luca__pani","id":"2176193576"}],"urls":[{"start":104,"end":126,"url":"http://t.co/FY54mVIjJx","expanded_url":"http://bit.ly/1BTkzml","display_url":"bit.ly/1BTkzml"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @luca__pani: Target populations in clinical trials. Editorial in JAMA on analysis of new guidelines. http://t.co/FY54mVIjJx","source":"TweetDeck","id":"544839418713210880","lang":"en","created_at":"2014-12-16T13:00:14.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544839011307909122","author_id":"116716199","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":70,"end":92,"url":"http://t.co/qKYTq1jeIR","expanded_url":"http://goo.gl/K4imht","display_url":"goo.gl/K4imht"}],"hashtags":[{"start":62,"end":69,"tag":"cancer"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EFPIA: New targeted drugs could treat drug-resistant skin #cancer\nhttp://t.co/qKYTq1jeIR","source":"TweetDeck","id":"544839011307909122","lang":"en","created_at":"2014-12-16T12:58:37.000Z","referenced_tweets":[{"type":"retweeted","id":"544838126708211713"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544838891157880832","author_id":"116716199","entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":116,"end":138,"url":"http://t.co/y6qM6xptOx","expanded_url":"http://bit.ly/1BQjfOi","display_url":"bit.ly/1BQjfOi"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @LV_MPA: The Swedish medicines agency has analysed actions to achieve reduced environmental impact of medicines: http://t.co/y6qM6xptOx","source":"TweetDeck","id":"544838891157880832","lang":"en","created_at":"2014-12-16T12:58:08.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544837138354044928","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":75,"end":97,"url":"http://t.co/5Yw5m1OEtt","expanded_url":"http://bit.ly/1IXaHtu","display_url":"bit.ly/1IXaHtu"}],"hashtags":[{"start":13,"end":19,"tag":"Ebola"}],"annotations":{}},"possibly_sensitive":false,"text":"Experimental #Ebola treatments are still at an early stage of development: http://t.co/5Yw5m1OEtt","source":"Bitly","id":"544837138354044928","lang":"en","created_at":"2014-12-16T12:51:11.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544826823419645952","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":90,"end":112,"url":"http://t.co/ERSjFjAylb","expanded_url":"http://bit.ly/1wSoQ89","display_url":"bit.ly/1wSoQ89"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":29,"end":40,"tag":"veterinary"}],"annotations":{}},"possibly_sensitive":false,"text":"The #minutes of the November #veterinary medicine (CVMP) committee meeting are available: http://t.co/ERSjFjAylb","source":"Twitter Web Client","id":"544826823419645952","lang":"en","created_at":"2014-12-16T12:10:11.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544825606270357504","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":102,"end":124,"url":"http://t.co/89aFNOmYYv","expanded_url":"http://bit.ly/12VvzR9","display_url":"bit.ly/12VvzR9"}],"hashtags":[{"start":125,"end":138,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"Comment now on our guideline on minimal residue disease as endpoint in chronic lymphocytic leukaemia: http://t.co/89aFNOmYYv #consultation","source":"Twitter Web Client","id":"544825606270357504","lang":"en","created_at":"2014-12-16T12:05:21.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544825277566943232","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":88,"end":110,"url":"http://t.co/1xXZikkJlD","expanded_url":"http://bit.ly/1wSoDSy","display_url":"bit.ly/1wSoDSy"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":44,"end":55,"tag":"Paediatric"}],"annotations":{}},"possibly_sensitive":false,"text":"The #minutes of the November meeting of the #Paediatric Committee (PDCO) are available: http://t.co/1xXZikkJlD","source":"Twitter Web Client","id":"544825277566943232","lang":"en","created_at":"2014-12-16T12:04:03.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544825116627333120","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":88,"end":110,"url":"http://t.co/NFGRQAkBFE","expanded_url":"http://bit.ly/1ISXuC1","display_url":"bit.ly/1ISXuC1"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":29,"end":47,"tag":"pharmacovigilance"}],"annotations":{}},"possibly_sensitive":false,"text":"The #minutes of the November #pharmacovigilance committee (PRAC) meeting are available: http://t.co/NFGRQAkBFE","source":"Twitter Web Client","id":"544825116627333120","lang":"en","created_at":"2014-12-16T12:03:24.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544824122371735554","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":97,"end":119,"url":"http://t.co/ucJU4eCNOP","expanded_url":"http://bit.ly/1w9nJiz","display_url":"bit.ly/1w9nJiz"}],"hashtags":[{"start":53,"end":60,"tag":"herbal"},{"start":74,"end":85,"tag":"Centaurium"},{"start":120,"end":133,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"Send us scientific data to support the review of the #herbal monograph on #Centaurium erythraea: http://t.co/ucJU4eCNOP #consultation","source":"Twitter Web Client","id":"544824122371735554","lang":"en","created_at":"2014-12-16T11:59:27.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544823777734197248","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":91,"end":113,"url":"http://t.co/LawLq4wjfm","expanded_url":"http://bit.ly/1yRFCzv","display_url":"bit.ly/1yRFCzv"}],"hashtags":[{"start":53,"end":60,"tag":"herbal"},{"start":74,"end":83,"tag":"Fragaria"},{"start":114,"end":127,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"Send us scientific data to support the review of the #herbal monograph on #Fragaria vesca: http://t.co/LawLq4wjfm #consultation","source":"Twitter Web Client","id":"544823777734197248","lang":"en","created_at":"2014-12-16T11:58:05.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544823556245557248","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":95,"end":117,"url":"http://t.co/oC3QYNKLX8","expanded_url":"http://bit.ly/13610b9","display_url":"bit.ly/13610b9"}],"hashtags":[{"start":53,"end":60,"tag":"herbal"},{"start":74,"end":81,"tag":"Salvia"},{"start":118,"end":131,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"Send us scientific data to support the review of the #herbal monograph on #Salvia officinalis: http://t.co/oC3QYNKLX8 #consultation","source":"Twitter Web Client","id":"544823556245557248","lang":"en","created_at":"2014-12-16T11:57:12.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544823022054834176","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":96,"end":118,"url":"http://t.co/QQaGNL4EZF","expanded_url":"http://bit.ly/16nYoaU","display_url":"bit.ly/16nYoaU"}],"hashtags":[{"start":53,"end":60,"tag":"herbal"},{"start":74,"end":82,"tag":"Althaea"},{"start":119,"end":132,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"Send us scientific data to support the review of the #herbal monograph on #Althaea officinalis: http://t.co/QQaGNL4EZF #consultation","source":"Twitter Web Client","id":"544823022054834176","lang":"en","created_at":"2014-12-16T11:55:05.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544822784934023169","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":119,"end":141,"url":"http://t.co/gOG8UKyqWF","expanded_url":"http://bit.ly/1AyOdJk","display_url":"bit.ly/1AyOdJk"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"Scientists argue scientific &amp; political changes will make adaptive pathways preferred approach for new treatments: http://t.co/gOG8UKyqWF","source":"Twitter Web Client","id":"544822784934023169","lang":"en","created_at":"2014-12-16T11:54:08.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544822322444902400","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":82,"end":104,"url":"http://t.co/YA6NLyTK36","expanded_url":"http://bit.ly/1suEOUD","display_url":"bit.ly/1suEOUD"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"}],"annotations":{}},"possibly_sensitive":false,"text":"The #agenda for this week's human medicine committee (CHMP) meeting is available: http://t.co/YA6NLyTK36","source":"Twitter Web Client","id":"544822322444902400","lang":"en","created_at":"2014-12-16T11:52:18.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544821326373216256","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @EU_ECHA: ECHA Newsletter guest column: Communicating about safety - compliance through efficient substance tracking. http://t.co/RV6VG5…","source":"TweetDeck","id":"544821326373216256","lang":"en","created_at":"2014-12-16T11:48:21.000Z","referenced_tweets":[{"type":"retweeted","id":"544814258140495872"}],"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544820239754887169","author_id":"116716199","entities":{"mentions":[{"start":3,"end":18,"username":"ECDC_Outbreaks","id":"2754484003"}],"urls":{},"hashtags":[{"start":27,"end":32,"tag":"CDTR"},{"start":48,"end":54,"tag":"Ebola"},{"start":81,"end":92,"tag":"poliovirus"}],"annotations":[{"start":131,"end":135,"probability":0.942,"type":"Place","normalized_text":"Egypt"}]},"possibly_sensitive":false,"text":"RT @ECDC_Outbreaks: Weekly #CDTR out, 50/2014:  #Ebola update; new cases of wild #poliovirus; new human cases influenza A(H5N1) in Egypt ht…","source":"TweetDeck","id":"544820239754887169","lang":"en","created_at":"2014-12-16T11:44:02.000Z","referenced_tweets":[{"type":"retweeted","id":"544798939757969408"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544820082191654912","author_id":"116716199","entities":{"mentions":[{"start":3,"end":14,"username":"luca__pani","id":"2176193576"}],"urls":[{"start":104,"end":126,"url":"http://t.co/Vwx0XjJLao","expanded_url":"http://bit.ly/1sw5vT9","display_url":"bit.ly/1sw5vT9"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @luca__pani: Pneumonia: antibiotics do not work without rules. NICE: simple blood test can limit use http://t.co/Vwx0XjJLao","source":"TweetDeck","id":"544820082191654912","lang":"en","created_at":"2014-12-16T11:43:24.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544819768684212224","author_id":"116716199","entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"urls":[{"start":105,"end":127,"url":"http://t.co/Icpze22k5X","expanded_url":"http://bit.ly/1yM6AcQ","display_url":"bit.ly/1yM6AcQ"}],"hashtags":[{"start":17,"end":34,"tag":"Genericmedicines"},{"start":128,"end":140,"tag":"EGAgenerics"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @egagenerics: #Genericmedicines can be marketed after the patent for their branded equivalent expires http://t.co/Icpze22k5X #EGAgenerics","source":"TweetDeck","id":"544819768684212224","lang":"en","created_at":"2014-12-16T11:42:09.000Z","referenced_tweets":[{"type":"retweeted","id":"544794069658898433"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544819092352679936","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":83,"end":105,"url":"http://t.co/9CHEXb8vqW","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_000098.jsp&mid=WC0b01ac0580028c2f","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":{},"annotations":[{"start":37,"end":58,"probability":0.2578,"type":"Other","normalized_text":"EMA's Management Board"}]},"possibly_sensitive":false,"text":"RT @GCessak: The 86th meeting of the EMA's Management Board will be start tomorrow http://t.co/9CHEXb8vqW","source":"TweetDeck","id":"544819092352679936","lang":"en","created_at":"2014-12-16T11:39:28.000Z","referenced_tweets":[{"type":"retweeted","id":"544781683300773888"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544818700126535681","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":86,"end":108,"url":"http://t.co/c6ywSBHzr3","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/12/news_detail_002234.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @GCessak: Adaptive pathways: a future approach to bring new medicines to patients? http://t.co/c6ywSBHzr3","source":"TweetDeck","id":"544818700126535681","lang":"en","created_at":"2014-12-16T11:37:55.000Z","referenced_tweets":[{"type":"retweeted","id":"544780835183157248"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544817223874150401","author_id":"116716199","entities":{"mentions":[{"start":3,"end":16,"username":"IDFEuropeBXL","id":"848831221"},{"start":80,"end":89,"username":"eu2015lv","id":"3217949032"},{"start":96,"end":111,"username":"guntisbelevics","id":"138015667"},{"start":115,"end":124,"username":"Parlimag","id":"21223877"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @IDFEuropeBxl: Healthy lifestyle &amp; patient safety amongst priorities for @eu2015lv, says @guntisbelevics to @Parlimag http://t.co/1iPpt2…","source":"TweetDeck","id":"544817223874150401","lang":"en","created_at":"2014-12-16T11:32:03.000Z","referenced_tweets":[{"type":"retweeted","id":"544775933379747840"}],"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544538663229874176","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"FDAMedia","id":"2528303509"}],"urls":[{"start":78,"end":100,"url":"http://t.co/1mWpnIv1Be","expanded_url":"http://go.usa.gov/FAJT","display_url":"go.usa.gov/FAJT"}],"hashtags":{},"annotations":[{"start":14,"end":16,"probability":0.8862,"type":"Organization","normalized_text":"FDA"},{"start":46,"end":53,"probability":0.6482,"type":"Person","normalized_text":"Tourette"}]},"possibly_sensitive":false,"text":"RT @FDAMedia: FDA expands drug’s use to treat Tourette’s Disorder in children http://t.co/1mWpnIv1Be","source":"TweetDeck","id":"544538663229874176","lang":"en","created_at":"2014-12-15T17:05:09.000Z","referenced_tweets":[{"type":"retweeted","id":"544538197255278592"}],"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544525263988858880","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/89aFNOmYYv","expanded_url":"http://bit.ly/12VvzR9","display_url":"bit.ly/12VvzR9"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"#Consultation open on our guideline on minimal residue disease as endpoint in chronic lymphocytic leukaemia studies: http://t.co/89aFNOmYYv","source":"Bitly","id":"544525263988858880","lang":"en","created_at":"2014-12-15T16:11:54.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544523772964134912","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":89,"end":111,"url":"http://t.co/X0ur6dWJgm","expanded_url":"http://bit.ly/16okIRI","display_url":"bit.ly/16okIRI"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @AEMPSGOB: November 2014 monthly bulletin from the Spanish medicines agency published http://t.co/X0ur6dWJgm","source":"TweetDeck","id":"544523772964134912","lang":"en","created_at":"2014-12-15T16:05:58.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544523326174281728","author_id":"116716199","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":[{"start":107,"end":129,"url":"http://t.co/M8fNP9XkXd","expanded_url":"http://bit.ly/webinarsCall3-4","display_url":"bit.ly/webinarsCall3-4"}],"hashtags":[{"start":73,"end":82,"tag":"patients"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @IMI_JU: Webinar on IMI’s Call topic on medicines adaptive pathway to #patients (MAPPs): 17/12 at 14:30 http://t.co/M8fNP9XkXd","source":"TweetDeck","id":"544523326174281728","lang":"en","created_at":"2014-12-15T16:04:12.000Z","referenced_tweets":[{"type":"retweeted","id":"544515984221290497"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544472551179956224","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/ERSjFjAylb","expanded_url":"http://bit.ly/1wSoQ89","display_url":"bit.ly/1wSoQ89"}],"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":45,"end":56,"tag":"veterinary"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the #minutes of the November #veterinary medicine (CVMP) committee meeting: http://t.co/ERSjFjAylb","source":"Bitly","id":"544472551179956224","lang":"en","created_at":"2014-12-15T12:42:26.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544472130617094144","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":90,"end":112,"url":"http://t.co/1xXZikkJlD","expanded_url":"http://bit.ly/1wSoDSy","display_url":"bit.ly/1wSoDSy"}],"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":60,"end":71,"tag":"Paediatric"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the #minutes of the November meeting of the #Paediatric Committee (PDCO): http://t.co/1xXZikkJlD","source":"Bitly","id":"544472130617094144","lang":"en","created_at":"2014-12-15T12:40:46.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544471645852041216","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":90,"end":112,"url":"http://t.co/NFGRQAkBFE","expanded_url":"http://bit.ly/1ISXuC1","display_url":"bit.ly/1ISXuC1"}],"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":45,"end":63,"tag":"pharmacovigilance"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the #minutes of the November #pharmacovigilance committee (PRAC) meeting: http://t.co/NFGRQAkBFE","source":"Bitly","id":"544471645852041216","lang":"en","created_at":"2014-12-15T12:38:50.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544468270905323520","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/ucJU4eCNOP","expanded_url":"http://bit.ly/1w9nJiz","display_url":"bit.ly/1w9nJiz"}],"hashtags":[{"start":71,"end":78,"tag":"herbal"},{"start":92,"end":103,"tag":"Centaurium"}],"annotations":{}},"possibly_sensitive":false,"text":"We've launched a call for scientific data to support the review of the #herbal monograph on #Centaurium erythraea: http://t.co/ucJU4eCNOP","source":"Bitly","id":"544468270905323520","lang":"en","created_at":"2014-12-15T12:25:26.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544467631261368320","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/LawLq4wjfm","expanded_url":"http://bit.ly/1yRFCzv","display_url":"bit.ly/1yRFCzv"}],"hashtags":[{"start":71,"end":78,"tag":"herbal"},{"start":92,"end":101,"tag":"Fragaria"}],"annotations":{}},"possibly_sensitive":false,"text":"We've launched a call for scientific data to support the review of the #herbal monograph on #Fragaria vesca: http://t.co/LawLq4wjfm","source":"Bitly","id":"544467631261368320","lang":"en","created_at":"2014-12-15T12:22:53.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544467016787435520","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":113,"end":135,"url":"http://t.co/oC3QYNKLX8","expanded_url":"http://bit.ly/13610b9","display_url":"bit.ly/13610b9"}],"hashtags":[{"start":71,"end":78,"tag":"herbal"},{"start":92,"end":99,"tag":"Salvia"}],"annotations":{}},"possibly_sensitive":false,"text":"We've launched a call for scientific data to support the review of the #herbal monograph on #Salvia officinalis: http://t.co/oC3QYNKLX8","source":"Bitly","id":"544467016787435520","lang":"en","created_at":"2014-12-15T12:20:27.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544466492969213952","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/QQaGNL4EZF","expanded_url":"http://bit.ly/16nYoaU","display_url":"bit.ly/16nYoaU"}],"hashtags":[{"start":71,"end":78,"tag":"herbal"},{"start":92,"end":100,"tag":"Althaea"}],"annotations":{}},"possibly_sensitive":false,"text":"We've launched a call for scientific data to support the review of the #herbal monograph on #Althaea officinalis: http://t.co/QQaGNL4EZF","source":"Bitly","id":"544466492969213952","lang":"en","created_at":"2014-12-15T12:18:22.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544464232105136128","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":76,"end":98,"url":"http://t.co/gOG8UKyqWF","expanded_url":"http://bit.ly/1AyOdJk","display_url":"bit.ly/1AyOdJk"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"Are adaptive pathways a future approach to bring new medicines to patients? http://t.co/gOG8UKyqWF","source":"Bitly","id":"544464232105136128","lang":"en","created_at":"2014-12-15T12:09:23.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544463098577690624","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":107,"end":129,"url":"http://t.co/xDeMNeykeR","expanded_url":"http://bit.ly/1ux49Z2","display_url":"bit.ly/1ux49Z2"}],"hashtags":[{"start":68,"end":77,"tag":"vultures"},{"start":94,"end":105,"tag":"diclofenac"}],"annotations":{}},"possibly_sensitive":false,"text":"We've recommended that measures be put in place to protect European #vultures from veterinary #diclofenac: http://t.co/xDeMNeykeR","source":"Twitter Web Client","id":"544463098577690624","lang":"en","created_at":"2014-12-15T12:04:52.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544462663351562240","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/F84YfeQI1N","expanded_url":"http://bit.ly/1soq8k6","display_url":"bit.ly/1soq8k6"}],"hashtags":[{"start":54,"end":65,"tag":"veterinary"},{"start":66,"end":76,"tag":"medicines"}],"annotations":{}},"possibly_sensitive":false,"text":"On Friday we published the highlights of the December #veterinary #medicines committee (CVMP) meeting: http://t.co/F84YfeQI1N","source":"Twitter Web Client","id":"544462663351562240","lang":"en","created_at":"2014-12-15T12:03:09.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544462126942015490","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":84,"end":106,"url":"http://t.co/YA6NLyTK36","expanded_url":"http://bit.ly/1suEOUD","display_url":"bit.ly/1suEOUD"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the #agenda of this week's human medicine committee (CHMP) meeting: http://t.co/YA6NLyTK36","source":"Bitly","id":"544462126942015490","lang":"en","created_at":"2014-12-15T12:01:01.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544460612743729153","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":86,"end":92,"tag":"OCABR"}],"annotations":[{"start":79,"end":80,"probability":0.4709,"type":"Organization","normalized_text":"EU"}]},"possibly_sensitive":false,"text":"RT @edqm_news: The list of contact persons for results and questions regarding EU/EEA #OCABR was recently updated. See our new list: http:/…","source":"TweetDeck","id":"544460612743729153","lang":"en","created_at":"2014-12-15T11:55:00.000Z","referenced_tweets":[{"type":"retweeted","id":"544446367561949184"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544459170314223616","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":[{"start":70,"end":92,"url":"http://t.co/ihOtuDjPPo","expanded_url":"http://ow.ly/FqEdd","display_url":"ow.ly/FqEdd"}],"hashtags":[{"start":93,"end":105,"tag":"RareDisease"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @eurordis: 1 new orphan medicinal product marketing authorisation! http://t.co/ihOtuDjPPo #RareDisease","source":"TweetDeck","id":"544459170314223616","lang":"en","created_at":"2014-12-15T11:49:16.000Z","referenced_tweets":[{"type":"retweeted","id":"544429203949903874"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"544423967474188289","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":61,"end":83,"url":"http://t.co/Yphui3ImD3","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Newsletter/2014/12/WC500178940.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @GCessak: EMA: Human medicines highlights - November 2014 http://t.co/Yphui3ImD3","source":"TweetDeck","id":"544423967474188289","lang":"en","created_at":"2014-12-15T09:29:23.000Z","referenced_tweets":[{"type":"retweeted","id":"544420190826811392"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543473014621609984","author_id":"116716199","entities":{"mentions":[{"start":0,"end":14,"username":"BarendsWereld","id":"1452235320"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"@BarendsWereld Dicolofenac is an anti-inflammatory agent and painkiller.","source":"TweetDeck","id":"544423635306692608","lang":"en","created_at":"2014-12-15T09:28:04.000Z","referenced_tweets":[{"type":"replied_to","id":"543494696837054464"}],"in_reply_to_user_id":"1452235320","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543475955420119042","author_id":"116716199","entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":[{"start":98,"end":120,"url":"http://t.co/8g11wTJBQO","expanded_url":"http://go.usa.gov/FQHB","display_url":"go.usa.gov/FQHB"}],"hashtags":[{"start":78,"end":89,"tag":"lungcancer"},{"start":90,"end":96,"tag":"NSCLC"}],"annotations":[{"start":19,"end":21,"probability":0.9122,"type":"Organization","normalized_text":"FDA"}]},"possibly_sensitive":false,"text":"RT @FDA_Drug_Info: FDA expands use of drug to treat aggressive non-small cell #lungcancer #NSCLC: http://t.co/8g11wTJBQO.","source":"TweetDeck","id":"543475955420119042","lang":"en","created_at":"2014-12-12T18:42:19.000Z","referenced_tweets":[{"type":"retweeted","id":"543474232576188416"}],"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543475909886754816","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/NTeFlS7KA8","expanded_url":"http://bit.ly/1wH5XF4","display_url":"bit.ly/1wH5XF4"}],"hashtags":[{"start":24,"end":34,"tag":"medicines"}],"annotations":{}},"possibly_sensitive":false,"text":"Our committee for human #medicines (CHMP) is meeting next week. Highlights out next Friday: http://t.co/NTeFlS7KA8","source":"TweetDeck","id":"543475909886754816","lang":"en","created_at":"2014-12-12T18:42:08.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543475825698689024","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/zyidfgeMza","expanded_url":"http://bit.ly/1v3ljjr","display_url":"bit.ly/1v3ljjr"}],"hashtags":[{"start":127,"end":139,"tag":"recruitment"}],"annotations":{}},"possibly_sensitive":false,"text":"A week left to apply to our vacancy for an Enterprise Architect in our Information Technology Division: http://t.co/zyidfgeMza #recruitment","source":"TweetDeck","id":"543475825698689024","lang":"en","created_at":"2014-12-12T18:41:48.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543475741896491009","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":96,"end":118,"url":"http://t.co/2VsQuXxTpi","expanded_url":"http://bit.ly/1vuWBu1","display_url":"bit.ly/1vuWBu1"}],"hashtags":[{"start":43,"end":54,"tag":"paediatric"},{"start":79,"end":84,"tag":"DTaP"},{"start":85,"end":94,"tag":"vaccines"},{"start":119,"end":132,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"A week left to comment on key elements for #paediatric investigation plans for #DTaP #vaccines: http://t.co/2VsQuXxTpi #consultation","source":"TweetDeck","id":"543475741896491009","lang":"en","created_at":"2014-12-12T18:41:28.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543473266305019904","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":87,"end":109,"url":"http://t.co/F84YfeQI1N","expanded_url":"http://bit.ly/1soq8k6","display_url":"bit.ly/1soq8k6"}],"hashtags":[{"start":46,"end":57,"tag":"veterinary"},{"start":58,"end":68,"tag":"medicines"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the highlights of this week's #veterinary #medicines committee (CVMP): http://t.co/F84YfeQI1N","source":"Bitly","id":"543473266305019904","lang":"en","created_at":"2014-12-12T18:31:38.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543473014621609984","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":63,"end":85,"url":"http://t.co/xDeMNeykeR","expanded_url":"http://bit.ly/1ux49Z2","display_url":"bit.ly/1ux49Z2"}],"hashtags":[{"start":0,"end":11,"tag":"Diclofenac"},{"start":52,"end":61,"tag":"vultures"}],"annotations":{}},"possibly_sensitive":false,"text":"#Diclofenac use in animals poses a risk to European #vultures: http://t.co/xDeMNeykeR","source":"Bitly","id":"543473014621609984","lang":"en","created_at":"2014-12-12T18:30:38.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":28,"reply_count":5,"like_count":8,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543432296876240896","author_id":"116716199","entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":76,"end":98,"url":"http://t.co/WDExbQsT0t","expanded_url":"http://bit.ly/1z05tJa","display_url":"bit.ly/1z05tJa"}],"hashtags":[{"start":18,"end":28,"tag":"Parkinson"},{"start":31,"end":39,"tag":"vaccine"},{"start":41,"end":44,"tag":"EU"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @euparkinsons: #Parkinson's #vaccine: #EU-team launches clinical trial - http://t.co/WDExbQsT0t","source":"TweetDeck","id":"543432296876240896","lang":"en","created_at":"2014-12-12T15:48:50.000Z","referenced_tweets":[{"type":"retweeted","id":"543426339106070530"}],"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543344374026100736","author_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"BioRunUp","id":"102527566"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"@BioRunUp No but we will tweet the link as soon as published.","source":"TweetDeck","id":"543431209901379584","lang":"en","created_at":"2014-12-12T15:44:31.000Z","referenced_tweets":[{"type":"replied_to","id":"543410656100102145"}],"in_reply_to_user_id":"102527566","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543368496454070272","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":106,"end":128,"url":"http://t.co/WQigQKIx56","expanded_url":"http://bit.ly/1Dg8AAI","display_url":"bit.ly/1Dg8AAI"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @EU_ECHA: Keep an eye on substances being considered for risk management. Read more in our newsletter. http://t.co/WQigQKIx56 http://t.c…","source":"TweetDeck","id":"543368496454070272","lang":"en","created_at":"2014-12-12T11:35:19.000Z","referenced_tweets":[{"type":"retweeted","id":"543307859778228224"}],"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543368403520876544","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":102,"end":124,"url":"http://t.co/DQFCMwhtzS","expanded_url":"http://bit.ly/1qAa8jx","display_url":"bit.ly/1qAa8jx"}],"hashtags":[{"start":18,"end":30,"tag":"interactive"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EFSA_EU: EFSA #interactive report on pesticide residues: almost 79,000 food samples were analysed http://t.co/DQFCMwhtzS http://t.co/RM…","source":"TweetDeck","id":"543368403520876544","lang":"en","created_at":"2014-12-12T11:34:57.000Z","referenced_tweets":[{"type":"retweeted","id":"543321188169433088"}],"public_metrics":{"retweet_count":23,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543368186755031040","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":[{"start":117,"end":139,"url":"http://t.co/YJnR8NdrAz","expanded_url":"http://europa.eu/!Hn63hB","display_url":"europa.eu/!Hn63hB"}],"hashtags":[{"start":40,"end":43,"tag":"EU"},{"start":44,"end":51,"tag":"Health"},{"start":73,"end":86,"tag":"mentalhealth"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EU_Health: Have you seen our latest #EU #Health newsletter? Focus on #mentalhealth: Let's put plans into action! http://t.co/YJnR8NdrAz","source":"TweetDeck","id":"543368186755031040","lang":"en","created_at":"2014-12-12T11:34:05.000Z","referenced_tweets":[{"type":"retweeted","id":"543337264236224512"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543368167356387328","author_id":"116716199","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":103,"end":125,"url":"http://t.co/Kd9MBQ0UXb","expanded_url":"http://goo.gl/sxByuG","display_url":"goo.gl/sxByuG"}],"hashtags":[{"start":126,"end":139,"tag":"HealthforAll"}],"annotations":[{"start":77,"end":101,"probability":0.3548,"type":"Organization","normalized_text":"Universal Health Coverage"}]},"possibly_sensitive":false,"text":"RT @WHO: WHO is supporting countries to develop their health systems towards Universal Health Coverage http://t.co/Kd9MBQ0UXb #HealthforAll","source":"TweetDeck","id":"543368167356387328","lang":"en","created_at":"2014-12-12T11:34:01.000Z","referenced_tweets":[{"type":"retweeted","id":"543338778366992385"}],"public_metrics":{"retweet_count":147,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543367976532324352","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @eurordis: Take part: the Association for Information &amp; Prevention of Sickle Cell Disease's Christmas tree event - 13 Dec, Paris http://…","source":"TweetDeck","id":"543367976532324352","lang":"en","created_at":"2014-12-12T11:33:15.000Z","referenced_tweets":[{"type":"retweeted","id":"543344639861063680"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543367932148207616","author_id":"116716199","entities":{"mentions":[{"start":3,"end":18,"username":"AGE_PlatformEU","id":"537373439"},{"start":72,"end":85,"username":"HelloBrainEU","id":"2558621846"}],"urls":{},"hashtags":{},"annotations":[{"start":24,"end":39,"probability":0.2286,"type":"Organization","normalized_text":"Lancet Neurology"}]},"possibly_sensitive":false,"text":"RT @AGE_PlatformEU: The Lancet Neurology features a great review of the @HelloBrainEU app. Thanks to all our members who contributed! http:…","source":"TweetDeck","id":"543367932148207616","lang":"en","created_at":"2014-12-12T11:33:04.000Z","referenced_tweets":[{"type":"retweeted","id":"543347209719533568"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543367604124254208","author_id":"116716199","entities":{"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":132,"end":142,"username":"EU_Health","id":"606325697"}],"urls":[{"start":109,"end":131,"url":"http://t.co/Wyb62OznVK","expanded_url":"http://ow.ly/FMiqe","display_url":"ow.ly/FMiqe"}],"hashtags":[{"start":32,"end":45,"tag":"mentalhealth"},{"start":52,"end":60,"tag":"suicide"},{"start":98,"end":106,"tag":"eHealth"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EU_eHealth: EU Joint Action #mentalhealth &amp; #suicide 3 year initiative - Special focus on #eHealth - http://t.co/Wyb62OznVK @EU_Health","source":"TweetDeck","id":"543367604124254208","lang":"en","created_at":"2014-12-12T11:31:46.000Z","referenced_tweets":[{"type":"retweeted","id":"543352680895508480"}],"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543367360389083136","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":32,"end":41,"tag":"European"},{"start":42,"end":56,"tag":"Pharmacopoeia"},{"start":95,"end":106,"tag":"monographs"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @edqm_news: Since 1964,  the #European #Pharmacopoeia Commission has adopted more than 2600 #monographs and general texts: http://t.co/g…","source":"TweetDeck","id":"543367360389083136","lang":"en","created_at":"2014-12-12T11:30:48.000Z","referenced_tweets":[{"type":"retweeted","id":"543360740573601792"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543367235109388288","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":43,"end":58,"tag":"pharmaceutical"},{"start":75,"end":80,"tag":"EDQM"},{"start":100,"end":111,"tag":"secondment"},{"start":112,"end":121,"tag":"joboffer"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @edqm_news: If you have a background in #pharmaceutical technology, the #EDQM is looking for you #secondment #joboffer http://t.co/1CSYW…","source":"TweetDeck","id":"543367235109388288","lang":"en","created_at":"2014-12-12T11:30:18.000Z","referenced_tweets":[{"type":"retweeted","id":"543362600483164160"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543367056264282112","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":107,"end":129,"url":"http://t.co/CxzGySw8Ba","expanded_url":"http://bit.ly/1BmaVpf","display_url":"bit.ly/1BmaVpf"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @EU_ECHA: Committee for Risk Assessment adopts 23 opinions for harmonised classification and labelling. http://t.co/CxzGySw8Ba","source":"TweetDeck","id":"543367056264282112","lang":"en","created_at":"2014-12-12T11:29:36.000Z","referenced_tweets":[{"type":"retweeted","id":"543364578122665984"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543357180129607680","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":74,"end":96,"url":"http://t.co/cFDK7GRFAk","expanded_url":"http://bit.ly/18SjN71","display_url":"bit.ly/18SjN71"}],"hashtags":[{"start":43,"end":64,"tag":"pharmacoepidemiology"},{"start":97,"end":109,"tag":"procurement"}],"annotations":{}},"possibly_sensitive":false,"text":"Apply for our tender for effectiveness and #pharmacoepidemiology studies: http://t.co/cFDK7GRFAk #procurement","source":"TweetDeck","id":"543357180129607680","lang":"en","created_at":"2014-12-12T10:50:21.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543348676211798016","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":101,"end":123,"url":"http://t.co/zyidfgeMza","expanded_url":"http://bit.ly/1v3ljjr","display_url":"bit.ly/1v3ljjr"}],"hashtags":[{"start":124,"end":136,"tag":"recruitment"}],"annotations":{}},"possibly_sensitive":false,"text":"One week to apply to our vacancy for an Enterprise Architect in our Information Technology Division: http://t.co/zyidfgeMza #recruitment","source":"Bitly","id":"543348676211798016","lang":"en","created_at":"2014-12-12T10:16:33.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543348392781676544","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":102,"end":124,"url":"http://t.co/2VsQuXxTpi","expanded_url":"http://bit.ly/1vuWBu1","display_url":"bit.ly/1vuWBu1"}],"hashtags":[{"start":40,"end":51,"tag":"paediatric"},{"start":85,"end":90,"tag":"DTaP"},{"start":91,"end":100,"tag":"vaccines"},{"start":125,"end":138,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"One week to comment on key elements for #paediatric investigation plans for combined #DTaP #vaccines: http://t.co/2VsQuXxTpi #consultation","source":"Bitly","id":"543348392781676544","lang":"en","created_at":"2014-12-12T10:15:26.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543344374026100736","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":87,"end":109,"url":"http://t.co/NTeFlS7KA8","expanded_url":"http://bit.ly/1wH5XF4","display_url":"bit.ly/1wH5XF4"}],"hashtags":[{"start":24,"end":34,"tag":"medicines"}],"annotations":{}},"possibly_sensitive":false,"text":"Our committee for human #medicines (CHMP) meets next week. Highlights out next Friday: http://t.co/NTeFlS7KA8","source":"Bitly","id":"543344374026100736","lang":"en","created_at":"2014-12-12T09:59:28.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543091778837286912","author_id":"116716199","entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"urls":[{"start":115,"end":137,"url":"http://t.co/zBvAyoyGLs","expanded_url":"http://ow.ly/FJymZ","display_url":"ow.ly/FJymZ"}],"hashtags":[{"start":56,"end":60,"tag":"HPV"}],"annotations":[{"start":22,"end":24,"probability":0.9582,"type":"Organization","normalized_text":"FDA"}]},"possibly_sensitive":false,"text":"RT @DrugInfoAssn: The FDA has approved a new version of #HPV vaccine that protects against five additional strains http://t.co/zBvAyoyGLs","source":"TweetDeck","id":"543091778837286912","lang":"en","created_at":"2014-12-11T17:15:44.000Z","referenced_tweets":[{"type":"retweeted","id":"543089191224348672"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543091603511214080","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"},{"start":49,"end":56,"username":"US_FDA","id":"208120290"},{"start":57,"end":64,"username":"CDCgov","id":"146569971"},{"start":65,"end":72,"username":"PHEgov","id":"1413194267326046216"},{"start":73,"end":83,"username":"NIAIDNews","id":"59769395"},{"start":84,"end":98,"username":"DeptofDefense","id":"66369181"}],"urls":[{"start":99,"end":121,"url":"http://t.co/WwcJaB1tRS","expanded_url":"http://ht.ly/FJEnQ","display_url":"ht.ly/FJEnQ"}],"hashtags":[{"start":20,"end":26,"tag":"Ebola"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @FDA_MCMi: 12/12 #Ebola vaccine workshop from @US_FDA @CDCgov @PHEgov @NIAIDNews @DeptofDefense http://t.co/WwcJaB1tRS - follow #EbolaIm…","source":"TweetDeck","id":"543091603511214080","lang":"en","created_at":"2014-12-11T17:15:03.000Z","referenced_tweets":[{"type":"retweeted","id":"543089127294771200"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543082343993704449","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":77,"end":99,"url":"http://t.co/cFDK7GRFAk","expanded_url":"http://bit.ly/18SjN71","display_url":"bit.ly/18SjN71"}],"hashtags":[{"start":100,"end":112,"tag":"procurement"}],"annotations":{}},"possibly_sensitive":false,"text":"Apply now for our tender for effectiveness and pharmacoepidemiology studies: http://t.co/cFDK7GRFAk #procurement","source":"Bitly","id":"543082343993704449","lang":"en","created_at":"2014-12-11T16:38:15.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543075142512177152","author_id":"116716199","entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"urls":[{"start":98,"end":120,"url":"http://t.co/TAHlNq3eJa","expanded_url":"http://bit.ly/1vdr2Ql","display_url":"bit.ly/1vdr2Ql"}],"hashtags":[{"start":39,"end":56,"tag":"genericmedicines"},{"start":122,"end":134,"tag":"EGAgenerics"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @egagenerics: Are you interested in #genericmedicines? Check out and download our publications http://t.co/TAHlNq3eJa  #EGAgenerics","source":"TweetDeck","id":"543075142512177152","lang":"en","created_at":"2014-12-11T16:09:38.000Z","referenced_tweets":[{"type":"retweeted","id":"543072757294964736"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543072052606148608","author_id":"116716199","entities":{"mentions":[{"start":3,"end":14,"username":"BushbyKate","id":"1216228962"},{"start":33,"end":42,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":79,"end":90,"tag":"translarna"},{"start":95,"end":104,"tag":"duchenne"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @BushbyKate: Paper describing @EMA_News process for conditional approval of #translarna for #duchenne shows v considered approach http:/…","source":"TweetDeck","id":"543072052606148608","lang":"en","created_at":"2014-12-11T15:57:21.000Z","referenced_tweets":[{"type":"retweeted","id":"543054929838219265"}],"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543071428862812160","author_id":"116716199","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":88,"end":110,"url":"http://t.co/5vYj9EcBMm","expanded_url":"http://goo.gl/zbeJUY","display_url":"goo.gl/zbeJUY"}],"hashtags":[{"start":54,"end":64,"tag":"stemcells"},{"start":65,"end":86,"tag":"RegenerativeMedicine"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EFPIA: Putting the case for regenerative medicine #stemcells #RegenerativeMedicine \nhttp://t.co/5vYj9EcBMm","source":"TweetDeck","id":"543071428862812160","lang":"en","created_at":"2014-12-11T15:54:53.000Z","referenced_tweets":[{"type":"retweeted","id":"543046788060819456"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543071009780531201","author_id":"116716199","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":66,"end":77,"username":"RDA_Europe","id":"817074074"}],"urls":[{"start":102,"end":124,"url":"http://t.co/lH2XgvshLK","expanded_url":"http://bit.ly/1vH6j7N","display_url":"bit.ly/1vH6j7N"}],"hashtags":[{"start":16,"end":26,"tag":"Alzheimer"},{"start":88,"end":93,"tag":"data"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @IMI_JU: IMI #Alzheimer’s projects PharmaCog and EMIF cited in @RDA_Europe report on #data sharing http://t.co/lH2XgvshLK","source":"TweetDeck","id":"543071009780531201","lang":"en","created_at":"2014-12-11T15:53:13.000Z","referenced_tweets":[{"type":"retweeted","id":"543037789127061504"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543033559695769602","author_id":"116716199","entities":{"mentions":[{"start":0,"end":15,"username":"ArnaudGoessens","id":"2915419521"}],"urls":[{"start":117,"end":139,"url":"http://t.co/z7tcrNHqqo","expanded_url":"http://bit.ly/1s9Nv6r","display_url":"bit.ly/1s9Nv6r"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"@ArnaudGoessens Veterinary committee planned to adopt opinion this week. We're publishing meeting outcomes tomorrow: http://t.co/z7tcrNHqqo","source":"TweetDeck","id":"543070284698640384","lang":"en","created_at":"2014-12-11T15:50:20.000Z","referenced_tweets":[{"type":"replied_to","id":"543033559695769602"}],"in_reply_to_user_id":"2915419521","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543022275248025600","author_id":"116716199","entities":{"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @MHRAmedicines: Seminar on Composite Coordinated Collections (CCCs) 5/6 Feb 15 - limited spaces available - book now http://t.co/TCZk3rd…","source":"TweetDeck","id":"543022275248025600","lang":"en","created_at":"2014-12-11T12:39:33.000Z","referenced_tweets":[{"type":"retweeted","id":"543019392779685888"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543015765235224577","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":80,"end":102,"url":"http://t.co/cFDK7GRFAk","expanded_url":"http://bit.ly/18SjN71","display_url":"bit.ly/18SjN71"}],"hashtags":[{"start":63,"end":69,"tag":"audit"},{"start":104,"end":116,"tag":"procurement"}],"annotations":{}},"possibly_sensitive":false,"text":"Applications now open for our tender for provision of internal #audit services: http://t.co/cFDK7GRFAk  #procurement","source":"Twitter Web Client","id":"543015765235224577","lang":"en","created_at":"2014-12-11T12:13:41.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543014089732415488","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":82,"end":104,"url":"http://t.co/SSaYHJJrTL","expanded_url":"http://bit.ly/1sfC1ys","display_url":"bit.ly/1sfC1ys"}],"hashtags":[{"start":34,"end":42,"tag":"vacancy"},{"start":106,"end":118,"tag":"recruitment"}],"annotations":{}},"possibly_sensitive":false,"text":"Applications are now open for our #vacancy for a Quality of Medicines Specialist: http://t.co/SSaYHJJrTL  #recruitment","source":"Twitter Web Client","id":"543014089732415488","lang":"en","created_at":"2014-12-11T12:07:02.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543013536973471744","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":64,"end":86,"url":"http://t.co/APg1U6OztY","expanded_url":"http://bit.ly/1zTdBJX","display_url":"bit.ly/1zTdBJX"}],"hashtags":[{"start":34,"end":42,"tag":"vacancy"},{"start":88,"end":100,"tag":"recruitment"}],"annotations":{}},"possibly_sensitive":false,"text":"Applications are now open for our #vacancy for a Legal Officer: http://t.co/APg1U6OztY  #recruitment","source":"Twitter Web Client","id":"543013536973471744","lang":"en","created_at":"2014-12-11T12:04:50.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543007468302139392","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":68,"end":90,"url":"http://t.co/cFDK7GRFAk","expanded_url":"http://bit.ly/18SjN71","display_url":"bit.ly/18SjN71"}],"hashtags":[{"start":51,"end":57,"tag":"audit"},{"start":91,"end":103,"tag":"procurement"}],"annotations":{}},"possibly_sensitive":false,"text":"Apply now for our tender for provision of internal #audit services: http://t.co/cFDK7GRFAk #procurement","source":"Bitly","id":"543007468302139392","lang":"en","created_at":"2014-12-11T11:40:43.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"543000130287587329","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":66,"end":88,"url":"http://t.co/SSaYHJJrTL","expanded_url":"http://bit.ly/1sfC1ys","display_url":"bit.ly/1sfC1ys"}],"hashtags":[{"start":18,"end":26,"tag":"vacancy"},{"start":89,"end":101,"tag":"recruitment"}],"annotations":{}},"possibly_sensitive":false,"text":"Apply now for our #vacancy for a Quality of Medicines Specialist: http://t.co/SSaYHJJrTL #recruitment","source":"Bitly","id":"543000130287587329","lang":"en","created_at":"2014-12-11T11:11:34.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542999182945292288","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":48,"end":70,"url":"http://t.co/APg1U6OztY","expanded_url":"http://bit.ly/1zTdBJX","display_url":"bit.ly/1zTdBJX"}],"hashtags":[{"start":18,"end":26,"tag":"vacancy"},{"start":71,"end":83,"tag":"recruitment"}],"annotations":{}},"possibly_sensitive":false,"text":"Apply now for our #vacancy for a Legal Officer: http://t.co/APg1U6OztY #recruitment","source":"Bitly","id":"542999182945292288","lang":"en","created_at":"2014-12-11T11:07:48.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542997996359925760","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":15,"end":24,"tag":"European"},{"start":25,"end":39,"tag":"Pharmacopoeia"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @edqm_news: #European #Pharmacopoeia Commission adopts 13 new texts, 28 revised monographs and 6 revised general chapters: http://t.co/g…","source":"TweetDeck","id":"542997996359925760","lang":"en","created_at":"2014-12-11T11:03:05.000Z","referenced_tweets":[{"type":"retweeted","id":"542990614393282560"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542997982103474176","author_id":"116716199","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":[{"start":91,"end":113,"url":"http://t.co/M8fNP9XkXd","expanded_url":"http://bit.ly/webinarsCall3-4","display_url":"bit.ly/webinarsCall3-4"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @IMI_JU: IMI2 Call4: Meds adaptive pathways to patients - We'll hold a webinar on 17/12 http://t.co/M8fNP9XkXd to provide info and answe…","source":"TweetDeck","id":"542997982103474176","lang":"en","created_at":"2014-12-11T11:03:02.000Z","referenced_tweets":[{"type":"retweeted","id":"542990349036425216"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542997679832584192","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"},{"start":115,"end":123,"username":"GCessak","id":"556859372"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @URPLWMiPB: Patients can and should report side effects observed during the use of over-the-counter medicines - @GCessak","source":"TweetDeck","id":"542997679832584192","lang":"en","created_at":"2014-12-11T11:01:49.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542994763264557056","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"},{"start":100,"end":108,"username":"GCessak","id":"556859372"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @URPLWMiPB: As with other medicines, over-the-counter medicines are monitored for their safety - @GCessak","source":"TweetDeck","id":"542994763264557056","lang":"en","created_at":"2014-12-11T10:50:14.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542994530438766592","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"},{"start":131,"end":139,"username":"GCessak","id":"556859372"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @URPLWMiPB: Over-the-counter medicines, like all medicines authorised, may be the cause of adverse reactions and interactions - @GCessak","source":"TweetDeck","id":"542994530438766592","lang":"en","created_at":"2014-12-11T10:49:19.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542993890232762368","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"},{"start":100,"end":108,"username":"GCessak","id":"556859372"}],"urls":[{"start":109,"end":131,"url":"http://t.co/gvZXakMyDB","expanded_url":"http://bit.ly/1yBUDdB","display_url":"bit.ly/1yBUDdB"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @URPLWMiPB: Polish medicines agency press conference \"Safety of over-the-counter medicines\" with @GCessak http://t.co/gvZXakMyDB","source":"TweetDeck","id":"542993890232762368","lang":"en","created_at":"2014-12-11T10:46:46.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542752581584699392","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"enisa_eu","id":"806850055"}],"urls":[{"start":110,"end":132,"url":"http://t.co/bXyHp5LZS5","expanded_url":"http://bit.ly/1vwgwZz","display_url":"bit.ly/1vwgwZz"}],"hashtags":[{"start":42,"end":50,"tag":"eHealth"},{"start":103,"end":109,"tag":"ENISA"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @enisa_eu: \"Security and Resilience in #eHealth infrastructures and services\"  - Call for Tender by #ENISA http://t.co/bXyHp5LZS5","source":"TweetDeck","id":"542752581584699392","lang":"en","created_at":"2014-12-10T18:47:53.000Z","referenced_tweets":[{"type":"retweeted","id":"542738532499226624"}],"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542730985390243842","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":{},"hashtags":[{"start":61,"end":73,"tag":"RareDisease"}],"annotations":[{"start":33,"end":56,"probability":0.4631,"type":"Other","normalized_text":"2014 European Conference"}]},"possibly_sensitive":false,"text":"RT @eurordis: Did you attend the 2014 European Conference on #RareDisease? Read about it in the newly available Executive Summary http://t.…","source":"TweetDeck","id":"542730985390243842","lang":"en","created_at":"2014-12-10T17:22:05.000Z","referenced_tweets":[{"type":"retweeted","id":"542665288651907072"}],"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542730933066280961","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"IlaeWeb","id":"611701745"}],"urls":{},"hashtags":[{"start":43,"end":52,"tag":"epilepsy"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @IlaeWeb: The course of childhood-onset #epilepsy over the first two decades: A prospective, longitudinal study. (Epilepsia) http://t.co…","source":"TweetDeck","id":"542730933066280961","lang":"en","created_at":"2014-12-10T17:21:52.000Z","referenced_tweets":[{"type":"retweeted","id":"542670802773377025"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542730894545788928","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"},{"start":96,"end":105,"username":"cancereu","id":"140344419"},{"start":124,"end":133,"username":"ESTRO_RT","id":"2428699813"}],"urls":{},"hashtags":[{"start":24,"end":37,"tag":"radiotherapy"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @cancereu: Access to #radiotherapy &amp; appropriate infrastructure key for cancer patients. @cancereu looks fwd to meet @ESTRO_RT  http://t…","source":"TweetDeck","id":"542730894545788928","lang":"en","created_at":"2014-12-10T17:21:43.000Z","referenced_tweets":[{"type":"retweeted","id":"542678099046203392"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542730829315993600","author_id":"116716199","entities":{"mentions":[{"start":3,"end":10,"username":"my_ueg","id":"487344065"}],"urls":{},"hashtags":[{"start":109,"end":117,"tag":"adenoma"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @my_ueg: A study evaluated the sensitivity of faecal immunochemical testing for the detection of advanced #adenoma's. http://t.co/SVNClA…","source":"TweetDeck","id":"542730829315993600","lang":"en","created_at":"2014-12-10T17:21:27.000Z","referenced_tweets":[{"type":"retweeted","id":"542686951938465792"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542730769551347712","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":96,"end":100,"username":"WHO","id":"14499829"}],"urls":[{"start":101,"end":123,"url":"http://t.co/rNLJSboHsy","expanded_url":"http://www.who.int/mediacentre/events/meetings/2014/ebola-health-systems/en/","display_url":"who.int/mediacentre/ev…"}],"hashtags":[{"start":34,"end":48,"tag":"healthsystems"},{"start":52,"end":58,"tag":"Ebola"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EU_Health: Building resilient #healthsystems in #Ebola affected countries, 10-11.12, Geneva @WHO http://t.co/rNLJSboHsy http://t.co/0rR…","source":"TweetDeck","id":"542730769551347712","lang":"en","created_at":"2014-12-10T17:21:13.000Z","referenced_tweets":[{"type":"retweeted","id":"542689125657485312"}],"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542730633563611137","author_id":"116716199","entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"urls":[{"start":85,"end":107,"url":"http://t.co/ngoEnst4vZ","expanded_url":"http://ow.ly/FFFYT","display_url":"ow.ly/FFFYT"}],"hashtags":[{"start":12,"end":15,"tag":"PD"},{"start":75,"end":84,"tag":"Lymphoma"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @myESMO: #PD-1 blockade shows safety and efficacy in pretreated Hodgkin #Lymphoma http://t.co/ngoEnst4vZ","source":"TweetDeck","id":"542730633563611137","lang":"en","created_at":"2014-12-10T17:20:41.000Z","referenced_tweets":[{"type":"retweeted","id":"542701906469335040"}],"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542730509793918976","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @edqm_news: Orders of online versions of publications received on 17/12 will be dispatched by 18/12. See our ordering deadlines: http://…","source":"TweetDeck","id":"542730509793918976","lang":"en","created_at":"2014-12-10T17:20:11.000Z","referenced_tweets":[{"type":"retweeted","id":"542709041240489985"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542730453552484353","author_id":"116716199","entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":108,"end":130,"url":"http://t.co/qgfpaMCW03","expanded_url":"http://www.epda.eu.com/en/research-papers/2014/prd-jul-dec/12-08-prelatdisord/","display_url":"epda.eu.com/en/research-pa…"}],"hashtags":[{"start":44,"end":54,"tag":"Parkinson"},{"start":69,"end":82,"tag":"Parkinsonian"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @euparkinsons: Distinguishing Idiopathic #Parkinson’s  From Other #Parkinsonian Syndromes By Breath Test http://t.co/qgfpaMCW03","source":"TweetDeck","id":"542730453552484353","lang":"en","created_at":"2014-12-10T17:19:58.000Z","referenced_tweets":[{"type":"retweeted","id":"542711393313894401"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542730252242669569","author_id":"116716199","entities":{"mentions":[{"start":3,"end":15,"username":"CPME_EUROPA","id":"440810430"}],"urls":[{"start":115,"end":137,"url":"http://t.co/1m1u7zMorO","expanded_url":"http://bit.ly/1IACCPR","display_url":"bit.ly/1IACCPR"}],"hashtags":[{"start":22,"end":33,"tag":"guidelines"},{"start":37,"end":50,"tag":"transparency"},{"start":76,"end":87,"tag":"physicians"},{"start":94,"end":105,"tag":"healthcare"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @CPME_EUROPA: CPME #guidelines on #transparency of relationships between #physicians &amp; #healthcare industry http://t.co/1m1u7zMorO @euho…","source":"TweetDeck","id":"542730252242669569","lang":"en","created_at":"2014-12-10T17:19:10.000Z","referenced_tweets":[{"type":"retweeted","id":"542718697195192321"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542730158571278336","author_id":"116716199","entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":107,"end":129,"url":"http://t.co/VSxxfqqH8R","expanded_url":"http://1.usa.gov/1AfQmcF","display_url":"1.usa.gov/1AfQmcF"}],"hashtags":[{"start":21,"end":25,"tag":"FDA"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @FDAanimalhealth: #FDA Issues Import Alert for Unapproved Follicle Stimulating Hormone Drugs for Cattle http://t.co/VSxxfqqH8R","source":"TweetDeck","id":"542730158571278336","lang":"en","created_at":"2014-12-10T17:18:47.000Z","referenced_tweets":[{"type":"retweeted","id":"542724163509968896"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542420213543608320","author_id":"116716199","entities":{"mentions":[{"start":0,"end":10,"username":"kayfball1","id":"2834833600"},{"start":11,"end":25,"username":"_Ivan_Ramirez","id":"261338066"},{"start":26,"end":36,"username":"MarkAvery","id":"17560522"}],"urls":[{"start":111,"end":133,"url":"http://t.co/w1o7B3QaXs","expanded_url":"http://bit.ly/1urXdPz","display_url":"bit.ly/1urXdPz"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"@kayfball1 @_Ivan_Ramirez @MarkAvery Currently authorised in 5 Member States. More information on our website: http://t.co/w1o7B3QaXs","source":"TweetDeck","id":"542727665665724416","lang":"en","created_at":"2014-12-10T17:08:53.000Z","referenced_tweets":[{"type":"replied_to","id":"542586279717007360"}],"in_reply_to_user_id":"2834833600","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542658871027040256","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":79,"end":101,"url":"http://t.co/QpkrANlcY0","expanded_url":"http://bit.ly/1yyDvAt","display_url":"bit.ly/1yyDvAt"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":28,"end":39,"tag":"Paediatric"}],"annotations":{}},"possibly_sensitive":false,"text":"The #agenda of this week's  #Paediatric Committee (PDCO) meeting is available: http://t.co/QpkrANlcY0","source":"TweetDeck","id":"542658871027040256","lang":"en","created_at":"2014-12-10T12:35:31.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542658621738614784","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":85,"end":107,"url":"http://t.co/z7tcrNHqqo","expanded_url":"http://bit.ly/1s9Nv6r","display_url":"bit.ly/1s9Nv6r"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":41,"end":52,"tag":"veterinary"},{"start":53,"end":63,"tag":"medicines"}],"annotations":{}},"possibly_sensitive":false,"text":"The #agenda of this week's committee for #veterinary #medicines (CVMP) is available: http://t.co/z7tcrNHqqo","source":"TweetDeck","id":"542658621738614784","lang":"en","created_at":"2014-12-10T12:34:32.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542374435979018240","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":82,"end":104,"url":"http://t.co/z7tcrNHqqo","expanded_url":"http://bit.ly/1s9Nv6r","display_url":"bit.ly/1s9Nv6r"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":43,"end":54,"tag":"veterinary"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the #agenda of this week's #veterinary medicine (CVMP) committee: http://t.co/z7tcrNHqqo","source":"Bitly","id":"542374435979018240","lang":"en","created_at":"2014-12-09T17:45:17.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542372638472282112","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"}],"urls":[{"start":118,"end":140,"url":"http://t.co/uVp5p259Pj","expanded_url":"http://bit.ly/12nPPuc","display_url":"bit.ly/12nPPuc"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @agesnews: Medicine: Faked bioequivalence studies could lead to suspension of authorisation of individual generics http://t.co/uVp5p259Pj","source":"TweetDeck","id":"542372638472282112","lang":"en","created_at":"2014-12-09T17:38:08.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542371223288963072","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"},{"start":18,"end":29,"username":"SecBurwell","id":"2458567464"}],"urls":[{"start":106,"end":128,"url":"http://t.co/Jr71RHWv3y","expanded_url":"http://ht.ly/FBONs","display_url":"ht.ly/FBONs"}],"hashtags":[{"start":90,"end":96,"tag":"Ebola"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @FDA_MCMi: HHS @SecBurwell issues declaration under PREP Act to support development of #Ebola vaccines http://t.co/Jr71RHWv3y","source":"TweetDeck","id":"542371223288963072","lang":"en","created_at":"2014-12-09T17:32:31.000Z","referenced_tweets":[{"type":"retweeted","id":"542343224191631360"}],"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542341513762848770","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":81,"end":103,"url":"http://t.co/QpkrANlcY0","expanded_url":"http://bit.ly/1yyDvAt","display_url":"bit.ly/1yyDvAt"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":43,"end":54,"tag":"Paediatric"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the #agenda of this week's #Paediatric Committee (PDCO) meeting: http://t.co/QpkrANlcY0","source":"Bitly","id":"542341513762848770","lang":"en","created_at":"2014-12-09T15:34:27.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542338585283006464","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"FDAWomen","id":"65416742"}],"urls":{},"hashtags":[{"start":118,"end":127,"tag":"NIVW2014"}],"annotations":[{"start":33,"end":35,"probability":0.4313,"type":"Organization","normalized_text":"CDC"},{"start":39,"end":45,"probability":0.5282,"type":"Product","normalized_text":"Twitter"}]},"possibly_sensitive":false,"text":"RT @FDAWomen: Don’t forget! Join CDC’s Twitter chat TODAY about flu vaccination! Have Q’s? We’ll answer them! 1pm EST #NIVW2014","source":"TweetDeck","id":"542338585283006464","lang":"en","created_at":"2014-12-09T15:22:49.000Z","referenced_tweets":[{"type":"retweeted","id":"542334157125611520"}],"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542326480433598465","author_id":"116716199","entities":{"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"urls":[{"start":110,"end":132,"url":"http://t.co/oEX7SZqhX9","expanded_url":"http://ow.ly/FBq6F","display_url":"ow.ly/FBq6F"}],"hashtags":[{"start":19,"end":26,"tag":"GMDP14"}],"annotations":[{"start":48,"end":83,"probability":0.3868,"type":"Other","normalized_text":"Good Distribution Practice Symposium"}]},"possibly_sensitive":false,"text":"RT @MHRAmedicines: #GMDP14 picture from today's Good Distribution Practice Symposium. Future MHRA event info: http://t.co/oEX7SZqhX9 http:/…","source":"TweetDeck","id":"542326480433598465","lang":"en","created_at":"2014-12-09T14:34:43.000Z","referenced_tweets":[{"type":"retweeted","id":"542322388973940736"}],"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542326317421961216","author_id":"116716199","entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":104,"end":126,"url":"http://t.co/I0TBMuBpr7","expanded_url":"http://1.usa.gov/162T1h6","display_url":"1.usa.gov/162T1h6"}],"hashtags":[{"start":21,"end":25,"tag":"FDA"},{"start":90,"end":97,"tag":"Animal"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @FDAanimalhealth: #FDA Issues Final Guidance on Electronic Adverse Event Reporting for #Animal Drugs http://t.co/I0TBMuBpr7","source":"TweetDeck","id":"542326317421961216","lang":"en","created_at":"2014-12-09T14:34:04.000Z","referenced_tweets":[{"type":"retweeted","id":"542321965395361792"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542319133292261376","author_id":"116716199","entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":{},"hashtags":[{"start":23,"end":27,"tag":"FDA"},{"start":40,"end":46,"tag":"DSCSA"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @FDA_Drug_Info: New #FDA guidance on #DSCSA reporting for Rx drug wholesale distributors/3rd-party logistics providers http://t.co/I5vWz…","source":"TweetDeck","id":"542319133292261376","lang":"en","created_at":"2014-12-09T14:05:31.000Z","referenced_tweets":[{"type":"retweeted","id":"542318793998237696"}],"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542318660241850368","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"},{"start":19,"end":23,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @EFSA_EU: EFSA, @WHO and stakeholders discussed Threshold of Toxicological Concern concept: meeting documents are now available http://t…","source":"TweetDeck","id":"542318660241850368","lang":"en","created_at":"2014-12-09T14:03:39.000Z","referenced_tweets":[{"type":"retweeted","id":"542317945960280064"}],"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542290851645640704","author_id":"116716199","entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"},{"start":122,"end":128,"username":"EFPIA","id":"52084584"}],"urls":[{"start":95,"end":117,"url":"http://t.co/RMYnpZ2k3f","expanded_url":"http://www.egagenerics.com/index.php/press-room/press-releases/2014/377-research-and-generic-biosimilar-industries-join-forces-against-counterfeiting","display_url":"egagenerics.com/index.php/pres…"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @egagenerics: Research and Generic/Biosimilar Industries Join Forces against Counterfeiting http://t.co/RMYnpZ2k3f via @EFPIA @egageneri…","source":"TweetDeck","id":"542290851645640704","lang":"en","created_at":"2014-12-09T12:13:08.000Z","referenced_tweets":[{"type":"retweeted","id":"542280422332583936"}],"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542290777146413056","author_id":"116716199","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":105,"end":127,"url":"http://t.co/59lbDXpIkr","expanded_url":"http://goo.gl/M9yid3","display_url":"goo.gl/M9yid3"}],"hashtags":[{"start":89,"end":104,"tag":"Counterfeiting"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EFPIA: Press Release: Research and Generic/Biosimilar Industries Join Forces against #Counterfeiting\nhttp://t.co/59lbDXpIkr","source":"TweetDeck","id":"542290777146413056","lang":"en","created_at":"2014-12-09T12:12:51.000Z","referenced_tweets":[{"type":"retweeted","id":"542279668280606721"}],"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542290128929304576","author_id":"116716199","entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"urls":[{"start":71,"end":93,"url":"http://t.co/Ltx84ar1Lw","expanded_url":"http://bit.ly/1xOy5UU","display_url":"bit.ly/1xOy5UU"}],"hashtags":[{"start":50,"end":70,"tag":"biosimilarmedicines"},{"start":94,"end":109,"tag":"EGAbiosimilars"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @egagenerics: Know the reasons for introducing #biosimilarmedicines http://t.co/Ltx84ar1Lw #EGAbiosimilars","source":"TweetDeck","id":"542290128929304576","lang":"en","created_at":"2014-12-09T12:10:16.000Z","referenced_tweets":[{"type":"retweeted","id":"542272456686174208"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542018207687917568","author_id":"116716199","entities":{"mentions":[{"start":3,"end":8,"username":"Eu2P","id":"420241833"}],"urls":{},"hashtags":[{"start":29,"end":50,"tag":"Pharmacoepidemiology"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @Eu2P: Apr 2015: Bordeaux #Pharmacoepidemiology Festival after the @ICPE @S_ISPE  mid-year meeting http://t.co/WbMhmLm5p7 http://t.co/ui…","source":"TweetDeck","id":"542018207687917568","lang":"en","created_at":"2014-12-08T18:09:45.000Z","referenced_tweets":[{"type":"retweeted","id":"541974527061020672"}],"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542018120551247872","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":87,"end":99,"tag":"Antibiotics"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @edqm_news: EDQM invites laboratories to participate in International Standards for #Antibiotics (ISA) establishment studies http://t.co…","source":"TweetDeck","id":"542018120551247872","lang":"ro","created_at":"2014-12-08T18:09:24.000Z","referenced_tweets":[{"type":"retweeted","id":"541979995129004032"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"542017379442917378","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/1W32GtTZDH","expanded_url":"http://bit.ly/11HRWZM","display_url":"bit.ly/11HRWZM"}],"hashtags":[{"start":54,"end":63,"tag":"Capsicum"},{"start":127,"end":140,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"One week left to comment on draft herbal monograph on #Capsicum annuum L. var. minimum (Miller) Heiser: http://t.co/1W32GtTZDH #consultation","source":"TweetDeck","id":"542017379442917378","lang":"en","created_at":"2014-12-08T18:06:28.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"541967256247603201","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":{},"hashtags":[{"start":13,"end":24,"tag":"acrylamide"},{"start":26,"end":31,"tag":"EFSA"}],"annotations":[{"start":78,"end":85,"probability":0.9777,"type":"Place","normalized_text":"Brussels"}]},"possibly_sensitive":false,"text":"RT @EFSA_EU: #acrylamide: #EFSA to discuss draft opinion with stakeholders in Brussels this Wednesday.Check the agenda http://t.co/UQpfnUnR…","source":"TweetDeck","id":"541967256247603201","lang":"en","created_at":"2014-12-08T14:47:17.000Z","referenced_tweets":[{"type":"retweeted","id":"541924014818856961"}],"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"541967133211885568","author_id":"116716199","entities":{"mentions":[{"start":3,"end":18,"username":"ECDC_Outbreaks","id":"2754484003"},{"start":107,"end":115,"username":"ECDC_EU","id":"204752573"}],"urls":{},"hashtags":[{"start":32,"end":40,"tag":"measles"},{"start":116,"end":121,"tag":"CDTR"}],"annotations":[{"start":44,"end":51,"probability":0.9977,"type":"Place","normalized_text":"Slovenia"}]},"possibly_sensitive":false,"text":"RT @ECDC_Outbreaks: Outbreak of #measles in Slovenia linked to an international dog exhibition. See latest @ECDC_EU #CDTR: http://t.co/5vqW…","source":"TweetDeck","id":"541967133211885568","lang":"en","created_at":"2014-12-08T14:46:48.000Z","referenced_tweets":[{"type":"retweeted","id":"541937240583450626"}],"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"541967065545203713","author_id":"116716199","entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"urls":[{"start":93,"end":115,"url":"http://t.co/JzmtKUwQR3","expanded_url":"http://bit.ly/1vdiF7r","display_url":"bit.ly/1vdiF7r"}],"hashtags":[{"start":31,"end":40,"tag":"patients"},{"start":116,"end":123,"tag":"hcsmeu"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @egagenerics: Nearly 40% of #patients are unsure if their physician uses a patient portal http://t.co/JzmtKUwQR3 #hcsmeu http://t.co/BO2…","source":"TweetDeck","id":"541967065545203713","lang":"en","created_at":"2014-12-08T14:46:32.000Z","referenced_tweets":[{"type":"retweeted","id":"541940265049538560"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"541967016815779841","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"escardio","id":"21572529"}],"urls":[{"start":112,"end":134,"url":"http://t.co/nV0YGKb87q","expanded_url":"http://bit.ly/1vvyBSq","display_url":"bit.ly/1vvyBSq"}],"hashtags":[{"start":102,"end":111,"tag":"euroecho"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @escardio: Improved strategies for evaluating patients presenting with acute chest pain are needed #euroecho http://t.co/nV0YGKb87q","source":"TweetDeck","id":"541967016815779841","lang":"en","created_at":"2014-12-08T14:46:20.000Z","referenced_tweets":[{"type":"retweeted","id":"541940270921576449"}],"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"541966924037779456","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"IlaeWeb","id":"611701745"}],"urls":{},"hashtags":[{"start":26,"end":35,"tag":"Epilepsy"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @IlaeWeb: MRI-Negative #Epilepsy: New book: critically appraises the role &amp; value of specific diagnostic &amp; treatment http://t.co/VeXfQev…","source":"TweetDeck","id":"541966924037779456","lang":"en","created_at":"2014-12-08T14:45:58.000Z","referenced_tweets":[{"type":"retweeted","id":"541949342257807361"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"541966795591389186","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"escardio","id":"21572529"}],"urls":{},"hashtags":[{"start":119,"end":128,"tag":"euroecho"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @escardio: Innovations in atrial fibrillation therapy highlight promise of 2D, 3D, CMR and speckle tracking imaging #euroecho http://t.c…","source":"TweetDeck","id":"541966795591389186","lang":"en","created_at":"2014-12-08T14:45:27.000Z","referenced_tweets":[{"type":"retweeted","id":"541955380364853248"}],"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"541966753958735872","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":[{"start":84,"end":106,"url":"http://t.co/CDOf72jbnA","expanded_url":"http://ow.ly/F2dV9","display_url":"ow.ly/F2dV9"}],"hashtags":[{"start":14,"end":23,"tag":"EUROPLAN"},{"start":71,"end":83,"tag":"RareDisease"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @eurordis: #EUROPLAN National Conferences foster National Plans for #RareDisease http://t.co/CDOf72jbnA","source":"TweetDeck","id":"541966753958735872","lang":"en","created_at":"2014-12-08T14:45:18.000Z","referenced_tweets":[{"type":"retweeted","id":"541956707535306752"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"541966702159069184","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"urls":{},"hashtags":[{"start":60,"end":66,"tag":"Ebola"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @FDA_MCMi: Workshop 12/8 - Immunology of Protection from #Ebola Virus Infection. Reg. full, but event will be webcast: http://t.co/HgO8Y…","source":"TweetDeck","id":"541966702159069184","lang":"en","created_at":"2014-12-08T14:45:05.000Z","referenced_tweets":[{"type":"retweeted","id":"541958242763829248"}],"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"541966663793790980","author_id":"116716199","entities":{"mentions":[{"start":3,"end":16,"username":"eumsplatform","id":"600110872"},{"start":103,"end":115,"username":"EUneurology","id":"619868597"}],"urls":{},"hashtags":[{"start":66,"end":82,"tag":"pharmaceuticals"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @eumsplatform: Interested about influencing decision-making on #pharmaceuticals? Book your place at @EUneurology's workshop: http://t.co…","source":"TweetDeck","id":"541966663793790980","lang":"en","created_at":"2014-12-08T14:44:56.000Z","referenced_tweets":[{"type":"retweeted","id":"541958257024438273"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"541917216548335616","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":103,"end":112,"tag":"european"},{"start":113,"end":127,"tag":"pharmacopoeia"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @edqm_news: Supplement 8.5 includes 6 new and 47 revised texts and will be released in January 2015 #european #pharmacopoeia http://t.co…","source":"TweetDeck","id":"541917216548335616","lang":"en","created_at":"2014-12-08T11:28:27.000Z","referenced_tweets":[{"type":"retweeted","id":"541863052027908096"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"541917199402041344","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"EUTenders","id":"294046348"}],"urls":{},"hashtags":[{"start":81,"end":99,"tag":"PublicProcurement"},{"start":103,"end":106,"tag":"EU"},{"start":107,"end":111,"tag":"EEA"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EUTenders: Do you need clarifications on rules, thresholds and guidelines on #PublicProcurement in #EU #EEA? Find them here http://t.co…","source":"TweetDeck","id":"541917199402041344","lang":"en","created_at":"2014-12-08T11:28:23.000Z","referenced_tweets":[{"type":"retweeted","id":"541863534188326912"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"541917029964709889","author_id":"116716199","entities":{"mentions":[{"start":3,"end":18,"username":"PrimaryCare4um","id":"164835748"},{"start":53,"end":63,"username":"EU_Health","id":"606325697"},{"start":64,"end":69,"username":"OECD","id":"25390350"}],"urls":{},"hashtags":[{"start":40,"end":47,"tag":"Europe"},{"start":112,"end":124,"tag":"PrimaryCare"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @PrimaryCare4um: Health at a Glance: #Europe 2014 @EU_Health @OECD on page 86 chapter 4.2 on “Prescribing in #PrimaryCare” http://t.co/0…","source":"TweetDeck","id":"541917029964709889","lang":"en","created_at":"2014-12-08T11:27:42.000Z","referenced_tweets":[{"type":"retweeted","id":"541878588824649728"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"541916610110701568","author_id":"116716199","entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":93,"end":115,"url":"http://t.co/3eJx2tpmmW","expanded_url":"http://bit.ly/1ARMRtV","display_url":"bit.ly/1ARMRtV"}],"hashtags":[{"start":27,"end":32,"tag":"ANSM"},{"start":116,"end":132,"tag":"medicamentsgouv"}],"annotations":[{"start":85,"end":90,"probability":0.9963,"type":"Place","normalized_text":"France"}]},"possibly_sensitive":false,"text":"RT @ansm: Take part in the #ANSM satisfaction survey on public medicines database in France: http://t.co/3eJx2tpmmW #medicamentsgouv","source":"TweetDeck","id":"541916610110701568","lang":"en","created_at":"2014-12-08T11:26:02.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"541916015261913088","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"H2020SME","id":"874591855626858496"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @H2020SME: This year we will support ≈ 170 projects in the field of diagnostics devices. Get up to €2.5m funding and mentoring http://t.…","source":"TweetDeck","id":"541916015261913088","lang":"en","created_at":"2014-12-08T11:23:41.000Z","referenced_tweets":[{"type":"retweeted","id":"541912625777754113"}],"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"541915849972789248","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":[{"start":27,"end":49,"url":"http://t.co/osjJYLfi3M","expanded_url":"http://europa.eu/!hu94nQ","display_url":"europa.eu/!hu94nQ"}],"hashtags":[{"start":64,"end":67,"tag":"EU"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EU_Health: Did you see http://t.co/osjJYLfi3M? Great to see #EU mobilising qualified, trained &amp; experienced health workers #EbolaRespon…","source":"TweetDeck","id":"541915849972789248","lang":"en","created_at":"2014-12-08T11:23:01.000Z","referenced_tweets":[{"type":"retweeted","id":"541913459408261121"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"541915698482933760","author_id":"116716199","entities":{"mentions":[{"start":3,"end":10,"username":"fet_eu","id":"122458732"}],"urls":[{"start":120,"end":142,"url":"http://t.co/3YEi5vnl9d","expanded_url":"http://europa.eu/!Nx34GH","display_url":"europa.eu/!Nx34GH"}],"hashtags":[{"start":17,"end":23,"tag":"brain"},{"start":39,"end":51,"tag":"prosthetics"},{"start":65,"end":77,"tag":"interactive"},{"start":85,"end":92,"tag":"FET_eu"},{"start":93,"end":102,"tag":"research"},{"start":106,"end":119,"tag":"NEUROSCIENCE"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @fet_eu: From #brain function &amp; #prosthetics to alternate #interactive tools! #FET_eu #research in #NEUROSCIENCE http://t.co/3YEi5vnl9d …","source":"TweetDeck","id":"541915698482933760","lang":"en","created_at":"2014-12-08T11:22:25.000Z","referenced_tweets":[{"type":"retweeted","id":"541915154783694848"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"541915278364667904","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":84,"end":106,"url":"http://t.co/Lpdyn4An6l","expanded_url":"http://bit.ly/1yx7gVZ","display_url":"bit.ly/1yx7gVZ"}],"hashtags":[{"start":41,"end":45,"tag":"GVK"}],"annotations":[{"start":66,"end":81,"probability":0.4844,"type":"Place","normalized_text":"Hyderabad, India"}]},"possibly_sensitive":false,"text":"Update on review of studies performed at #GVK Biosciences site in Hyderabad, India: http://t.co/Lpdyn4An6l","source":"TweetDeck","id":"541915278364667904","lang":"en","created_at":"2014-12-08T11:20:45.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"541914659390226432","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":79,"end":101,"url":"http://t.co/eTK63cWq6f","expanded_url":"http://bit.ly/1tQGJgT","display_url":"bit.ly/1tQGJgT"}],"hashtags":[{"start":34,"end":52,"tag":"pharmacovigilance"}],"annotations":{}},"possibly_sensitive":false,"text":"See the highlights of last week's #pharmacovigilance committee (PRAC) meeting: http://t.co/eTK63cWq6f","source":"TweetDeck","id":"541914659390226432","lang":"en","created_at":"2014-12-08T11:18:17.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"541914457333837824","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/ZqGmSkkddr","expanded_url":"http://bit.ly/1vwftJ7","display_url":"bit.ly/1vwftJ7"}],"hashtags":[{"start":29,"end":37,"tag":"Duaklir"},{"start":38,"end":46,"tag":"Genuair"},{"start":48,"end":59,"tag":"aclidinium"},{"start":70,"end":81,"tag":"formoterol"},{"start":111,"end":116,"tag":"COPD"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the EPAR for #Duaklir #Genuair (#aclidinium bromide / #formoterol fumarate dihydrate), used in #COPD: http://t.co/ZqGmSkkddr","source":"TweetDeck","id":"541914457333837824","lang":"en","created_at":"2014-12-08T11:17:29.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"541914074347757568","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":113,"end":135,"url":"http://t.co/8q86JHg8mz","expanded_url":"http://bit.ly/1vnsYWB","display_url":"bit.ly/1vnsYWB"}],"hashtags":[{"start":29,"end":36,"tag":"Vylaer"},{"start":37,"end":46,"tag":"Spiromax"},{"start":48,"end":59,"tag":"budesonide"},{"start":62,"end":73,"tag":"formoterol"},{"start":78,"end":87,"tag":"medicine"},{"start":92,"end":99,"tag":"asthma"},{"start":106,"end":111,"tag":"COPD"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the EPAR for #Vylaer #Spiromax (#budesonide / #formoterol), a #medicine for #asthma &amp; #COPD: http://t.co/8q86JHg8mz","source":"TweetDeck","id":"541914074347757568","lang":"en","created_at":"2014-12-08T11:15:58.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"541913853593137152","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/1W32GtTZDH","expanded_url":"http://bit.ly/11HRWZM","display_url":"bit.ly/11HRWZM"}],"hashtags":[{"start":54,"end":63,"tag":"Capsicum"},{"start":127,"end":140,"tag":"consultation"}],"annotations":{}},"possibly_sensitive":false,"text":"One more week to comment on draft herbal monograph on #Capsicum annuum L. var. minimum (Miller) Heiser: http://t.co/1W32GtTZDH #consultation","source":"Bitly","id":"541913853593137152","lang":"en","created_at":"2014-12-08T11:15:05.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540940028340633600","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/Lpdyn4An6l","expanded_url":"http://bit.ly/1yx7gVZ","display_url":"bit.ly/1yx7gVZ"}],"hashtags":[{"start":0,"end":4,"tag":"GVK"}],"annotations":{}},"possibly_sensitive":false,"text":"#GVK Biosciences review: some Member States have suspended marketing authorisations for concerned medicines: http://t.co/Lpdyn4An6l","source":"Bitly","id":"540940028340633600","lang":"en","created_at":"2014-12-05T18:45:27.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":3,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540912116753252352","author_id":"116716199","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":98,"end":120,"url":"http://t.co/9bq88YT6tb","expanded_url":"http://goo.gl/DKxYoP","display_url":"goo.gl/DKxYoP"}],"hashtags":[{"start":72,"end":84,"tag":"drugtesting"},{"start":85,"end":97,"tag":"vaccination"}],"annotations":[{"start":42,"end":45,"probability":0.6856,"type":"Person","normalized_text":"oher"}]},"possibly_sensitive":false,"text":"RT @EFPIA: Ebola, ethics, scary germs and oher problems we need to face #drugtesting #vaccination http://t.co/9bq88YT6tb","source":"TweetDeck","id":"540912116753252352","lang":"en","created_at":"2014-12-05T16:54:32.000Z","referenced_tweets":[{"type":"retweeted","id":"540909725047873536"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540907787828871168","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/ZqGmSkkddr","expanded_url":"http://bit.ly/1vwftJ7","display_url":"bit.ly/1vwftJ7"}],"hashtags":[{"start":42,"end":50,"tag":"Duaklir"},{"start":51,"end":59,"tag":"Genuair"},{"start":61,"end":72,"tag":"aclidinium"},{"start":83,"end":94,"tag":"formoterol"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the assessment report for #Duaklir #Genuair (#aclidinium bromide / #formoterol fumarate dihydrate): http://t.co/ZqGmSkkddr","source":"Bitly","id":"540907787828871168","lang":"en","created_at":"2014-12-05T16:37:20.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540907300421386240","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":120,"end":142,"url":"http://t.co/8q86JHg8mz","expanded_url":"http://bit.ly/1vnsYWB","display_url":"bit.ly/1vnsYWB"}],"hashtags":[{"start":38,"end":45,"tag":"Vylaer"},{"start":46,"end":55,"tag":"Spiromax"},{"start":57,"end":68,"tag":"budesonide"},{"start":71,"end":82,"tag":"formoterol"},{"start":85,"end":94,"tag":"medicine"},{"start":99,"end":106,"tag":"asthma"},{"start":113,"end":118,"tag":"COPD"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published assessment report for #Vylaer #Spiromax (#budesonide / #formoterol), #medicine for #asthma &amp; #COPD: http://t.co/8q86JHg8mz","source":"Bitly","id":"540907300421386240","lang":"en","created_at":"2014-12-05T16:35:24.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540881679460880384","author_id":"116716199","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @WHO: For &gt;50 yrs WHO has been encouraging countries to reinforce their pharmacovigilance – the surveillance of adverse drug reactions","source":"TweetDeck","id":"540881679460880384","lang":"en","created_at":"2014-12-05T14:53:36.000Z","referenced_tweets":[{"type":"retweeted","id":"540881030534557696"}],"public_metrics":{"retweet_count":64,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540881644165820416","author_id":"116716199","entities":{"mentions":[{"start":3,"end":17,"username":"Rzecznik_URPL","id":"2227841533"},{"start":19,"end":27,"username":"GCessak","id":"556859372"}],"urls":[{"start":118,"end":140,"url":"http://t.co/NPy9eLnhZv","expanded_url":"http://bit.ly/1tYU06f","display_url":"bit.ly/1tYU06f"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @Rzecznik_URPL: @GCessak invites you to press conference \"safety of medicines used without a medical prescription\" http://t.co/NPy9eLnhZv","source":"TweetDeck","id":"540881644165820416","lang":"en","created_at":"2014-12-05T14:53:27.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540881096536518656","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":112,"end":134,"url":"http://t.co/WVhKqEoCR7","expanded_url":"http://bit.ly/1tYTuF8","display_url":"bit.ly/1tYTuF8"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @GCessak: Press conference: \"Safety of medicines used without a medical prescription\" on 11 December 2014... http://t.co/WVhKqEoCR7","source":"TweetDeck","id":"540881096536518656","lang":"en","created_at":"2014-12-05T14:51:17.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":3,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540870570788012032","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":102,"end":124,"url":"http://t.co/AZkiosLWid","expanded_url":"http://bit.ly/12rkRBj","display_url":"bit.ly/12rkRBj"}],"hashtags":[{"start":4,"end":15,"tag":"veterinary"}],"annotations":{}},"possibly_sensitive":false,"text":"Our #veterinary committee (CVMP) is holding its December meeting next week. Highlights out on Friday: http://t.co/AZkiosLWid","source":"Twitter Web Client","id":"540870570788012032","lang":"en","created_at":"2014-12-05T14:09:27.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540870069803552768","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":93,"end":115,"url":"http://t.co/eTK63cWq6f","expanded_url":"http://bit.ly/1tQGJgT","display_url":"bit.ly/1tQGJgT"}],"hashtags":[{"start":48,"end":66,"tag":"pharmacovigilance"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the highlights from this week's #pharmacovigilance committee (PRAC) meeting: http://t.co/eTK63cWq6f","source":"Bitly","id":"540870069803552768","lang":"en","created_at":"2014-12-05T14:07:28.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540869362081857536","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":88,"end":110,"url":"http://t.co/zyidfgeMza","expanded_url":"http://bit.ly/1v3ljjr","display_url":"bit.ly/1v3ljjr"}],"hashtags":[{"start":112,"end":124,"tag":"recruitment"}],"annotations":{}},"possibly_sensitive":false,"text":"Two more weeks to apply for our vacancy for an Enterprise Architect in our IT Division: http://t.co/zyidfgeMza  #recruitment","source":"Twitter Web Client","id":"540869362081857536","lang":"en","created_at":"2014-12-05T14:04:39.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540869214996021249","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":91,"end":113,"url":"http://t.co/cFDK7GRFAk","expanded_url":"http://bit.ly/18SjN71","display_url":"bit.ly/18SjN71"}],"hashtags":[{"start":41,"end":52,"tag":"monitoring"},{"start":115,"end":127,"tag":"procurement"}],"annotations":{}},"possibly_sensitive":false,"text":"One more week to apply to our tender for #monitoring of scientific and medical literature: http://t.co/cFDK7GRFAk  #procurement","source":"Twitter Web Client","id":"540869214996021249","lang":"en","created_at":"2014-12-05T14:04:04.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540869056178692096","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":98,"end":120,"url":"http://t.co/2VsQuXxTpi","expanded_url":"http://bit.ly/1vuWBu1","display_url":"bit.ly/1vuWBu1"}],"hashtags":[{"start":46,"end":57,"tag":"paediatric"},{"start":58,"end":63,"tag":"DTaP"},{"start":87,"end":96,"tag":"vaccines"}],"annotations":{}},"possibly_sensitive":false,"text":"Two more weeks to comment on requirements for #paediatric #DTaP-containing combination #vaccines: http://t.co/2VsQuXxTpi","source":"Twitter Web Client","id":"540869056178692096","lang":"en","created_at":"2014-12-05T14:03:26.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540857776176893952","author_id":"116716199","entities":{"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"urls":[{"start":100,"end":123,"url":"https://t.co/3v5CnU6G3m","expanded_url":"https://e-recruitment.emcdda.europa.eu/e-recruitment/jobvacancies","display_url":"e-recruitment.emcdda.europa.eu/e-recruitment/…"}],"hashtags":{},"annotations":[{"start":66,"end":71,"probability":0.9887,"type":"Place","normalized_text":"Lisbon"}]},"possibly_sensitive":false,"text":"RT @EMCDDA: New traineeship positions available at our offices in Lisbon. Deadline 15 January 2015: https://t.co/3v5CnU6G3m","source":"TweetDeck","id":"540857776176893952","lang":"en","created_at":"2014-12-05T13:18:37.000Z","referenced_tweets":[{"type":"retweeted","id":"540848358076977152"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540857621801345025","author_id":"116716199","entities":{"mentions":[{"start":3,"end":14,"username":"luca__pani","id":"2176193576"},{"start":71,"end":81,"username":"lucasofri","id":"20910977"},{"start":82,"end":94,"username":"wireditalia","id":"119711344"},{"start":95,"end":105,"username":"MedBunker","id":"622354597"},{"start":106,"end":117,"username":"le_scienze","id":"194192566"},{"start":118,"end":132,"username":"PopSci_italia","id":"2530362500"}],"urls":[{"start":48,"end":70,"url":"http://t.co/E0c6KgcZs2","expanded_url":"http://bit.ly/15Su9sg","display_url":"bit.ly/15Su9sg"}],"hashtags":[{"start":16,"end":22,"tag":"Fluad"},{"start":23,"end":31,"tag":"vaccine"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @luca__pani: #Fluad #vaccine: the day after. http://t.co/E0c6KgcZs2 @lucasofri @wireditalia @MedBunker @le_scienze @PopSci_italia","source":"TweetDeck","id":"540857621801345025","lang":"en","created_at":"2014-12-05T13:18:00.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540823698987843585","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":97,"end":119,"url":"http://t.co/GJLYM9X7DF","expanded_url":"http://bit.ly/1yRSJmP","display_url":"bit.ly/1yRSJmP"}],"hashtags":[{"start":13,"end":24,"tag":"Budesonide"},{"start":25,"end":36,"tag":"Formoterol"},{"start":46,"end":53,"tag":"asthma"},{"start":58,"end":63,"tag":"COPD"}],"annotations":{}},"possibly_sensitive":false,"text":"The EPAR for #Budesonide/#Formoterol Teva for #asthma and #COPD is now available on our website: http://t.co/GJLYM9X7DF","source":"Twitter Web Client","id":"540823698987843585","lang":"en","created_at":"2014-12-05T11:03:12.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540823274452946946","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":{},"annotations":[{"start":121,"end":129,"probability":0.9665,"type":"Other","normalized_text":"Christmas"}]},"possibly_sensitive":false,"text":"RT @edqm_news: Publications ordered on 15 Dec by 4pm CET will be processed and dispatched by 17 Dec. More on orders over Christmas: http://…","source":"TweetDeck","id":"540823274452946946","lang":"en","created_at":"2014-12-05T11:01:31.000Z","referenced_tweets":[{"type":"retweeted","id":"540818193737322496"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540822921196085248","author_id":"116716199","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":48,"end":70,"url":"http://t.co/FY06LQIGpu","expanded_url":"http://goo.gl/aZHbGu","display_url":"goo.gl/aZHbGu"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @EFPIA: This week's EFPIA newsletter is out!\nhttp://t.co/FY06LQIGpu","source":"TweetDeck","id":"540822921196085248","lang":"en","created_at":"2014-12-05T11:00:07.000Z","referenced_tweets":[{"type":"retweeted","id":"540811222527254529"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540822520023498752","author_id":"116716199","entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"urls":[{"start":81,"end":103,"url":"http://t.co/Icpze22k5X","expanded_url":"http://bit.ly/1yM6AcQ","display_url":"bit.ly/1yM6AcQ"}],"hashtags":[{"start":104,"end":116,"tag":"EGAgenerics"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @egagenerics: How is medicine quality, safety and efficacy ensured in the EU? http://t.co/Icpze22k5X #EGAgenerics","source":"TweetDeck","id":"540822520023498752","lang":"en","created_at":"2014-12-05T10:58:31.000Z","referenced_tweets":[{"type":"retweeted","id":"540807797944754176"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540822406370455552","author_id":"116716199","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":88,"end":110,"url":"http://t.co/hvKsAq3N8k","expanded_url":"http://goo.gl/DuTvJl","display_url":"goo.gl/DuTvJl"}],"hashtags":[{"start":75,"end":86,"tag":"fluvaccine"}],"annotations":[{"start":11,"end":13,"probability":0.7265,"type":"Organization","normalized_text":"CDC"}]},"possibly_sensitive":false,"text":"RT @EFPIA: CDC says it is too late to make new flu vaccine for this season #fluvaccine \nhttp://t.co/hvKsAq3N8k","source":"TweetDeck","id":"540822406370455552","lang":"en","created_at":"2014-12-05T10:58:04.000Z","referenced_tweets":[{"type":"retweeted","id":"540806304991047680"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540822170025615360","author_id":"116716199","entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":69,"end":91,"url":"http://t.co/Cbg2wpGxdB","expanded_url":"http://bit.ly/1tXNMU8","display_url":"bit.ly/1tXNMU8"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @Aifa_ufficiale: EMA updates its policy on conflicts of interests http://t.co/Cbg2wpGxdB","source":"TweetDeck","id":"540822170025615360","lang":"en","created_at":"2014-12-05T10:57:07.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540801719631097856","author_id":"116716199","entities":{"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"urls":[{"start":65,"end":87,"url":"http://t.co/kU4CXGmPtF","expanded_url":"http://ow.ly/Fpbl5","display_url":"ow.ly/Fpbl5"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @MHRAmedicines: Pre-order the new edition of the Orange Guide http://t.co/kU4CXGmPtF (out Jan 2015) Good Manufacturing / Distribution Pr…","source":"TweetDeck","id":"540801719631097856","lang":"en","created_at":"2014-12-05T09:35:52.000Z","referenced_tweets":[{"type":"retweeted","id":"540801006565867520"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540801677553831936","author_id":"116716199","entities":{"mentions":[{"start":3,"end":14,"username":"luca__pani","id":"2176193576"}],"urls":[{"start":122,"end":144,"url":"http://t.co/ydCtwQzlS6","expanded_url":"http://bit.ly/1tXsciy","display_url":"bit.ly/1tXsciy"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @luca__pani: Italian medicines agency presents antipsychotic case - EMA-EFPIA workshop on dose finding &amp; selection http://t.co/ydCtwQzlS6","source":"TweetDeck","id":"540801677553831936","lang":"en","created_at":"2014-12-05T09:35:42.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540801176443576320","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":88,"end":110,"url":"http://t.co/zyidfgeMza","expanded_url":"http://bit.ly/1v3ljjr","display_url":"bit.ly/1v3ljjr"}],"hashtags":[{"start":111,"end":123,"tag":"recruitment"}],"annotations":{}},"possibly_sensitive":false,"text":"Two weeks left to apply for our vacancy for an Enterprise Architect in our IT Division: http://t.co/zyidfgeMza #recruitment","source":"Bitly","id":"540801176443576320","lang":"en","created_at":"2014-12-05T09:33:42.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540800535067373568","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":91,"end":113,"url":"http://t.co/cFDK7GRFAk","expanded_url":"http://bit.ly/18SjN71","display_url":"bit.ly/18SjN71"}],"hashtags":[{"start":41,"end":52,"tag":"monitoring"},{"start":115,"end":127,"tag":"procurement"}],"annotations":{}},"possibly_sensitive":false,"text":"One week left to apply to our tender for #monitoring of scientific and medical literature: http://t.co/cFDK7GRFAk  #procurement","source":"Twitter Web Client","id":"540800535067373568","lang":"en","created_at":"2014-12-05T09:31:09.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540799860438740992","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":99,"end":121,"url":"http://t.co/2VsQuXxTpi","expanded_url":"http://bit.ly/1vuWBu1","display_url":"bit.ly/1vuWBu1"}],"hashtags":[{"start":47,"end":58,"tag":"paediatric"},{"start":59,"end":64,"tag":"DTaP"},{"start":88,"end":97,"tag":"vaccines"}],"annotations":{}},"possibly_sensitive":false,"text":"Two weeks left to comment on  requirements for #paediatric #DTaP-containing combination #vaccines: http://t.co/2VsQuXxTpi","source":"Bitly","id":"540799860438740992","lang":"en","created_at":"2014-12-05T09:28:28.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540797628372762624","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":76,"end":98,"url":"http://t.co/AZkiosLWid","expanded_url":"http://bit.ly/12rkRBj","display_url":"bit.ly/12rkRBj"}],"hashtags":[{"start":4,"end":15,"tag":"veterinary"}],"annotations":{}},"possibly_sensitive":false,"text":"Our #veterinary committee (CVMP) meets next week. Highlights out on Friday: http://t.co/AZkiosLWid","source":"Bitly","id":"540797628372762624","lang":"en","created_at":"2014-12-05T09:19:36.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540549781677162496","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":90,"end":112,"url":"http://t.co/GJLYM9X7DF","expanded_url":"http://bit.ly/1yRSJmP","display_url":"bit.ly/1yRSJmP"}],"hashtags":[{"start":38,"end":49,"tag":"Budesonide"},{"start":50,"end":61,"tag":"Formoterol"},{"start":71,"end":78,"tag":"asthma"},{"start":83,"end":88,"tag":"COPD"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the assessment report #Budesonide/#Formoterol Teva for #asthma and #COPD: http://t.co/GJLYM9X7DF","source":"Bitly","id":"540549781677162496","lang":"en","created_at":"2014-12-04T16:54:45.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540540586302779392","author_id":"116716199","entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"},{"start":106,"end":117,"username":"JPNDeurope","id":"300289123"}],"urls":[{"start":83,"end":105,"url":"http://t.co/FXdfrT9eQb","expanded_url":"http://bit.ly/1hzEP22","display_url":"bit.ly/1hzEP22"}],"hashtags":[{"start":18,"end":36,"tag":"Neurodegenerative"},{"start":57,"end":64,"tag":"Europe"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @euparkinsons: #Neurodegenerative disease research in #Europe gets it together:\nhttp://t.co/FXdfrT9eQb @JPNDeurope","source":"TweetDeck","id":"540540586302779392","lang":"en","created_at":"2014-12-04T16:18:13.000Z","referenced_tweets":[{"type":"retweeted","id":"540540290482712577"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540540442686025729","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":[{"start":107,"end":129,"url":"http://t.co/0qwtTRuQoY","expanded_url":"http://bit.ly/1F0mVNh","display_url":"bit.ly/1F0mVNh"}],"hashtags":[{"start":23,"end":38,"tag":"pharmacopoeial"},{"start":69,"end":81,"tag":"Pharmeuropa"},{"start":130,"end":139,"tag":"European"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @edqm_news: 5 draft #pharmacopoeial texts were added this week to #Pharmeuropa: 1 month left to comment http://t.co/0qwtTRuQoY #European…","source":"TweetDeck","id":"540540442686025729","lang":"en","created_at":"2014-12-04T16:17:38.000Z","referenced_tweets":[{"type":"retweeted","id":"540540088061816832"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540540201811333120","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"}],"urls":[{"start":72,"end":95,"url":"https://t.co/KjniBvtdHw","expanded_url":"https://www.youtube.com/playlist?list=PLvpwIjZTs-LgEOae64RygLDbo25t6HVJb","display_url":"youtube.com/playlist?list=…"},{"start":96,"end":118,"url":"http://t.co/WWXR4JYGjf","expanded_url":"http://ec.europa.eu/research/iscp/index.cfm?lg=en&pg=destinationEurope","display_url":"ec.europa.eu/research/iscp/…"}],"hashtags":[{"start":119,"end":130,"tag":"H2020World"}],"annotations":[{"start":26,"end":31,"probability":0.5145,"type":"Place","normalized_text":"Europe"},{"start":65,"end":70,"probability":0.9883,"type":"Place","normalized_text":"Europe"}]},"possibly_sensitive":false,"text":"RT @EU_H2020: Destination Europe - a new playlist on research in Europe https://t.co/KjniBvtdHw http://t.co/WWXR4JYGjf #H2020World http://t…","source":"TweetDeck","id":"540540201811333120","lang":"en","created_at":"2014-12-04T16:16:41.000Z","referenced_tweets":[{"type":"retweeted","id":"540536516532264960"}],"public_metrics":{"retweet_count":21,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540540177471774720","author_id":"116716199","entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":[{"start":79,"end":102,"url":"https://t.co/syDplfodKH","expanded_url":"https://www.youtube.com/playlist?list=PLvpwIjZTs-LgEOae64RygLDbo25t6HVJb","display_url":"youtube.com/playlist?list=…"},{"start":103,"end":125,"url":"http://t.co/j28HlaViwI","expanded_url":"http://ec.europa.eu/research/iscp/index.cfm?lg=en&pg=destinationEurope","display_url":"ec.europa.eu/research/iscp/…"}],"hashtags":[{"start":126,"end":137,"tag":"H2020World"}],"annotations":[{"start":33,"end":38,"probability":0.5218,"type":"Place","normalized_text":"Europe"},{"start":72,"end":77,"probability":0.9851,"type":"Place","normalized_text":"Europe"}]},"possibly_sensitive":false,"text":"RT @innovationunion: Destination Europe - a new playlist on research in Europe https://t.co/syDplfodKH http://t.co/j28HlaViwI #H2020World h…","source":"TweetDeck","id":"540540177471774720","lang":"en","created_at":"2014-12-04T16:16:35.000Z","referenced_tweets":[{"type":"retweeted","id":"540536516444188673"}],"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540539328578191360","author_id":"116716199","entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"urls":[{"start":73,"end":95,"url":"http://t.co/Icpze22k5X","expanded_url":"http://bit.ly/1yM6AcQ","display_url":"bit.ly/1yM6AcQ"},{"start":109,"end":131,"url":"http://t.co/ZvHJ8y93ZK","expanded_url":"https://twitter.com/egagenerics/status/540520918557024260/photo/1","display_url":"pic.twitter.com/ZvHJ8y93ZK"}],"hashtags":[{"start":54,"end":71,"tag":"genericmedicines"},{"start":96,"end":108,"tag":"EGAgenerics"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @egagenerics: What are the key treatment areas for #genericmedicines? http://t.co/Icpze22k5X #EGAgenerics http://t.co/ZvHJ8y93ZK","source":"TweetDeck","id":"540539328578191360","lang":"en","created_at":"2014-12-04T16:13:13.000Z","referenced_tweets":[{"type":"retweeted","id":"540520918557024260"}],"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_540520918489894912"]}},{"conversation_id":"540539106603053056","author_id":"116716199","entities":{"mentions":[{"start":3,"end":15,"username":"CPME_EUROPA","id":"440810430"}],"urls":[{"start":97,"end":119,"url":"http://t.co/DHhJPPCt0C","expanded_url":"http://bit.ly/1vQ99Le","display_url":"bit.ly/1vQ99Le"}],"hashtags":[{"start":22,"end":33,"tag":"Newsletter"},{"start":36,"end":41,"tag":"TTIP"},{"start":42,"end":55,"tag":"transparency"},{"start":56,"end":62,"tag":"Ebola"},{"start":63,"end":67,"tag":"DoH"},{"start":68,"end":72,"tag":"AMR"},{"start":73,"end":81,"tag":"alcohol"},{"start":82,"end":96,"tag":"patientsafety"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @CPME_EUROPA: CPME #Newsletter : #TTIP #transparency #Ebola #DoH #AMR #alcohol #patientsafety http://t.co/DHhJPPCt0C","source":"TweetDeck","id":"540539106603053056","lang":"pt","created_at":"2014-12-04T16:12:20.000Z","referenced_tweets":[{"type":"retweeted","id":"540514712044449792"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540538708760743936","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"urls":[{"start":100,"end":122,"url":"http://t.co/dWUgJzmANP","expanded_url":"https://twitter.com/EAAD_EU/status/540505870107287552/photo/1","display_url":"pic.twitter.com/dWUgJzmANP"}],"hashtags":[{"start":57,"end":69,"tag":"antibiotics"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EAAD_EU: Most winter illnesses are of viral origin - #antibiotics will not make you feel better http://t.co/dWUgJzmANP","source":"TweetDeck","id":"540538708760743936","lang":"en","created_at":"2014-12-04T16:10:45.000Z","referenced_tweets":[{"type":"retweeted","id":"540505870107287552"}],"public_metrics":{"retweet_count":35,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_539396433258893312"]}},{"conversation_id":"540538444674764800","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"},{"start":105,"end":110,"username":"NEJM","id":"25950355"}],"urls":[{"start":112,"end":134,"url":"http://t.co/BuGGDHA9x3","expanded_url":"http://ht.ly/FlRU6","display_url":"ht.ly/FlRU6"}],"hashtags":[{"start":25,"end":31,"tag":"Ebola"}],"annotations":[{"start":86,"end":88,"probability":0.4696,"type":"Organization","normalized_text":"FDA"}]},"possibly_sensitive":false,"text":"RT @FDA_MCMi: Evaluating #Ebola therapies: the case for randomized controlled trials. FDA perspective in @NEJM: http://t.co/BuGGDHA9x3","source":"TweetDeck","id":"540538444674764800","lang":"en","created_at":"2014-12-04T16:09:42.000Z","referenced_tweets":[{"type":"retweeted","id":"540502153719476224"}],"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540519867431264256","author_id":"116716199","entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"},{"start":16,"end":20,"username":"WHO","id":"14499829"}],"urls":[{"start":82,"end":104,"url":"http://t.co/8SY32hnJbB","expanded_url":"http://ow.ly/FlGFB","display_url":"ow.ly/FlGFB"}],"hashtags":[{"start":50,"end":65,"tag":"cervicalcancer"},{"start":66,"end":81,"tag":"cancercongress"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @myESMO: New @WHO guide to prevent and control #cervicalcancer #cancercongress http://t.co/8SY32hnJbB","source":"TweetDeck","id":"540519867431264256","lang":"en","created_at":"2014-12-04T14:55:53.000Z","referenced_tweets":[{"type":"retweeted","id":"540487543243173888"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540519696047812608","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":85,"end":107,"url":"http://t.co/cKYhunYdpW","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/12/news_detail_002228.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":{},"annotations":[{"start":13,"end":25,"probability":0.7755,"type":"Organization","normalized_text":"EMA Committee"}]},"possibly_sensitive":false,"text":"RT @GCessak: EMA Committee review reassures Member States over safety of flu vaccine http://t.co/cKYhunYdpW","source":"TweetDeck","id":"540519696047812608","lang":"en","created_at":"2014-12-04T14:55:12.000Z","referenced_tweets":[{"type":"retweeted","id":"540481694420459520"}],"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540519617660473344","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":113,"end":135,"url":"http://t.co/5mXhfE9rmK","expanded_url":"http://bit.ly/1fmq9xd","display_url":"bit.ly/1fmq9xd"}],"hashtags":{},"annotations":[{"start":53,"end":56,"probability":0.4178,"type":"Place","normalized_text":"ECHA"}]},"possibly_sensitive":false,"text":"RT @EU_ECHA: Last days to apply for a traineeship at ECHA. Check the profiles and the requirements and apply now http://t.co/5mXhfE9rmK","source":"TweetDeck","id":"540519617660473344","lang":"en","created_at":"2014-12-04T14:54:53.000Z","referenced_tweets":[{"type":"retweeted","id":"540477719541460993"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540519415947993088","author_id":"116716199","entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":53,"end":75,"url":"http://t.co/4G52NiDbPb","expanded_url":"http://bit.ly/1zV108y","display_url":"bit.ly/1zV108y"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @LV_MPA: Monthly report from CHMP (November 2014) http://t.co/4G52NiDbPb","source":"TweetDeck","id":"540519415947993088","lang":"en","created_at":"2014-12-04T14:54:05.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540517580893863936","author_id":"116716199","entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"urls":[{"start":41,"end":63,"url":"http://t.co/Icpze22k5X","expanded_url":"http://bit.ly/1yM6AcQ","display_url":"bit.ly/1yM6AcQ"}],"hashtags":[{"start":64,"end":76,"tag":"EGAgenerics"},{"start":77,"end":94,"tag":"genericmedicines"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @egagenerics: What is bioequivalence? http://t.co/Icpze22k5X #EGAgenerics #genericmedicines","source":"TweetDeck","id":"540517580893863936","lang":"en","created_at":"2014-12-04T14:46:48.000Z","referenced_tweets":[{"type":"retweeted","id":"540445408615354369"}],"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540438020911288320","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":105,"end":127,"url":"http://t.co/KuzOVhZNj3","expanded_url":"http://bit.ly/1zQKary","display_url":"bit.ly/1zQKary"}],"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"},{"start":97,"end":103,"tag":"Fluad"}],"annotations":{}},"possibly_sensitive":false,"text":"Our #pharmacovigilance committee has reassured Member States about the safety of the flu vaccine #Fluad: http://t.co/KuzOVhZNj3","source":"Twitter Web Client","id":"540438020911288320","lang":"en","created_at":"2014-12-04T09:30:39.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540437566160654336","author_id":"116716199","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":84,"end":106,"url":"http://t.co/JqgqhPJLFf","expanded_url":"http://goo.gl/UhVqM8","display_url":"goo.gl/UhVqM8"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @EFPIA: F.D.A. Revamps System Explaining the Risks of Medicines During Pregnancy\nhttp://t.co/JqgqhPJLFf","source":"TweetDeck","id":"540437566160654336","lang":"en","created_at":"2014-12-04T09:28:51.000Z","referenced_tweets":[{"type":"retweeted","id":"540434206758039552"}],"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540202833770213376","author_id":"116716199","entities":{"mentions":[{"start":0,"end":12,"username":"itsmePanda1","id":"1312511150437924869"},{"start":13,"end":28,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":103,"end":125,"url":"http://t.co/kcV5QnSch2","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"@itsmepanda1 @Aifa_ufficiale If you'd like to send us a question about this conclusion please do so at http://t.co/kcV5QnSch2.","source":"TweetDeck","id":"540436829372424192","lang":"en","created_at":"2014-12-04T09:25:55.000Z","referenced_tweets":[{"type":"replied_to","id":"540204194301747200"}],"in_reply_to_user_id":"232934834","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540203575704834050","author_id":"116716199","entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"},{"start":20,"end":29,"username":"EMA_News","id":"116716199"}],"urls":[{"start":115,"end":137,"url":"http://t.co/a9gp3oKpmK","expanded_url":"http://bit.ly/1zQKary","display_url":"bit.ly/1zQKary"}],"hashtags":[{"start":76,"end":82,"tag":"Fluad"}],"annotations":[{"start":108,"end":112,"probability":0.9934,"type":"Place","normalized_text":"Italy"}]},"possibly_sensitive":false,"text":"RT @Aifa_ufficiale: @EMA_News PRAC concluded that there is no evidence that #Fluad vaccine caused deaths in Italy: http://t.co/a9gp3oKpmK","source":"Twitter for iPhone","id":"540203575704834050","lang":"en","created_at":"2014-12-03T17:59:03.000Z","referenced_tweets":[{"type":"retweeted","id":"540202833770213376"}],"public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540190752803139585","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":86,"end":108,"url":"http://t.co/KuzOVhZNj3","expanded_url":"http://bit.ly/1zQKary","display_url":"bit.ly/1zQKary"}],"hashtags":[{"start":47,"end":53,"tag":"Fluad"}],"annotations":[{"start":79,"end":83,"probability":0.994,"type":"Place","normalized_text":"Italy"}]},"possibly_sensitive":false,"text":"We've concluded that there is no evidence that #Fluad vaccine caused deaths in Italy: http://t.co/KuzOVhZNj3","source":"Bitly","id":"540190752803139585","lang":"en","created_at":"2014-12-03T17:08:06.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":30,"reply_count":0,"like_count":4,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540168901527891968","author_id":"116716199","entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"},{"start":73,"end":82,"username":"EMA_News","id":"116716199"}],"urls":[{"start":83,"end":105,"url":"http://t.co/Ez7FLlfX4a","expanded_url":"http://www.egagenerics.com/index.php/press-room/press-releases/2014/375-ega-strongly-supports-european-medicines-agency-position-on-biosimilar-labelling","display_url":"egagenerics.com/index.php/pres…"}],"hashtags":[{"start":50,"end":62,"tag":"biosimilars"}],"annotations":[{"start":17,"end":19,"probability":0.3368,"type":"Organization","normalized_text":"EGA"}]},"possibly_sensitive":false,"text":"RT @egagenerics: EGA strongly supports the EMA on #biosimilars labelling @EMA_News http://t.co/Ez7FLlfX4a","source":"TweetDeck","id":"540168901527891968","lang":"en","created_at":"2014-12-03T15:41:16.000Z","referenced_tweets":[{"type":"retweeted","id":"540160626749112320"}],"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540149590813863936","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"FDAMedia","id":"2528303509"}],"urls":{},"hashtags":{},"annotations":[{"start":14,"end":16,"probability":0.7159,"type":"Organization","normalized_text":"FDA"}]},"possibly_sensitive":false,"text":"RT @FDAMedia: FDA issues final rule on how to better convey pregnancy and lactation information in prescription drug labeling http://t.co/r…","source":"TweetDeck","id":"540149590813863936","lang":"en","created_at":"2014-12-03T14:24:32.000Z","referenced_tweets":[{"type":"retweeted","id":"540149362337525761"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540149558375116800","author_id":"116716199","entities":{"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"urls":{},"hashtags":{},"annotations":[{"start":12,"end":14,"probability":0.7552,"type":"Organization","normalized_text":"FDA"}]},"possibly_sensitive":false,"text":"RT @US_FDA: FDA issues final rule on providing more useful pregnancy &amp; lactation info for prescription drugs &amp; biologic products. http://t.…","source":"TweetDeck","id":"540149558375116800","lang":"en","created_at":"2014-12-03T14:24:24.000Z","referenced_tweets":[{"type":"retweeted","id":"540149198101159936"}],"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540146589546070017","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":125,"end":140,"username":"EUCouncilPress","id":"198618575"}],"urls":[{"start":62,"end":84,"url":"http://t.co/whybIZxVJy","expanded_url":"http://ow.ly/F9TVs","display_url":"ow.ly/F9TVs"}],"hashtags":[{"start":31,"end":37,"tag":"EPSCO"},{"start":38,"end":45,"tag":"Health"},{"start":85,"end":97,"tag":"vaccination"},{"start":98,"end":113,"tag":"MedicalDevices"},{"start":114,"end":120,"tag":"Ebola"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EU_Health: Main results of #EPSCO #Health Council on 1/12 http://t.co/whybIZxVJy #vaccination #MedicalDevices #Ebola via @EUCouncilPress","source":"TweetDeck","id":"540146589546070017","lang":"en","created_at":"2014-12-03T14:12:37.000Z","referenced_tweets":[{"type":"retweeted","id":"540146266341388288"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540144630596374528","author_id":"116716199","entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"},{"start":47,"end":56,"username":"EMA_News","id":"116716199"}],"urls":[{"start":110,"end":132,"url":"http://t.co/c4UpZjRNH5","expanded_url":"http://bit.ly/1zDf3zy","display_url":"bit.ly/1zDf3zy"}],"hashtags":[{"start":97,"end":109,"tag":"biosimilars"}],"annotations":[{"start":21,"end":45,"probability":0.3078,"type":"Organization","normalized_text":"European Medicines Agency"}]},"possibly_sensitive":false,"text":"RT @egagenerics: The European Medicines Agency @EMA_News has published its revised guidelines on #biosimilars http://t.co/c4UpZjRNH5","source":"TweetDeck","id":"540144630596374528","lang":"en","created_at":"2014-12-03T14:04:49.000Z","referenced_tweets":[{"type":"retweeted","id":"540143468811530242"}],"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540144400236830720","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":106,"end":128,"url":"http://t.co/aJWgttbesX","expanded_url":"http://bit.ly/1vjdWkr","display_url":"bit.ly/1vjdWkr"}],"hashtags":{},"annotations":[{"start":13,"end":16,"probability":0.5186,"type":"Organization","normalized_text":"ECHA"}]},"possibly_sensitive":false,"text":"RT @EU_ECHA: ECHA is preparing a systematic approach to assess read-across cases under dossier evaluation http://t.co/aJWgttbesX","source":"TweetDeck","id":"540144400236830720","lang":"en","created_at":"2014-12-03T14:03:55.000Z","referenced_tweets":[{"type":"retweeted","id":"540142844179382272"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540144325922131968","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @EU_ECHA: We have updated our Biocides Guidance web pages to reflect the new Biocidal Products Regulation guidance structure. http://t.c…","source":"TweetDeck","id":"540144325922131968","lang":"en","created_at":"2014-12-03T14:03:37.000Z","referenced_tweets":[{"type":"retweeted","id":"540142507309674496"}],"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540139569531092992","author_id":"116716199","entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":83,"end":105,"url":"http://t.co/votr96m1q2","expanded_url":"http://bit.ly/12tb12S","display_url":"bit.ly/12tb12S"}],"hashtags":[{"start":33,"end":41,"tag":"Sovaldi"},{"start":42,"end":53,"tag":"sofosbuvir"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @Aifa_ufficiale: Inclusion of #Sovaldi #sofosbuvir in the web platform registry http://t.co/votr96m1q2","source":"TweetDeck","id":"540139569531092992","lang":"en","created_at":"2014-12-03T13:44:43.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540136278134910977","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":{},"hashtags":{},"annotations":[{"start":38,"end":78,"probability":0.2285,"type":"Organization","normalized_text":"Blood Products Advisory Committee Meeting"}]},"possibly_sensitive":false,"text":"RT @FDACBER: Did you miss yesterday’s Blood Products Advisory Committee Meeting? You can watch today’s live webcast here: http://t.co/zuDAL…","source":"TweetDeck","id":"540136278134910977","lang":"en","created_at":"2014-12-03T13:31:38.000Z","referenced_tweets":[{"type":"retweeted","id":"540135972784988161"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540136113621712896","author_id":"116716199","entities":{"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"urls":[{"start":105,"end":127,"url":"http://t.co/W5g2fsec3M","expanded_url":"http://ow.ly/FhNnT","display_url":"ow.ly/FhNnT"}],"hashtags":[{"start":128,"end":135,"tag":"HTIA15"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @MHRAmedicines: Early bird rate for Hot Topics in Advertising seminar finishes at 5pm today. Register http://t.co/W5g2fsec3M #HTIA15","source":"TweetDeck","id":"540136113621712896","lang":"en","created_at":"2014-12-03T13:30:59.000Z","referenced_tweets":[{"type":"retweeted","id":"540134646231887872"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540129567684698112","author_id":"116716199","entities":{"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"urls":{},"hashtags":[{"start":82,"end":88,"tag":"GCP15"}],"annotations":[{"start":38,"end":59,"probability":0.6126,"type":"Other","normalized_text":"Good Clinical Practice"}]},"possibly_sensitive":false,"text":"RT @MHRAmedicines: Register today for Good Clinical Practice symposium 3 March 15 #GCP15","source":"TweetDeck","id":"540129567684698112","lang":"en","created_at":"2014-12-03T13:04:58.000Z","referenced_tweets":[{"type":"retweeted","id":"540128867365945344"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540129514589020160","author_id":"116716199","entities":{"mentions":[{"start":3,"end":17,"username":"EUAuditorsECA","id":"803430727844888576"}],"urls":[{"start":112,"end":134,"url":"http://t.co/osZuVKAThL","expanded_url":"http://ow.ly/i/7NQ4w","display_url":"ow.ly/i/7NQ4w"}],"hashtags":[{"start":26,"end":32,"tag":"audit"},{"start":36,"end":39,"tag":"EU"},{"start":61,"end":70,"tag":"chemical"},{"start":71,"end":82,"tag":"biological"},{"start":83,"end":96,"tag":"radiological"},{"start":97,"end":105,"tag":"nuclear"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EUAuditorsECA: TODAY: #audit of #EU initiative to tackle #chemical #biological #radiological #nuclear risks http://t.co/osZuVKAThL http…","source":"TweetDeck","id":"540129514589020160","lang":"en","created_at":"2014-12-03T13:04:46.000Z","referenced_tweets":[{"type":"retweeted","id":"540128600490803201"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540114915621888000","author_id":"116716199","entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":65,"end":87,"url":"http://t.co/lYU5bwAKcC","expanded_url":"http://1.usa.gov/1rWTRAm","display_url":"1.usa.gov/1rWTRAm"}],"hashtags":[{"start":21,"end":28,"tag":"Animal"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @FDAanimalhealth: #Animal Drug Approvals December 2014 Update http://t.co/lYU5bwAKcC","source":"TweetDeck","id":"540114915621888000","lang":"en","created_at":"2014-12-03T12:06:45.000Z","referenced_tweets":[{"type":"retweeted","id":"540114445952106496"}],"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540113786074836993","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":83,"end":105,"url":"http://t.co/rjDFxB6OUK","expanded_url":"http://bit.ly/1w1JAKe","display_url":"bit.ly/1w1JAKe"}],"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":36,"end":43,"tag":"herbal"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the #minutes of our #herbal committee (HMPC) meeting in September: http://t.co/rjDFxB6OUK","source":"Twitter Web Client","id":"540113786074836993","lang":"en","created_at":"2014-12-03T12:02:16.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540112586331918337","author_id":"116716199","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":33,"end":48,"username":"CPathInstitute","id":"861749209"}],"urls":[{"start":121,"end":143,"url":"http://t.co/m7f7DzZeQK","expanded_url":"http://bit.ly/1zL2CBW","display_url":"bit.ly/1zL2CBW"}],"hashtags":[{"start":52,"end":57,"tag":"PPPs"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @IMI_JU: Our joint event with @CPathInstitute on #PPPs &amp; drug development today will be live online. Watch it via http://t.co/m7f7DzZeQK","source":"TweetDeck","id":"540112586331918337","lang":"en","created_at":"2014-12-03T11:57:30.000Z","referenced_tweets":[{"type":"retweeted","id":"540105834055745538"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540105127290765312","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"},{"start":69,"end":78,"username":"EMA_News","id":"116716199"}],"urls":[{"start":105,"end":127,"url":"http://t.co/h1VdeIenOm","expanded_url":"http://bit.ly/11T6jKS","display_url":"bit.ly/11T6jKS"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @TOPRANEWS: \"Great annual review\": year-end look at activities of @EMA_News and 2015 outlook - report http://t.co/h1VdeIenOm http://t.co…","source":"TweetDeck","id":"540105127290765312","lang":"en","created_at":"2014-12-03T11:27:51.000Z","referenced_tweets":[{"type":"retweeted","id":"540104736268374016"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540105017416769536","author_id":"116716199","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":{},"annotations":[{"start":9,"end":15,"probability":0.9159,"type":"Person","normalized_text":"Dr Chan"}]},"possibly_sensitive":false,"text":"RT @WHO: Dr Chan: Handing out medicines is easy. Changing behaviour of ppl, including medical staff, is one of hardest tasks facing public …","source":"TweetDeck","id":"540105017416769536","lang":"en","created_at":"2014-12-03T11:27:25.000Z","referenced_tweets":[{"type":"retweeted","id":"540104547482746880"}],"public_metrics":{"retweet_count":200,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540104953730465792","author_id":"116716199","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":{},"annotations":[{"start":13,"end":19,"probability":0.6058,"type":"Person","normalized_text":"Dr Chan"}]},"possibly_sensitive":false,"text":"RT @WHO: 2/2 Dr Chan: In still other parts of the world, people continue to die needlessly from lack of access to these life-saving medicin…","source":"TweetDeck","id":"540104953730465792","lang":"en","created_at":"2014-12-03T11:27:10.000Z","referenced_tweets":[{"type":"retweeted","id":"540104305819533314"}],"public_metrics":{"retweet_count":58,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540104939557912576","author_id":"116716199","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":{},"annotations":[{"start":13,"end":19,"probability":0.7367,"type":"Person","normalized_text":"Dr Chan"}]},"possibly_sensitive":false,"text":"RT @WHO: 1/2 Dr Chan: In some countries, antimicrobials overprescribed. Doctors may hand out antimicrobials to be on the safe side","source":"TweetDeck","id":"540104939557912576","lang":"en","created_at":"2014-12-03T11:27:06.000Z","referenced_tweets":[{"type":"retweeted","id":"540104176718860288"}],"public_metrics":{"retweet_count":61,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540104857227902976","author_id":"116716199","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":{},"annotations":[{"start":9,"end":15,"probability":0.9451,"type":"Person","normalized_text":"Dr Chan"}]},"possibly_sensitive":false,"text":"RT @WHO: Dr Chan: Most troubling is accelerated pace at which drug resistance is developing, Ppl dying from previously easily treated infec…","source":"TweetDeck","id":"540104857227902976","lang":"en","created_at":"2014-12-03T11:26:47.000Z","referenced_tweets":[{"type":"retweeted","id":"540103304840486912"}],"public_metrics":{"retweet_count":84,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540104398593359873","author_id":"116716199","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":65,"end":87,"url":"http://t.co/K8Rw0C2SnS","expanded_url":"http://goo.gl/Q3fem0","display_url":"goo.gl/Q3fem0"}],"hashtags":[{"start":88,"end":92,"tag":"AMR"}],"annotations":[{"start":52,"end":58,"probability":0.7334,"type":"Person","normalized_text":"DG Chan"}]},"possibly_sensitive":false,"text":"RT @WHO: Join Antimicrobial Resistance Webinar with DG Chan now: http://t.co/K8Rw0C2SnS #AMR","source":"TweetDeck","id":"540104398593359873","lang":"en","created_at":"2014-12-03T11:24:57.000Z","referenced_tweets":[{"type":"retweeted","id":"540101441633792002"}],"public_metrics":{"retweet_count":41,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540104353450065921","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":105,"end":127,"url":"http://t.co/X9KHsXNhmE","expanded_url":"http://bit.ly/1w1MEpR","display_url":"bit.ly/1w1MEpR"}],"hashtags":[{"start":75,"end":84,"tag":"Biocides"}],"annotations":[{"start":32,"end":37,"probability":0.3537,"type":"Other","normalized_text":"R4BP 3"}]},"possibly_sensitive":false,"text":"RT @EU_ECHA: The new version of R4BP 3 introduces new features to make the #Biocides submissions easier. http://t.co/X9KHsXNhmE","source":"TweetDeck","id":"540104353450065921","lang":"en","created_at":"2014-12-03T11:24:47.000Z","referenced_tweets":[{"type":"retweeted","id":"540100499559964672"}],"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540104321468473344","author_id":"116716199","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @WHO: What you can do: only use antimicrobial drugs when prescribed; take the full prescription; never share w/ others http://t.co/mNFZL…","source":"TweetDeck","id":"540104321468473344","lang":"en","created_at":"2014-12-03T11:24:39.000Z","referenced_tweets":[{"type":"retweeted","id":"540100398510399488"}],"public_metrics":{"retweet_count":98,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540104211829383168","author_id":"116716199","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":[{"start":102,"end":106,"tag":"AMR"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @WHO: Antibiotic resistance is a global issue: pathogens, resistant or not, do not respect borders #AMR","source":"TweetDeck","id":"540104211829383168","lang":"en","created_at":"2014-12-03T11:24:13.000Z","referenced_tweets":[{"type":"retweeted","id":"540099395849445378"}],"public_metrics":{"retweet_count":152,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540104130006888448","author_id":"116716199","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @WHO: Common diseases become harder to treat as doctors must use drugs that are costly or unavailable and work slowly http://t.co/mNFZLH…","source":"TweetDeck","id":"540104130006888448","lang":"en","created_at":"2014-12-03T11:23:53.000Z","referenced_tweets":[{"type":"retweeted","id":"540098395151425537"}],"public_metrics":{"retweet_count":63,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540103867539927040","author_id":"116716199","entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"urls":[{"start":81,"end":103,"url":"http://t.co/1ijYWTXRUB","expanded_url":"http://bit.ly/1xxu4Ea","display_url":"bit.ly/1xxu4Ea"}],"hashtags":[{"start":17,"end":34,"tag":"Genericmedicines"},{"start":104,"end":116,"tag":"EGAgenerics"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @egagenerics: #Genericmedicines undergo strict scrutiny before being licensed http://t.co/1ijYWTXRUB #EGAgenerics","source":"TweetDeck","id":"540103867539927040","lang":"en","created_at":"2014-12-03T11:22:51.000Z","referenced_tweets":[{"type":"retweeted","id":"540098123507322880"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540103734647586817","author_id":"116716199","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @WHO: Patients infected by drug-resistant agents are sick longer &amp; at increased risk of death. Treatment is more expensive http://t.co/m…","source":"TweetDeck","id":"540103734647586817","lang":"en","created_at":"2014-12-03T11:22:19.000Z","referenced_tweets":[{"type":"retweeted","id":"540097398349889536"}],"public_metrics":{"retweet_count":59,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540103719334187008","author_id":"116716199","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @WHO: Antimicrobial resistance is when disease agents (bacteria, parasites, viruses &amp; fungi) change, meds no longer work http://t.co/kKB…","source":"TweetDeck","id":"540103719334187008","lang":"en","created_at":"2014-12-03T11:22:15.000Z","referenced_tweets":[{"type":"retweeted","id":"540096537100316672"}],"public_metrics":{"retweet_count":98,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540090086411739136","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":51,"end":56,"tag":"EDQM"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @edqm_news: Last chance to sign up for the free #EDQM newsletter before send-out! Receive the November edition today: http://t.co/dKDLcZ…","source":"TweetDeck","id":"540090086411739136","lang":"en","created_at":"2014-12-03T10:28:05.000Z","referenced_tweets":[{"type":"retweeted","id":"540089956673527809"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540090064483926016","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"urls":[{"start":84,"end":106,"url":"http://t.co/EyvbmYnHOi","expanded_url":"http://www.nice.org.uk/news/article/simple-blood-test-for-pneumonia-can-help-limit-use-of-antibiotics","display_url":"nice.org.uk/news/article/s…"},{"start":107,"end":129,"url":"http://t.co/EnWcpOGVtF","expanded_url":"https://twitter.com/NICEcomms/status/540089914646605824/photo/1","display_url":"pic.twitter.com/EnWcpOGVtF"}],"hashtags":[{"start":37,"end":47,"tag":"pneumonia"},{"start":70,"end":82,"tag":"antibiotics"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @NICEcomms: Simple blood test for #pneumonia can help limit use of #antibiotics:\nhttp://t.co/EyvbmYnHOi http://t.co/EnWcpOGVtF","source":"TweetDeck","id":"540090064483926016","lang":"en","created_at":"2014-12-03T10:28:00.000Z","referenced_tweets":[{"type":"retweeted","id":"540089914646605824"}],"public_metrics":{"retweet_count":38,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_540089913354760192"]}},{"conversation_id":"540088964666101760","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @ECDC_EU: We are looking for three Programme Managers for various disease programmes; deadline for application is 7 Jan. http://t.co/Al9…","source":"TweetDeck","id":"540088964666101760","lang":"en","created_at":"2014-12-03T10:23:38.000Z","referenced_tweets":[{"type":"retweeted","id":"540087255294283776"}],"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540084326357295104","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":80,"end":102,"url":"http://t.co/rjDFxB6OUK","expanded_url":"http://bit.ly/1w1JAKe","display_url":"bit.ly/1w1JAKe"}],"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":46,"end":53,"tag":"herbal"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the #minutes of our September #herbal committee (HMPC) meeting: http://t.co/rjDFxB6OUK","source":"Bitly","id":"540084326357295104","lang":"en","created_at":"2014-12-03T10:05:12.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540083842917621760","author_id":"116716199","entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":102,"end":124,"url":"http://t.co/ZgU8uV3pCl","expanded_url":"http://bit.ly/1AeXWF9","display_url":"bit.ly/1AeXWF9"}],"hashtags":[{"start":89,"end":101,"tag":"antibiotics"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @Aifa_ufficiale: \"Without rules, antibiotics don't work\" - campaign on correct use of #antibiotics http://t.co/ZgU8uV3pCl","source":"TweetDeck","id":"540083842917621760","lang":"en","created_at":"2014-12-03T10:03:17.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540083383674884096","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":75,"end":97,"url":"http://t.co/56EmkvORsv","expanded_url":"http://bit.ly/1ECPPD9","display_url":"bit.ly/1ECPPD9"},{"start":115,"end":137,"url":"http://t.co/5mXhfE9rmK","expanded_url":"http://bit.ly/1fmq9xd","display_url":"bit.ly/1fmq9xd"}],"hashtags":{},"annotations":[{"start":44,"end":47,"probability":0.5256,"type":"Place","normalized_text":"ECHA"}]},"possibly_sensitive":false,"text":"RT @EU_ECHA: Interested in a traineeship at ECHA? Meet our former trainees http://t.co/56EmkvORsv and apply today. http://t.co/5mXhfE9rmK","source":"TweetDeck","id":"540083383674884096","lang":"en","created_at":"2014-12-03T10:01:27.000Z","referenced_tweets":[{"type":"retweeted","id":"540082418641022976"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540081327924862976","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/xvjz1NzIlP","expanded_url":"http://bit.ly/15NMtmj","display_url":"bit.ly/15NMtmj"}],"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":58,"end":76,"tag":"AdvancedTherapies"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the #minutes of our October Committee for #AdvancedTherapies (CAT) meeting: http://t.co/xvjz1NzIlP","source":"Twitter Web Client","id":"540081327924862976","lang":"en","created_at":"2014-12-03T09:53:17.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540081189227593728","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/6UB4sH7BJB","expanded_url":"http://bit.ly/1rSz7PP","display_url":"bit.ly/1rSz7PP"}],"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":60,"end":78,"tag":"AdvancedTherapies"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the #minutes of our September Committee for #AdvancedTherapies (CAT) meeting: http://t.co/6UB4sH7BJB","source":"Twitter Web Client","id":"540081189227593728","lang":"en","created_at":"2014-12-03T09:52:44.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540080724955910144","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"EUnetHTA","id":"56493220"}],"urls":[{"start":91,"end":113,"url":"http://t.co/NNFUwMeIwu","expanded_url":"http://www.eunethta.eu/news/all-material-and-documents-hta-20-europe-conference-now-available","display_url":"eunethta.eu/news/all-mater…"}],"hashtags":[{"start":114,"end":126,"tag":"HTA2014Rome"}],"annotations":[{"start":48,"end":72,"probability":0.1141,"type":"Other","normalized_text":"HTA 2.0 Europe conference"}]},"possibly_sensitive":false,"text":"RT @EUnetHTA: All material &amp; documents from the HTA 2.0 Europe conference is available http://t.co/NNFUwMeIwu #HTA2014Rome","source":"TweetDeck","id":"540080724955910144","lang":"en","created_at":"2014-12-03T09:50:53.000Z","referenced_tweets":[{"type":"retweeted","id":"540080152303374336"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540080708996579328","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":66,"end":88,"url":"http://t.co/S0tYXscs5s","expanded_url":"http://www.who.int/mediacentre/news/releases/2014/preventing-cervical-cancer/en/","display_url":"who.int/mediacentre/ne…"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @GCessak: New WHO guide to prevent and control cervical cancer http://t.co/S0tYXscs5s","source":"TweetDeck","id":"540080708996579328","lang":"en","created_at":"2014-12-03T09:50:49.000Z","referenced_tweets":[{"type":"retweeted","id":"540080123928911872"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540080669935017984","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"EUnetHTA","id":"56493220"}],"urls":[{"start":92,"end":114,"url":"http://t.co/oYrpDBI7aG","expanded_url":"http://www.eunethta.eu/news/public-consultation-hta-core-model-version-21","display_url":"eunethta.eu/news/public-co…"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @EUnetHTA: Deadline extension for Public Consultation of the HTA Core Model version 2.1: http://t.co/oYrpDBI7aG","source":"TweetDeck","id":"540080669935017984","lang":"en","created_at":"2014-12-03T09:50:40.000Z","referenced_tweets":[{"type":"retweeted","id":"540079337303982080"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540080285405421569","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"hashtags":[{"start":75,"end":86,"tag":"carbapenem"},{"start":116,"end":121,"tag":"MRSA"},{"start":122,"end":128,"tag":"CDiff"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @ECDC_EU: National/intl guidance on infection prevention&amp;control of #carbapenem-resistant Enterobacteriaceae #MRSA #CDiff http://t.co/kt…","source":"TweetDeck","id":"540080285405421569","lang":"en","created_at":"2014-12-03T09:49:08.000Z","referenced_tweets":[{"type":"retweeted","id":"540073011550769153"}],"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540080275007766528","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"urls":{},"hashtags":[{"start":75,"end":86,"tag":"carbapenem"},{"start":116,"end":121,"tag":"MRSA"},{"start":122,"end":128,"tag":"CDiff"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EAAD_EU: National/intl guidance on infection prevention&amp;control of #carbapenem-resistant Enterobacteriaceae #MRSA #CDiff http://t.co/6z…","source":"TweetDeck","id":"540080275007766528","lang":"en","created_at":"2014-12-03T09:49:06.000Z","referenced_tweets":[{"type":"retweeted","id":"540072982958190592"}],"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540080075425992704","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"kardamyla","id":"59722141"},{"start":15,"end":24,"username":"EMA_News","id":"116716199"}],"urls":[{"start":93,"end":115,"url":"http://t.co/a6DVdEqPo2","expanded_url":"http://www.rarediseasematters.org/2014/12/regulators-move-patient-engagement-to-the-next-level-benefit-risk-assessment/","display_url":"rarediseasematters.org/2014/12/regula…"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @kardamyla: @EMA_News The EMA engages with patients in a professional and thorough manner http://t.co/a6DVdEqPo2","source":"TweetDeck","id":"540080075425992704","lang":"en","created_at":"2014-12-03T09:48:18.000Z","referenced_tweets":[{"type":"retweeted","id":"540071339273359360"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540079848002424832","author_id":"116716199","entities":{"mentions":[{"start":3,"end":14,"username":"luca__pani","id":"2176193576"}],"urls":[{"start":115,"end":137,"url":"http://t.co/LfNr8FY2M4","expanded_url":"http://bit.ly/1w1ITAF","display_url":"bit.ly/1w1ITAF"}],"hashtags":[{"start":71,"end":81,"tag":"pregnancy"},{"start":82,"end":87,"tag":"read"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @luca__pani: CMDh reinforces recommendations on use of valproate in #pregnancy #read | Italian medicines agency http://t.co/LfNr8FY2M4","source":"TweetDeck","id":"540079848002424832","lang":"en","created_at":"2014-12-03T09:47:24.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540078955894943744","author_id":"116716199","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":104,"end":126,"url":"http://t.co/KS4uYbNzcT","expanded_url":"http://goo.gl/VvUoOO","display_url":"goo.gl/VvUoOO"}],"hashtags":[{"start":127,"end":131,"tag":"HPV"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @WHO: New guidance: Vaccinate 9 to 13-year-old girls with two doses of human papilloma virus vaccine http://t.co/KS4uYbNzcT #HPV","source":"TweetDeck","id":"540078955894943744","lang":"en","created_at":"2014-12-03T09:43:51.000Z","referenced_tweets":[{"type":"retweeted","id":"540068703694368768"}],"public_metrics":{"retweet_count":168,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540078896784637952","author_id":"116716199","entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"urls":[{"start":116,"end":138,"url":"http://t.co/kK9lLaUqEQ","expanded_url":"http://goo.gl/4jJoSi","display_url":"goo.gl/4jJoSi"}],"hashtags":[{"start":33,"end":41,"tag":"webinar"},{"start":58,"end":67,"tag":"Clinical"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @DrugInfoAssn: Don't miss our #webinar - What's New in #Clinical Trials Regulation? Overview of the key changes. http://t.co/kK9lLaUqEQ","source":"TweetDeck","id":"540078896784637952","lang":"en","created_at":"2014-12-03T09:43:37.000Z","referenced_tweets":[{"type":"retweeted","id":"540068295060508672"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"540078114182033408","author_id":"116716199","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":64,"end":86,"url":"http://t.co/sjtJ8hZ6g1","expanded_url":"http://goo.gl/0Axmva","display_url":"goo.gl/0Axmva"}],"hashtags":[{"start":46,"end":55,"tag":"cervical"},{"start":56,"end":63,"tag":"cancer"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @WHO: New WHO guide to prevent and control #cervical #cancer http://t.co/sjtJ8hZ6g1","source":"TweetDeck","id":"540078114182033408","lang":"en","created_at":"2014-12-03T09:40:31.000Z","referenced_tweets":[{"type":"retweeted","id":"540065723104518144"}],"public_metrics":{"retweet_count":115,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539845352271405056","author_id":"116716199","entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":99,"end":121,"url":"http://t.co/fBxpzj3B9b","expanded_url":"http://bit.ly/1yDTVdo","display_url":"bit.ly/1yDTVdo"}],"hashtags":[{"start":10,"end":15,"tag":"ANSM"},{"start":26,"end":41,"tag":"clinicaltrials"},{"start":45,"end":52,"tag":"cancer"},{"start":62,"end":70,"tag":"genomic"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @ansm: #ANSM report on #clinicaltrials in #cancer based on #genomic characteristics of tumours: http://t.co/fBxpzj3B9b","source":"TweetDeck","id":"539845352271405056","lang":"en","created_at":"2014-12-02T18:15:36.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539844856290742272","author_id":"116716199","entities":{"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"urls":{},"hashtags":[{"start":32,"end":39,"tag":"GMDP14"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @MHRAmedicines: Download the #GMDP14 symposium app to network with other delegates and keep updated with info on the venue and agenda ht…","source":"TweetDeck","id":"539844856290742272","lang":"en","created_at":"2014-12-02T18:13:38.000Z","referenced_tweets":[{"type":"retweeted","id":"539837969243602946"}],"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539844805590003712","author_id":"116716199","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":51,"end":66,"username":"CPathInstitute","id":"861749209"}],"urls":[{"start":121,"end":143,"url":"http://t.co/1yGukiMI1K","expanded_url":"http://bit.ly/1zL2CBW","display_url":"bit.ly/1zL2CBW"}],"hashtags":[{"start":70,"end":75,"tag":"PPPs"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @IMI_JU: Can’t make it to tomorrow’s event with @CPathInstitute on #PPPs &amp; drug development? Follow it online via http://t.co/1yGukiMI1K","source":"TweetDeck","id":"539844805590003712","lang":"en","created_at":"2014-12-02T18:13:26.000Z","referenced_tweets":[{"type":"retweeted","id":"539842167515394048"}],"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539817645210873856","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":87,"end":109,"url":"http://t.co/xvjz1NzIlP","expanded_url":"http://bit.ly/15NMtmj","display_url":"bit.ly/15NMtmj"}],"hashtags":[{"start":20,"end":28,"tag":"minutes"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the #minutes of our committee for advanced therapies (CAT) in October: http://t.co/xvjz1NzIlP","source":"Bitly","id":"539817645210873856","lang":"en","created_at":"2014-12-02T16:25:30.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539817416298360834","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":89,"end":111,"url":"http://t.co/6UB4sH7BJB","expanded_url":"http://bit.ly/1rSz7PP","display_url":"bit.ly/1rSz7PP"}],"hashtags":[{"start":20,"end":28,"tag":"minutes"}],"annotations":{}},"possibly_sensitive":false,"text":"We've published the #minutes of our committee for advanced therapies (CAT) in September: http://t.co/6UB4sH7BJB","source":"Bitly","id":"539817416298360834","lang":"en","created_at":"2014-12-02T16:24:36.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539813705442402304","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"},{"start":104,"end":110,"username":"EDCTP","id":"125985779"}],"urls":[{"start":113,"end":135,"url":"http://t.co/SKulRnDIlg","expanded_url":"http://dlvr.it/7hwtcP","display_url":"dlvr.it/7hwtcP"}],"hashtags":[{"start":14,"end":21,"tag":"Europe"},{"start":26,"end":33,"tag":"Africa"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EU_H2020: #Europe and #Africa tackle infectious diseases with a €2 billion joint research programme @EDCTP 2 http://t.co/SKulRnDIlg #gl…","source":"TweetDeck","id":"539813705442402304","lang":"en","created_at":"2014-12-02T16:09:51.000Z","referenced_tweets":[{"type":"retweeted","id":"539811492208844800"}],"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539792754692587520","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":{},"hashtags":[{"start":108,"end":120,"tag":"statistical"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EFSA_EU: How to make EFSA scientific outputs easier to understand and reproduce? New guidance for smart #statistical reporting http://t…","source":"TweetDeck","id":"539792754692587520","lang":"en","created_at":"2014-12-02T14:46:36.000Z","referenced_tweets":[{"type":"retweeted","id":"539748309347631104"}],"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539792687587950592","author_id":"116716199","entities":{"mentions":[{"start":3,"end":18,"username":"ECDC_Outbreaks","id":"2754484003"}],"urls":{},"hashtags":[{"start":53,"end":61,"tag":"measles"},{"start":123,"end":128,"tag":"CDTR"}],"annotations":[{"start":102,"end":109,"probability":0.9969,"type":"Place","normalized_text":"Slovenia"}]},"possibly_sensitive":false,"text":"RT @ECDC_Outbreaks: In 2014, 7 EU countries reported #measles outbreaks. New outbreak now reported in Slovenia. See latest #CDTR: http://t.…","source":"TweetDeck","id":"539792687587950592","lang":"en","created_at":"2014-12-02T14:46:20.000Z","referenced_tweets":[{"type":"retweeted","id":"539751431205826560"}],"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539792570831081472","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":107,"end":129,"url":"http://t.co/RhHA6YStgg","expanded_url":"http://bit.ly/1vLA62p","display_url":"bit.ly/1vLA62p"}],"hashtags":{},"annotations":[{"start":13,"end":18,"probability":0.9798,"type":"Place","normalized_text":"Europe"},{"start":24,"end":29,"probability":0.9375,"type":"Place","normalized_text":"Africa"}]},"possibly_sensitive":false,"text":"RT @ECDC_EU: Europe and Africa double research efforts to tackle AIDS, Ebola and other infectious diseases http://t.co/RhHA6YStgg","source":"TweetDeck","id":"539792570831081472","lang":"en","created_at":"2014-12-02T14:45:52.000Z","referenced_tweets":[{"type":"retweeted","id":"539766669066133504"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539792462592872448","author_id":"116716199","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":{},"hashtags":[{"start":34,"end":54,"tag":"EuropeanLeadFactory"}],"annotations":[{"start":116,"end":121,"probability":0.9937,"type":"Place","normalized_text":"London"}]},"possibly_sensitive":false,"text":"RT @IMI_JU: Want to learn how our #EuropeanLeadFactory project can advance your drug development work? Meet them in London, 10/12 http://t.…","source":"TweetDeck","id":"539792462592872448","lang":"en","created_at":"2014-12-02T14:45:26.000Z","referenced_tweets":[{"type":"retweeted","id":"539769672871448576"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539792394997477378","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":76,"end":81,"tag":"EDQM"},{"start":99,"end":118,"tag":"referencestandards"}],"annotations":[{"start":15,"end":23,"probability":0.9438,"type":"Other","normalized_text":"Christmas"}]},"possibly_sensitive":false,"text":"RT @edqm_news: Christmas closure: Don't miss the deadlines for shipments of #EDQM publications and #referencestandards http://t.co/JJ7MJKHp…","source":"TweetDeck","id":"539792394997477378","lang":"en","created_at":"2014-12-02T14:45:10.000Z","referenced_tweets":[{"type":"retweeted","id":"539771657188278272"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539792382385213441","author_id":"116716199","entities":{"mentions":[{"start":3,"end":18,"username":"medicinesmalta","id":"357784930"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @medicinesmalta: Working with all stakeholders for the benefit of consumers and patients! Read the latest press release on the... http:/…","source":"TweetDeck","id":"539792382385213441","lang":"en","created_at":"2014-12-02T14:45:07.000Z","referenced_tweets":[{"type":"retweeted","id":"539771754680705025"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539792342178607104","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"EU_OSHA","id":"23600999"}],"urls":{},"hashtags":[{"start":13,"end":20,"tag":"FOHNEU"},{"start":39,"end":52,"tag":"Occupational"},{"start":76,"end":91,"tag":"EUmanagestress"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EU_OSHA: #FOHNEU The Federation of #Occupational Health Nurses promotes #EUmanagestress campaign on the front line: http://t.co/C5xQnt1…","source":"TweetDeck","id":"539792342178607104","lang":"en","created_at":"2014-12-02T14:44:57.000Z","referenced_tweets":[{"type":"retweeted","id":"539772286593953792"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539792306745122816","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":[{"start":94,"end":116,"url":"http://t.co/SjggQKB57Z","expanded_url":"http://go.usa.gov/6xvV","display_url":"go.usa.gov/6xvV"}],"hashtags":{},"annotations":[{"start":47,"end":91,"probability":0.4801,"type":"Organization","normalized_text":"FDA Blood Products Advisory Committee Meeting"}]},"possibly_sensitive":false,"text":"RT @FDACBER: Watch today’s live webcast of the FDA Blood Products Advisory Committee Meeting. http://t.co/SjggQKB57Z","source":"TweetDeck","id":"539792306745122816","lang":"en","created_at":"2014-12-02T14:44:49.000Z","referenced_tweets":[{"type":"retweeted","id":"539773528019443712"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539792153548161024","author_id":"116716199","entities":{"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"urls":[{"start":114,"end":136,"url":"http://t.co/jI0ABD2Dfc","expanded_url":"http://bit.ly/1w0PaMl","display_url":"bit.ly/1w0PaMl"}],"hashtags":[{"start":44,"end":52,"tag":"cancers"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @WHO_Europe: Globally, the proportion of #cancers related to obesity is higher in women (5.3%) than men (1.9%) http://t.co/jI0ABD2Dfc","source":"TweetDeck","id":"539792153548161024","lang":"en","created_at":"2014-12-02T14:44:12.000Z","referenced_tweets":[{"type":"retweeted","id":"539780395974549504"}],"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539792096065224705","author_id":"116716199","entities":{"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"}],"urls":[{"start":43,"end":65,"url":"http://t.co/73Ew9B41iC","expanded_url":"http://bit.ly/1FKVmtH","display_url":"bit.ly/1FKVmtH"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @IAPOtweets: Our newsletter is out now! http://t.co/73Ew9B41iC","source":"TweetDeck","id":"539792096065224705","lang":"en","created_at":"2014-12-02T14:43:59.000Z","referenced_tweets":[{"type":"retweeted","id":"539781609013383168"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539792034484486144","author_id":"116716199","entities":{"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"},{"start":17,"end":21,"username":"WHO","id":"14499829"}],"urls":[{"start":72,"end":94,"url":"http://t.co/teQofmKtkq","expanded_url":"http://bit.ly/1HUQZOz","display_url":"bit.ly/1HUQZOz"}],"hashtags":[{"start":52,"end":58,"tag":"Ebola"}],"annotations":[{"start":36,"end":40,"probability":0.9847,"type":"Place","normalized_text":"Spain"}]},"possibly_sensitive":false,"text":"RT @WHO_Europe: .@WHO congratulates Spain on ending #Ebola transmission http://t.co/teQofmKtkq","source":"TweetDeck","id":"539792034484486144","lang":"en","created_at":"2014-12-02T14:43:44.000Z","referenced_tweets":[{"type":"retweeted","id":"539784044700246016"}],"public_metrics":{"retweet_count":24,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539792012661510144","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"},{"start":55,"end":64,"username":"Anses_fr","id":"1108628533"}],"urls":{},"hashtags":[{"start":93,"end":104,"tag":"pesticides"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EFSA_EU: Science has no borders. Video on EFSA and @Anses_fr joint conference discussing #pesticides exposure. Find out more http://t.c…","source":"TweetDeck","id":"539792012661510144","lang":"en","created_at":"2014-12-02T14:43:39.000Z","referenced_tweets":[{"type":"retweeted","id":"539784338658045952"}],"public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539790787689848832","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":99,"end":121,"url":"http://t.co/qUQmhmcmOd","expanded_url":"http://bit.ly/1v551TB","display_url":"bit.ly/1v551TB"}],"hashtags":{},"annotations":[{"start":72,"end":96,"probability":0.5552,"type":"Organization","normalized_text":"EU Civil Service Tribunal"}]},"possibly_sensitive":false,"text":"Our Management Board has discussed next steps after the judgment of the EU Civil Service Tribunal: http://t.co/qUQmhmcmOd","source":"TweetDeck","id":"539790787689848832","lang":"en","created_at":"2014-12-02T14:38:47.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539469663609294848","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/qUQmhmcmOd","expanded_url":"http://bit.ly/1v551TB","display_url":"bit.ly/1v551TB"}],"hashtags":{},"annotations":[{"start":76,"end":100,"probability":0.5557,"type":"Organization","normalized_text":"EU Civil Service Tribunal"}]},"possibly_sensitive":false,"text":"Our Management Board has discussed the next steps after the judgment of the EU Civil Service Tribunal: http://t.co/qUQmhmcmOd","source":"Bitly","id":"539469663609294848","lang":"en","created_at":"2014-12-01T17:22:45.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539469324701151232","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":112,"end":134,"url":"http://t.co/e50dSg7AoX","expanded_url":"http://europa.eu/rapid/press-release_STATEMENT-14-2185_en.htm","display_url":"europa.eu/rapid/press-re…"}],"hashtags":{},"annotations":[{"start":57,"end":59,"probability":0.6537,"type":"Other","normalized_text":"HIV"},{"start":64,"end":69,"probability":0.9915,"type":"Place","normalized_text":"Europe"}]},"possibly_sensitive":false,"text":"RT @EUlondonrep: Last year 29k people were infected with HIV in Europe. Commission works to tackle the problem. http://t.co/e50dSg7AoX #wor…","source":"TweetDeck","id":"539469324701151232","lang":"en","created_at":"2014-12-01T17:21:24.000Z","referenced_tweets":[{"type":"retweeted","id":"539463680652742656"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539468999835516928","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"beuctweet","id":"3061421219"},{"start":16,"end":20,"username":"WHO","id":"14499829"}],"urls":[{"start":116,"end":138,"url":"http://t.co/ZO05xxeH6x","expanded_url":"http://www.newfoodmagazine.com/advent-calendar/antibiotic-resistance-a-major-concern-for-food-safety/#.VHyZAclWh8G","display_url":"newfoodmagazine.com/advent-calenda…"}],"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @beuctweet: .@WHO recalls antibiotic abuse in animals used for food has important consequences for public health http://t.co/ZO05xxeH6x …","source":"TweetDeck","id":"539468999835516928","lang":"en","created_at":"2014-12-01T17:20:07.000Z","referenced_tweets":[{"type":"retweeted","id":"539459356677644288"}],"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539468462301929474","author_id":"116716199","entities":{"mentions":[{"start":3,"end":15,"username":"Europarl_EN","id":"36329597"}],"urls":{},"hashtags":[{"start":33,"end":39,"tag":"Ebola"},{"start":51,"end":61,"tag":"terrorism"},{"start":70,"end":74,"tag":"ACP"},{"start":77,"end":80,"tag":"EU"},{"start":114,"end":125,"tag":"Strasbourg"}],"annotations":[{"start":17,"end":20,"probability":0.3769,"type":"Place","normalized_text":"MEPs"}]},"possibly_sensitive":false,"text":"RT @Europarl_EN: MEPs to discuss #Ebola crisis and #terrorism at 28th #ACP - #EU joint assembly, gets underway in #Strasbourg today: http:/…","source":"TweetDeck","id":"539468462301929474","lang":"en","created_at":"2014-12-01T17:17:58.000Z","referenced_tweets":[{"type":"retweeted","id":"539458914992283649"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539468386833825792","author_id":"116716199","entities":{"mentions":[{"start":3,"end":18,"username":"EUCouncilPress","id":"198618575"}],"urls":[{"start":68,"end":90,"url":"http://t.co/iw1FsLnPjB","expanded_url":"http://ow.ly/F9TVs","display_url":"ow.ly/F9TVs"}],"hashtags":[{"start":44,"end":50,"tag":"EPSCO"},{"start":51,"end":58,"tag":"Health"},{"start":92,"end":104,"tag":"vaccination"},{"start":105,"end":120,"tag":"MedicalDevices"},{"start":121,"end":127,"tag":"Ebola"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EUCouncilPress: Main results of today's #EPSCO #Health Council: http://t.co/iw1FsLnPjB. #vaccination #MedicalDevices #Ebola","source":"TweetDeck","id":"539468386833825792","lang":"en","created_at":"2014-12-01T17:17:40.000Z","referenced_tweets":[{"type":"retweeted","id":"539456370454827009"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539468173004009472","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":[{"start":88,"end":110,"url":"http://t.co/HeOFaZw87K","expanded_url":"http://go.usa.gov/Hu8P","display_url":"go.usa.gov/Hu8P"}],"hashtags":[{"start":74,"end":87,"tag":"WorldAIDSDay"}],"annotations":[{"start":22,"end":35,"probability":0.7256,"type":"Other","normalized_text":"World AIDS Day"},{"start":50,"end":52,"probability":0.5033,"type":"Organization","normalized_text":"FDA"},{"start":64,"end":66,"probability":0.5737,"type":"Other","normalized_text":"HIV"}]},"possibly_sensitive":false,"text":"RT @FDACBER: Today is World AIDS Day. Learn about FDA’s role in HIV/AIDS. #WorldAIDSDay http://t.co/HeOFaZw87K","source":"TweetDeck","id":"539468173004009472","lang":"en","created_at":"2014-12-01T17:16:49.000Z","referenced_tweets":[{"type":"retweeted","id":"539453265008939008"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539467941772009472","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":15,"end":26,"tag":"secondment"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @edqm_news: #secondment EDQM is hiring Programme Officer to support development of a European Formulary for Paediatric Medicines http://…","source":"TweetDeck","id":"539467941772009472","lang":"en","created_at":"2014-12-01T17:15:54.000Z","referenced_tweets":[{"type":"retweeted","id":"539448506130653185"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539446500854878208","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":105,"end":127,"url":"http://t.co/D2iB51h4XI","expanded_url":"http://www.independent.co.uk/news/world/world-aids-day-2014-campaigners-say-world-has-reached-beginning-of-end-of-aids-pandemic-9894572.html","display_url":"independent.co.uk/news/world/wor…"}],"hashtags":{},"annotations":[{"start":13,"end":26,"probability":0.6892,"type":"Other","normalized_text":"World Aids Day"},{"start":90,"end":102,"probability":0.5425,"type":"Other","normalized_text":"Aids pandemic"}]},"possibly_sensitive":false,"text":"RT @GCessak: World Aids Day 2014: Campaigners say world has reached 'beginning of end' of Aids pandemic  http://t.co/D2iB51h4XI","source":"TweetDeck","id":"539446500854878208","lang":"en","created_at":"2014-12-01T15:50:42.000Z","referenced_tweets":[{"type":"retweeted","id":"539445984716406785"}],"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539443972369022977","author_id":"116716199","entities":{"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"urls":[{"start":86,"end":108,"url":"http://t.co/VpoL6EsWcu","expanded_url":"http://www.emcdda.europa.eu/news/2014/hiv-infections","display_url":"emcdda.europa.eu/news/2014/hiv-…"},{"start":109,"end":131,"url":"http://t.co/XNWVTGcisT","expanded_url":"https://twitter.com/EMCDDA/status/539443583447998464/photo/1","display_url":"pic.twitter.com/XNWVTGcisT"}],"hashtags":[{"start":20,"end":24,"tag":"HIV"},{"start":71,"end":84,"tag":"WorldAIDSDay"}],"annotations":[{"start":43,"end":48,"probability":0.9684,"type":"Place","normalized_text":"Europe"}]},"possibly_sensitive":false,"text":"RT @EMCDDA: Gaps in #HIV prevention expose Europe to risk of outbreaks #WorldAIDSDay: http://t.co/VpoL6EsWcu http://t.co/XNWVTGcisT","source":"TweetDeck","id":"539443972369022977","lang":"en","created_at":"2014-12-01T15:40:40.000Z","referenced_tweets":[{"type":"retweeted","id":"539443583447998464"}],"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_539443582604550146"]}},{"conversation_id":"539443882355081217","author_id":"116716199","entities":{"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"urls":[{"start":94,"end":116,"url":"http://t.co/TCZk3rdzTU","expanded_url":"http://ow.ly/F9zKA","display_url":"ow.ly/F9zKA"}],"hashtags":[{"start":117,"end":132,"tag":"MHRAvariations"}],"annotations":[{"start":42,"end":74,"probability":0.635,"type":"Organization","normalized_text":"Composite Coordinated Collections"}]},"possibly_sensitive":false,"text":"RT @MHRAmedicines: Come to the seminar on Composite Coordinated Collections (CCCs) 5/6 Feb 15 http://t.co/TCZk3rdzTU #MHRAvariations","source":"TweetDeck","id":"539443882355081217","lang":"en","created_at":"2014-12-01T15:40:18.000Z","referenced_tweets":[{"type":"retweeted","id":"539443203033034752"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539443757842960384","author_id":"116716199","entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":93,"end":115,"url":"http://t.co/bCACkZuMaT","expanded_url":"http://bit.ly/1tDXZ7X","display_url":"bit.ly/1tDXZ7X"}],"hashtags":[{"start":40,"end":51,"tag":"Vigilances"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @ansm: Publication of new edition of #Vigilances bulletin by the French medicines agency. http://t.co/bCACkZuMaT","source":"TweetDeck","id":"539443757842960384","lang":"en","created_at":"2014-12-01T15:39:48.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539440656155148288","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"},{"start":23,"end":34,"username":"WHO_Europe","id":"125403342"}],"urls":{},"hashtags":{},"annotations":{}},"possibly_sensitive":false,"text":"RT @EFSA_EU: Tmrw EFSA/@WHO_Europe discuss with stakeholders Threshold of Toxicological Concern in risk assessment of chemicals http://t.co…","source":"TweetDeck","id":"539440656155148288","lang":"en","created_at":"2014-12-01T15:27:29.000Z","referenced_tweets":[{"type":"retweeted","id":"539440250041675776"}],"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539436964291039232","author_id":"116716199","entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":19,"end":41,"url":"http://t.co/FlpJEGsU52","expanded_url":"http://bit.ly/1wcdDhN","display_url":"bit.ly/1wcdDhN"}],"hashtags":[{"start":42,"end":49,"tag":"newjob"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @LV_MPA: Doctor http://t.co/FlpJEGsU52 #newjob","source":"TweetDeck","id":"539436964291039232","lang":"en","created_at":"2014-12-01T15:12:49.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539429912394731521","author_id":"116716199","entities":{"mentions":[{"start":3,"end":16,"username":"ECDC_HIVAIDS","id":"2182569746"}],"urls":{},"hashtags":[{"start":89,"end":93,"tag":"HIV"},{"start":108,"end":121,"tag":"WorldAIDSDay"}],"annotations":[{"start":39,"end":44,"probability":0.9957,"type":"Place","normalized_text":"Europe"}]},"possibly_sensitive":false,"text":"RT @ECDC_HIVAIDS: Did you know that in Europe, sex between men is still the main mode of #HIV transmission? #WorldAIDSDay http://t.co/zzf4M…","source":"TweetDeck","id":"539429912394731521","lang":"en","created_at":"2014-12-01T14:44:47.000Z","referenced_tweets":[{"type":"retweeted","id":"539429736632827904"}],"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539428346762133504","author_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"FDAWomen","id":"65416742"}],"urls":[{"start":88,"end":110,"url":"http://t.co/IBHfGdyYeN","expanded_url":"http://ow.ly/EWOGU","display_url":"ow.ly/EWOGU"}],"hashtags":[{"start":35,"end":46,"tag":"biomarkers"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @FDAWomen: Learn more about how #biomarkers can help innovation in drug development: http://t.co/IBHfGdyYeN","source":"TweetDeck","id":"539428346762133504","lang":"en","created_at":"2014-12-01T14:38:34.000Z","referenced_tweets":[{"type":"retweeted","id":"539424990761091072"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539421967917801473","author_id":"116716199","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":88,"end":110,"url":"http://t.co/uONprm1K7o","expanded_url":"http://goo.gl/XgOQz0","display_url":"goo.gl/XgOQz0"}],"hashtags":{},"annotations":[{"start":40,"end":46,"probability":0.5568,"type":"Product","normalized_text":"Twitter"},{"start":72,"end":74,"probability":0.58,"type":"Other","normalized_text":"HIV"}]},"possibly_sensitive":false,"text":"RT @WHO: Thank you for joining our AIDS Twitter chat. WHO Guidelines on HIV drugs here: http://t.co/uONprm1K7o","source":"TweetDeck","id":"539421967917801473","lang":"en","created_at":"2014-12-01T14:13:13.000Z","referenced_tweets":[{"type":"retweeted","id":"539421113101852672"}],"public_metrics":{"retweet_count":87,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539421876682907649","author_id":"116716199","entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":{},"hashtags":[{"start":15,"end":28,"tag":"WorldAIDSDay"},{"start":37,"end":41,"tag":"HIV"},{"start":43,"end":48,"tag":"AIDS"}],"annotations":[{"start":58,"end":59,"probability":0.6294,"type":"Place","normalized_text":"EU"}]},"possibly_sensitive":false,"text":"RT @EU_Health: #WorldAIDSDay: unlike #HIV, #AIDS cases in EU declined from 2.1 / 100 000 population in 2004 to 0.9 in 2013 http://t.co/Oguu…","source":"TweetDeck","id":"539421876682907649","lang":"en","created_at":"2014-12-01T14:12:52.000Z","referenced_tweets":[{"type":"retweeted","id":"539419794643357696"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539421615709499393","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"urls":{},"hashtags":[{"start":64,"end":75,"tag":"carbapenem"},{"start":105,"end":110,"tag":"MRSA"},{"start":111,"end":117,"tag":"CDiff"},{"start":119,"end":124,"tag":"EAAD"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @EAAD_EU: What measures to prevent and control infections by #carbapenem-resistant Enterobacteriaceae #MRSA #CDiff? #EAAD http://t.co/6z…","source":"TweetDeck","id":"539421615709499393","lang":"en","created_at":"2014-12-01T14:11:49.000Z","referenced_tweets":[{"type":"retweeted","id":"539418739523850241"}],"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539414412244049920","author_id":"116716199","entities":{"mentions":{},"urls":[{"start":106,"end":128,"url":"http://t.co/1W32GtTZDH","expanded_url":"http://bit.ly/11HRWZM","display_url":"bit.ly/11HRWZM"}],"hashtags":[{"start":49,"end":56,"tag":"herbal"},{"start":70,"end":79,"tag":"Capsicum"}],"annotations":{}},"possibly_sensitive":false,"text":"Two more weeks to comment on our draft Community #herbal monograph on #Capsicum annuum and C. frutescens: http://t.co/1W32GtTZDH","source":"Twitter Web Client","id":"539414412244049920","lang":"en","created_at":"2014-12-01T13:43:12.000Z","referenced_tweets":{},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539414135889739777","author_id":"116716199","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":{},"hashtags":[{"start":109,"end":114,"tag":"AIDS"},{"start":115,"end":128,"tag":"WorldAIDSDay"}],"annotations":[{"start":20,"end":33,"probability":0.8157,"type":"Other","normalized_text":"World Aids Day"}]},"possibly_sensitive":false,"text":"RT @EFPIA: Today is World Aids Day- Campaigners say fight against the virus is at the “Beginning of the end” #AIDS #WorldAIDSDay\nhttp://t.c…","source":"TweetDeck","id":"539414135889739777","lang":"en","created_at":"2014-12-01T13:42:06.000Z","referenced_tweets":[{"type":"retweeted","id":"539412738091798528"}],"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539413589887434753","author_id":"116716199","entities":{"mentions":[{"start":3,"end":14,"username":"eurogender","id":"146793059"},{"start":129,"end":133,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":[{"start":38,"end":42,"tag":"HIV"},{"start":101,"end":106,"tag":"AIDS"}],"annotations":[{"start":93,"end":95,"probability":0.6542,"type":"Other","normalized_text":"HIV"}]},"possibly_sensitive":false,"text":"RT @eurogender: Almost half a million #HIV diagnoses reported in the EU/EEA. 70% living with HIV and #AIDS are men and 30% women @WHO #AIDS…","source":"TweetDeck","id":"539413589887434753","lang":"en","created_at":"2014-12-01T13:39:56.000Z","referenced_tweets":[{"type":"retweeted","id":"539404693588688896"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539413552550117376","author_id":"116716199","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":[{"start":75,"end":82,"tag":"AskWHO"}],"annotations":[{"start":20,"end":39,"probability":0.9896,"type":"Person","normalized_text":"Gottfried Hirnschall"},{"start":57,"end":63,"probability":0.6085,"type":"Product","normalized_text":"Twitter"}]},"possibly_sensitive":false,"text":"RT @WHO: WHO expert Gottfried Hirnschall has opened AIDS Twitter chat. Use #AskWHO to send us your questions","source":"TweetDeck","id":"539413552550117376","lang":"en","created_at":"2014-12-01T13:39:47.000Z","referenced_tweets":[{"type":"retweeted","id":"539404031798808576"}],"public_metrics":{"retweet_count":56,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539412729027887106","author_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"hashtags":[{"start":13,"end":26,"tag":"WorldAIDSDay"},{"start":28,"end":32,"tag":"ART"},{"start":74,"end":79,"tag":"AIDS"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @ECDC_EU: #WorldAIDSDay: #ART had a strong effect on delaying onset of #AIDS and related deaths have declined significantly http://t.co/…","source":"TweetDeck","id":"539412729027887106","lang":"en","created_at":"2014-12-01T13:36:31.000Z","referenced_tweets":[{"type":"retweeted","id":"539390474851983363"}],"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}},{"conversation_id":"539412500757098496","author_id":"116716199","entities":{"mentions":[{"start":3,"end":16,"username":"ECDC_HIVAIDS","id":"2182569746"}],"urls":[{"start":116,"end":138,"url":"http://t.co/R0JiMAFUbl","expanded_url":"http://bit.ly/15Mkund","display_url":"bit.ly/15Mkund"}],"hashtags":[{"start":18,"end":31,"tag":"WorldAIDSDay"},{"start":78,"end":82,"tag":"ART"}],"annotations":{}},"possibly_sensitive":false,"text":"RT @ECDC_HIVAIDS: #WorldAIDSDay: in 29 European countries,number of people on #ART nearly doubled from 2009 to 2013 http://t.co/R0JiMAFUbl","source":"TweetDeck","id":"539412500757098496","lang":"en","created_at":"2014-12-01T13:35:36.000Z","referenced_tweets":[{"type":"retweeted","id":"539386023919493120"}],"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{}}}]
